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Immunity
Abstract
The gastrointestinal tract is replete with commensal microbes and dietary nutrients that provide
homeostatic signals. Antigen presenting dendritic cells (DC) residing in the underlying lamina propria (Lp)
respond to these signals; however, how they contribute to intestinal T cell homeostasis is unclear. In
Chapter 2, LpDC are revealed to uniquely induce naïve T cell differentiation into the Foxp3+ regulatory T
cell (Treg) subset. Further, the molecular mechanisms controlling this capacity both in vitro and in vivo are
shown to hinge on the vitamin A metabolite, retinoic acid (RA), which LpDC are equipped to synthesize,
and the cytokine, TGF-beta. T cell expression of retinoic acid receptor alpha (RARalpha) is shown to be
critical for RA to induce enhanced Foxp3+ Treg induction. Chapter 3 extends upon these findings and
addresses the influence of the commensal microbiota in the regulation of this pathway. A Toll like
receptor (TLR) 9 ligand, commensal derived DNA, is identified as a potent adjuvant in the gut mucosa,
which shapes T cell homeostasis in the GI tract. Accordingly Tlr9–⁄– mice display an intestinal sitespecific increase in Foxp3+Treg concomitant with a decrease in TH cells. Dysregulation in Foxp3+ Treg/
TH homeostasis results in mucosal-specific impaired immune responses in Tlr9–⁄– animals, which can
be reversed upon partial depletion of Foxp3+ Treg. Chapter 4 builds upon findings from Chapter 2. The
role of vitamin A metabolism in the regulation of mucosal immunity is examined. Vitamin A insufficient
(VAI) mice, which lack vitamin A and metabolic derivatives, mount impaired mucosal TH-1 and TH-17
responses. These defects are reversed upon administration of RA. Moreover, Rara–⁄– mice recapitulate
the homeostatic and immune defects observed in VAI mice. Strikingly, loss of basal RA/RARalpha
signaling hinders early T cell activation events. Cumulatively, the data argue that steady-state cues from
microbiota and nutrients shape the inflammatory tone of the Lp to prime mucosal TH responses. These
data also identify a fundamental role for vitamin A metabolism in T cell activation and suggest this
pathway may have evolved with the development of adaptive CD4+ T cell responses to coordinate host
protection.
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Abstract	
  
Vitamin A metabolism and commensal stimulation in the promotion of mucosal immunity
Jason A. Hall
Yasmine Belkaid

The gastrointestinal tract is replete with commensal microbes and dietary
nutrients that provide homeostatic signals. Antigen presenting dendritic cells (DC)
residing in the underlying lamina propria (Lp) respond to these signals; however, how
they contribute to intestinal T cell homeostasis is unclear. In Chapter 2, LpDC are
revealed to uniquely induce naïve T cell differentiation into the Foxp3+ regulatory T cell
(Treg) subset. Further, the molecular mechanisms controlling this capacity both in vitro
and in vivo are shown to hinge on the vitamin A metabolite, retinoic acid (RA), which
LpDC are equipped to synthesize, and the cytokine, TGF-β. T cell expression of retinoic
acid receptor alpha (RARα) is shown to be critical for RA to induce enhanced Foxp3+
Treg induction. Chapter 3 extends upon these findings and addresses the influence of the
commensal microbiota in the regulation of this pathway. A Toll like receptor (TLR) 9
ligand, commensal derived DNA, is identified as a potent adjuvant in the gut mucosa,
which shapes T cell homeostasis in the GI tract. Accordingly Tlr9–⁄– mice display an
intestinal site-specific increase in Foxp3+ Treg concomitant with a decrease in TH cells.
Dysregulation in Foxp3+ Treg/TH homeostasis results in mucosal-specific impaired
immune responses in Tlr9–⁄– animals, which can be reversed upon partial depletion of
Foxp3+ Treg. Chapter 4 builds upon findings from Chapter 2. The role of vitamin A
metabolism in the regulation of mucosal immunity is examined. Vitamin A insufficient
(VAI) mice, which lack vitamin A and metabolic derivatives, mount impaired mucosal TH-
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1 and TH-17 responses. These defects are reversed upon administration of RA.
Moreover, Rara–⁄– mice recapitulate the homeostatic and immune defects observed in
VAI mice. Strikingly, loss of basal RA/RARα signaling hinders early T cell activation
events. Cumulatively, the data argue that steady-state cues from microbiota and
nutrients shape the inflammatory tone of the Lp to prime mucosal TH responses. These
data also identify a fundamental role for vitamin A metabolism in T cell activation and
suggest this pathway may have evolved with the development of adaptive CD4+ T cell
responses to coordinate host protection.
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CHAPTER	
  1:	
  Intestinal	
  immune	
  homeostasis:	
  influential	
  contributions	
  by	
  
the	
  commensal	
  microbiota	
  and	
  vitamin	
  A	
  metabolism	
  	
  
The	
  intestinal	
  microbiota	
  establishes	
  a	
  commensal	
  relationship	
  with	
  the	
  
host	
  
The mucosal surfaces are comprised of the oronasopharyngeal, urogenital, and
gastrointestinal tracts and serve as the primary interface between the outside
environment and the body. Although they are opportunistic sites for pathogen entry, they
are also home to a dense array of microbial populations. The total number of these
microorganisms exceeds the number of cells in the body by at least an order of
magnitude (Garrett et al.). Far from bystanders, these microorganisms typically forge a
commensal relationship with the host. Nowhere is this more apparent than in the
gastrointestinal tract, which contains, by far, the densest microbial niche in the body.
Studies using germ-free or gnotobiotic, as well as, antibiotic treated animals have
highlighted the crucial role of the microbiota in the regulation of a broad range of
processes, which include: 1) Metabolism via degradation of otherwise indigestible
products and nutrient absorption (Hooper and Gordon, 2001; Hooper et al., 2002). 2)
Intestinal tissue development via the elaboration of underlying microvasculature and
isolated lymphoid follicles, respectively (Bouskra et al., 2008; Stappenbeck et al., 2002).
3) Intestinal tissue repair and maintenance via regulation of growth factor expressing
cells (Brown et al., 2007; Rakoff-Nahoum et al., 2004). 4) Immunity via growth and
proper development of secondary lymphoid tissue (Pollard and Sharon, 1970;
Stepankova et al., 1980). 5) Protection against opportunistic microbial invasion via
elicitation of microbicidal proteins from epithelial cells, most prominently, Paneth cells,
which reside at the base of intestinal crypts (Vaishnava et al., 2008); (Brandl et al.,
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2008). Release of these microbicidal proteins also regulates the composition of the
commensal microbiota under steady-state conditions (Salzman et al.).

Despite the plethora of benefits conferred onto the host by the presence commensal
microbiota, itʼs important to bear in mind that its compartmentalization is central to
maintaining a long-term advantage to the host, with impairments provoking an immunological
imbalance that can drive aberrant local immune responses, such as inflammatory bowel
disease (Nenci et al., 2007), and in other instances, distal or even systemic immune
responses, the most extreme example being sepsis (Cohen, 2002).

While the commensal barrier is maintained, in part, through goblet cell secretion of
an overlaying mucus layer and a dynamic and resilient epithelial layer (Johansson et al.,
2008; Turner, 2009), other cell populations interdigitated within or beneath this barrier also
play an essential role. These populations, which include cells of both the innate and adaptive
arms of immunity, have evolved in close association with the commensals and in contact
with their stimulatory ligands. Consequently, immune cells protecting this region, and by
extension other mucosal sites, have acquired specialized functions to facilitate coexistence
with the commensals, while maintaining the capacity to induce a potent immune response in
the event of a pathogenic encounter. The execution of these dichotomous functions also
contributes to the commensal composition, which is a critical factor in the establishment and
maintenance of intestinal immune homeostasis (Fagarasan et al., 2002; Garrett et al.;
Garrett et al., 2007).

In addition to aberrant immune reactivity against the commensals, aberrant reactivity
against dietary antigen also poses a substantial risk to intestinal immune homeostasis and
can promote a variety of outcomes, ranging from tissue destruction in the case of celiac
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disease to immunoglobulin E mediated anaphylaxis in the case of peanut allergy (Izcue et
al., 2006; Jabri and Ebert, 2007; Li et al., 2000). Thus, the orchestration of tolerance to foodborne antigen likely hinges on similar, if not, redundant immunological mechanisms with
those that are in place to regulate the presence of commensals.

The seemingly disparate tasks of the immune system protecting the GI tract, then,
are to maintain a state of détente with commensals and food antigens, while retaining the
capacity to mount a swift immune response upon pathogen encounter. Further, this must be
achieved in a manner that avoids grossly jeopardizing host tolerance to commensals and
food antigen. To begin to consider the cells and interactions that are involved in carrying out
these duties it is important to understand the basic anatomy and organization of the GI tract
and its associated lymphoid tissues. For conciseness and simplicity, the description to follow
is intended to provide a framework for considering the complex and dynamic regulation of
immunity in the small intestine. This tissue is of primary focus in the research to be described
herein.

The	
  intestinal	
  immune	
  system	
  is	
  composed	
  of	
  inductive	
  and	
  effector	
  sites	
  
Broadly, the immune system of the gastrointestinal (GI) tract and the associated
lymphoid tissues (GALT) can be separated into inductive sites and effector sites (Figure
1).
I.

Inductive sites, including the mesenteric lymph nodes (mln), which drain
the GI tract, and organized lymphoid aggregates called Peyer’s patches
(Pp). These structures increase in frequency as the density of the
commensal microbiota increases from the proximal duodenum to the
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terminal ileum, underscoring their dependence on interactions with
commensals (Neutra et al., 2001).
II.

Effector sites, which include the intestinal epithelial lymphocyte (IEL)
and lamina propria (Lp) compartments (Mowat, 2003; Newberry and
Lorenz, 2005).

I.	
  Lymphocyte	
  activation	
  in	
  inductive	
  sites	
  
Under steady-state conditions, naive T cells constitutively enter into the Pp and mln from
blood via high endothelial venules (HEV) (Jalkanen et al., 1987). Upon exit from HEVs,
these cells may come into contact with dendritic cells (DC), which have captured and
processed their cognate antigen (Ag) (Bajenoff et al., 2003). Ag is delivered into Pp
usually via microvilli-lacking, specialized epithelial cells, called M cells. Upon trancytosis
or endocytosis, these antigens are captured by DCs residing within the sub-epithelial
dome (Cerutti and Rescigno, 2008). While Ag may also be captured in this manner
within the Lp, upon entry into isolated lymphoid follicles (Jang et al., 2004; VallonEberhard et al., 2006), Ag can also be actively captured by DC that extend protrusions
into the intestinal lumen; however, the physiological importance of this latter mode of
capture remains controversial (Chieppa et al., 2006; Niess and Reinecker, 2005;
Rescigno et al., 2001). Ag-bearing DCs from the Lp, then, migrate via the afferent
lymphatics into the mln, where a cognate T cell potentially lies in wait. Intriguingly, the
subset of LpDC that undergo migration (CD103+) is reportedly different from those
capable of extending processes into the intestinal lumen (CX3CR1+CD103–) (Bogunovic
et al., 2009; Schulz et al., 2009); however, it remains unclear whether CD103+ LpDC are
also capable of this function (Chieppa et al., 2006).
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During activation in the Pp and mln, CD4+ T cells receive signals that result in the
upregulated expression of mucosal homing receptors including the chemokine receptor
CCR9 and the integrin heterodimer, α4β7, which facilitate their migration to and retention
in the Lp (Berlin et al., 1993; Iwata et al., 2004; Johansson-Lindbom et al., 2003; Kunkel
et al., 2000; Mora et al., 2003). Activated CD4+ T cells within Pp can also undergo
directed migration from T cell areas toward B cell areas and, in turn, induce
immunoglobulin A (IgA) class switching in B cells, which then migrate into the Lp to
undergo full differentiation into IgA secreting plasma cells (Allen and Cyster, 2008;
Fagarasan et al.). This process also occurs independently of T cells in situ, specifically
within ILFs (Tsuji et al., 2008). Although they were not investigated in the studies to be
described herein, IgA+ B cells have potent regulatory capacity and shape the luminal
composition of the commensal microbiota (Fagarasan et al., 2002).

II.	
  Lymphocyte	
  organization	
  in	
  effector	
  sites	
  
In spite of their adjacent locations, the IEL and Lp compartments are, in fact,
comprised of quite distinct lymphocyte populations during steady-state. One obvious
distinction is the presence of γδT cells in the IEL, which are largely absent in the Lp
(Bucy et al., 1988; Bucy et al., 1989). These cells were previously shown to promote
intestinal epithelial cell (IEC) survival and maturation via incompletely defined
mechanisms (Chen et al., 2002; Komano et al., 1995). Another striking distinction
between the IEL and Lp is the MHC class restriction of αβ T cells: while most in the IEL
are MHC I or MHC I-like restricted and are CD8+, the majority in the Lp are MHC II
restricted and CD4+ (Bonneville et al., 1988; Chiba et al., 1986; Park et al., 1999).
Nevertheless, MHC II restricted cells, such as Foxp3+ regulatory T cells, are still present
in this compartment and serve important function. The immunological basis for this
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dichotomy has several potential explanations. Notably, CD8+ cells are known to engage
in a vivid dialogue with the IEC barrier and can dispose of infected/damaged IECs via
the release of cytolytic granules without, necessarily, the concomitant release of proinflammatory cytokines (Hayday et al., 2001; Jabri and Ebert, 2007). This feature implies
that these cells are ideal sensors of tissue distress during steady-state conditions.
However, in situations of extreme tissue distress, for instance, upon encounter with an
alimentary allergen or infectious pathogen, resident CD8+ T cells may expand and
become potent producers of pro-inflammatory cytokines (Jabri and Ebert, 2007).
Moreover, such scenarios also foster the activation and recruitment of naive CD8+ αβ T
cells from inductive sites.
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Figure 1. Representation of the intestinal mucosal environment and several of
the important mediators of innate and adaptive immune responses
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LpDC	
  actively	
  sample	
  luminal	
  content:	
  
While one could argue that the primary duty of the IEL compartment is to avoid
direct engagement with antigen, the Lp compartment appears poised for active sampling
of the luminal environment during steady-state conditions. Indeed, the Lp is host to a
sizable population of antigen presenting cells (APC), which include resident
macrophages, as well as CCR7– and CCR7+ resident and migratory DCs, respectively
(Bogunovic et al., 2009; Chirdo et al., 2005; Jang et al., 2006; Johansson-Lindbom et al.,
2005; Mayrhofer et al., 1983; Schulz et al., 2009). Previous studies have shown that
specific subpopulations of CD11c+ MHC II+ cells, which may also encompass
macrophages in this tissue (Denning et al., 2007; Uematsu et al., 2008), are able to
extend balloon-like protrusions into the luminal space (Chieppa et al., 2006; Niess and
Reinecker, 2005). In this regard, the resident CX3CR1+ subpopulation (CCR7– CD103–)
which was the first population characterized to display this property in an intact tissue,
was revealed to readily take up both fluorescently-labeled non-pathogenic bacteria and
food antigen from the intestinal lumen (Niess and Reinecker, 2005; Schulz et al., 2009).
Although migratory CCR7+CD103+ LpDC are less phagocytic than their CX3CR1+CCR7–
counterparts (Brian Kellsall, personal communication), this sub-population was found to
possess inclusions of apoptotic cells, including epithelia, upon transit into the mln
(Huang et al., 2000). It was recently speculated that migratory LpDC also acquire
luminal-captured antigen from resident CX3CR1+CCR7– DC via a mechanism that
remains to be clarified (Rescigno, 2009). Cumulatively, these findings indicate that the
Lp compartment, via resident and migratory APC, constantly surveys the luminal
environment. These processes likely play a significant role in the composition of CD4+ T
cells residing within the Lp.
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APC	
  are	
  influenced	
  by	
  IEC	
  interactions	
  at	
  the	
  barrier	
  interface:	
  
Another element to consider is the effect of the luminal content on the exchange
of information between the IEC and Lp compartment. This conversation is likely
dependent on the sensing of microbial components relayed by pattern recognition
receptors, including: 1) intracellular nucleotide-binding-oligomerisation domains (Nod),
which recognize muramyl dipeptides derived from bacterial cell wall components, and 3)
extracellular and intracellular toll-like receptors (TLR), which recognize an array of
structurally conserved molecules derived from microbes (Garrett et al.; Lavelle et al.).
Nods, in particular Nod2, may influence microbiota composition via constitutive Paneth
cell secretion of antimicrobial peptides (Kobayashi et al., 2005; Petnicki-Ocwieja et al.,
2009). TLRs signal through the adaptor proteins TRIF and/or MyD88 (Yamamoto et al.,
2004). While TLR3 and TLR4 can utilize TRIF, all other TLRs, including TLR4, utilize
MyD88, which is recruited following recognition of: lipopeptides (TLR2/1 and TLR2/6)
peptidoglycans (TLR2), lipopolysaccharides (TLR4), flagellin (TLR5), ssRNA (TLR7/8)
bacterial and viral DNA (TLR9) (Kawai and Akira). Importantly, the localization,
expression, and regulation of each of these TLRs vary in the IEC and, therefore, may
differentially contribute to intestinal immune homeostasis (Artis, 2008). Nevertheless,
using a more encompassing strategy, Germain and colleagues found that the ability of
LpDC to sample the luminal small bowel was dependent on MyD88 signaling in the
epithelia (Chieppa et al., 2006). Thus, the rate at which LpDC sample the luminal
environment is likely tailored to the types of constituents present in the microbiota. As
such, one could imagine this mechanism especially coming into play when compositional
shifts in the commensals occur, such as during infection or inflammation (Finlay and
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Medzhitov, 2007; Heimesaat et al., 2006). Another example of IEC/Lp cross talk is the
influence of IEC secreted thymic stromal lymphopoietin (TSLP). This cytokine inhibits the
capacity of LpDC to induce proinflammatory cytokines (Rimoldi et al., 2005; Zaph et al.,
2007). Notably, the role of the commensal microbiota on the regulation of TSLP
production remains unclear. However, one could speculate that it may inversely
correlate with the pathogenicity of the microbiota.

GALT	
  activated	
  lymphocytes	
  are	
  imprinted	
  to	
  traffic	
  to	
  intestinal	
  effector	
  sites:	
  
A general feature of activation in Pp and mln is T and B lymphocyte upregulation
of α4β7 and CCR9, which equips these cells with the superior capacity to migrate into
intestinal effector tissues (Mora et al., 2008; Sigmundsdottir and Butcher, 2008).
Specifically, α4β7 enables activated lymphocytes to bind to mucosal vascular addressin
cell-adhesion molecule-1 (MadCAM-1) present on post capillary venules in the intestinal
Lp (Bargatze et al., 1995; Wagner et al., 1996). CCR9 reinforces adherence to post
capillary venules via binding to the chemokine, TECK (CCL25), which is generated and
secreted by small intestinal epithelia (Hieshima et al., 2004; Kunkel et al., 2000).
Strikingly, the upregulation of α4β7 and CCR9 is critically dependent on nutrient
metabolism of vitamin A, which will be discussed in greater detail further on (Iwata et al.,

2004; Mora et al., 2006).

CD4+	
  T	
  cell	
  composition	
  in	
  the	
  Lp:	
  
The composition of CD4+ T cells in the small intestinal Lp compartment is quite
heterogeneous and strongly reflects: I) the cytokines produced by the local tissue and II)
the types of antigens constantly available for survey in the intestinal lumen, which likely
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also influence the local cytokine milieu. Indeed, antigen sampling features heavily in this
region, and plays a probable role in the control of both steady-state tolerance and
responsiveness to pathogenic insult. In order to proceed with this crucial function intact,
the Lp tissue requires T cells with both immunoregulatory and sentinel effector
capacities. (I) On the immunoregulatory hand, this includes regulatory T cells (Treg),
which, in particular express the transcription factor, forkhead box protein 3 (Foxp3). (II)
On the effector hand, this includes T-Helper (TH) cells capable of producing proinflammatory cytokines, in particular IFN-γ (TH-1) and IL-17A (TH-17). As discussed
below, the balance of these opposing elements may exert a crucial influence on
the ability of the host to mount an immune response when this site is challenged.
The defining features of these cells, including their induction and their relevance to
mucosal immunity will be outlined in the proceeding sections.

I.	
  Foxp3+	
  regulatory	
  T	
  cells	
  (Foxp3+	
  Treg)	
  
Foxp3+ Treg, which in most secondary lymphoid tissues during steady-state can
be distinguished by constitutive expression of the high-affinity IL-2Rα (CD25), are key
mediators of the coordination and maintenance of peripheral tissue homeostasis
throughout the lifespan of the host (Bennett et al., 2001; Fontenot et al., 2003; Hori et al.,
2003; Kim et al., 2007; Wildin et al., 2001). Their absence culminates in fatal
inflammatory lesions propagated by the activation and proliferation of self-reactive
clones that have escaped negative selection in the thymus (Sakaguchi et al., 2008).
Thus, even in the absence of a commensal microbiota, ablation of Foxp3+ Treg results in
fatal autoimmunity, albeit with slower kinetics and altered pathogenesis (Chinen et al.).
Nevertheless Foxp3+ Treg are still crucial for the prevention of spontaneous reactivity
against both the commensal microbiota and food antigen and play an important role in
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regulating the intensity of immune responses to foreign pathogens (Izcue et al., 2006;
Josefowicz and Rudensky, 2009). They comprise typically 20% of the CD4+ T cell
population within the small intestinal Lp and a variable proportion actively produces the
potent immunoregulatory cytokine, IL-10, which can also be expressed by Foxp3 cells in
this tissue (Maynard et al., 2007). Given their widespread influence, Foxp3+ Treg are not
particularly limited in the means by which they can perform their regulatory duties, which
include but are not limited to: (1) secretion of IL-10 and/or TGF-β(Belkaid, 2002; Li et al.,
2007; Rubtsov et al., 2008; Zhang et al., 2009a), (2) contact dependent suppression of
APC function (Tadokoro et al., 2006; Tang et al., 2006), (3) control of DC homeostasis
(Liu et al., 2009), (4) and abrogation of certain effector functions through an as yet
defined mechanism (Mempel et al., 2006). Importantly, none of these mechanisms are
mutually exclusive (Figure 2).

To date, the precise signals that govern the induction of the Foxp3+ Treg program
remain an enigma (Gavin et al., 2007; Lin et al., 2007). Since, seminal thymectomy
experiments indicated that thymic development of Foxp3+ Treg was required for the
maintenance of self-tolerance (Sakaguchi and Sakaguchi, 1990), many studies have
looked to the thymus for clues into the differentiation pathway of these cells. In this
regard, several elegant studies have revealed that Foxp3+ Treg can develop and survive
negative selection in the presence of strong agonist ligands (Jordan et al., 2001; van
Santen et al., 2004). On the other hand, in the absence of a negatively selecting agonist
ligand, which can be achieved experimentally upon crossing a naive TCR transgene with
a recombination activating gene deficient (RAG–⁄–) mouse, these cells do not develop
intrathymically (Walker et al., 2003). Such mice, in turn, have served as ideal tools to
assess the extrathymic development of Foxp3+ Treg.
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Figure 2. Foxp3+ Treg regulate immune responses through multiple pathways
(1) Foxp3+ Treg produce immunoregulatory cytokines, including TGF-β and IL-10. (2) Their
interactions with dendritic cells (DC) can prevent stable interactions between naïve T cells
and antigen presenting DC. They can also inhibit immature DC maturation and/or
migration. (3) Foxp3+ Treg inhibit the production of FMS-like tyrosine kinase ligand (Flt3L),
which promotes DC maturation from precursor Pre DC. (4) They also can prohibit certain
effector functions, including the capacity of CD8+ cytotoxic T cells to kill. This mechanism
of suppression requires TGF-β signaling.
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In an effort to determine whether Foxp3+ Treg development could occur
extrathymically in vivo, Von Boehmer and colleagues administered prolonged subcutaneous low-dose infusions of hemagglutinin (HA) peptide to thymectomized, RAG–⁄– x
TCR-HA mice. This technique induced a long-lasting CD25+ population that
concomitantly expressed high levels of Foxp3 transcript and possessed suppressive
properties similar to Foxp3+ Treg (Apostolou and von Boehmer, 2004). Another study, in
which OVA-specific, Foxp3– CD4+ DO11.10 T cells were transferred into lymphopenic
hosts, engineered to secrete OVA, yielded similar findings (Knoechel et al., 2005). Using
a more refined strategy, subimmunogenic targeting of peptides to DCs was also shown
to induce antigen specific Foxp3+ Treg (Kretschmer et al., 2005). Altogether, these
findings suggest that chronic exposure to low doses of antigen and DC presentation in
non-inflamed settings can promote the de novo acquisition of Foxp3 by peripherally
activated cells. These criteria bear remarkable similarity to what one may consider
“status quo” in the GI tract, where, in fact, oral feeding of OVA was also shown to induce
CD25+ with high transcript levels of Foxp3 (Mucida et al., 2005). However, the immune
cells responsible for the coordination of this mechanism were not investigated.

Are DC in the GI tract specially equipped to foster the differentiation of Foxp3+
Treg from naïve precursors?
The cytokine, transforming growth factor-beta (TGF-β) is a heavily regulated
cytokine (Annes et al., 2003), which plays a dominant role in immune homeostasis. In
addition to promoting thymic Foxp3+ Treg survival and maintaining naïve T cell
quiescence, it’s been showcased to potently induce Foxp3+ Treg differentiation from naïve
CD4+ T cells upon stimulation, in vitro (Chen et al., 2003; Li et al., 2006; Marie et al.,
2006; Ouyang et al.). TGF-β is also produced in abundance by IEC; this source
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potentially serves a non-redundant function in maintaining good relations with the host
microbiota and dietary antigen (Barnard et al., 1993; Dignass and Podolsky, 1993). More
recent studies have revealed that APC upon phagocytosis of apoptotic cells are also
able to produce TGF-β (Perruche et al., 2008; Torchinsky et al., 2009). Assuming that
the apoptotic inclusions present in their cytoplasm are a result of phagocytosis,
migratory CD103+ LpDC may also be endowed with the capacity to produce this
cytokine. Further, this implies that this population may be uniquely poised to induce
Foxp3+ Treg under physiological settings. In Chapter 2, this possibility will be
investigated and the role of other mucosal factors in the induction of Foxp3 will be
considered.

II.	
  T-‐Helper	
  cells	
  in	
  the	
  Lp	
  compartment	
  
Foreign microbial challenge results in the elicitation of an adaptive immune
response, which accompanies CD4+ T helper (TH) cell differentiation. Analogous to this
type of challenge, the presence of the commensal microbiota and dietary antigen in the
GI tract also elicits an adaptive immune response, resulting in the sustained recruitment
of IgA+ B cells and various TH subsets into in the Lp (Atarashi et al., 2008; Klaasen et al.,
1993; Mazmanian et al., 2005). Until recently, the categories of TH subsets were cast in
essentially binary terms, namely TH-1 and TH-2, based on the classic experiments of
Coffman and colleagues (Mosmann et al., 1986). However, recent studies have upended
this paradigm, leading to the inclusion of several new subsets. While further study is
necessary to reconcile these newer subsets, which appear to retain less committed
features than their foregoing TH-1 and TH-2 counterparts (Locksley, 2009), one subset
has emerged as quite an important player in infectious disease and mucosal immunity.
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This subset of cells, referred to as TH-17, will be discussed along with TH-1 and TH-2
cells.

TH-1 cells are defined by production of IFN-γ and canonical expression of the
transcription factor, T-bet (Mullen et al., 2001; Szabo et al., 2000). They play
instrumental roles in priming and sustaining inflammatory macrophage function (Hu and
Ivashkiv, 2009), and as such help mediate adaptive immune responses against a range
of intracellular pathogens, including, those which infect the host through the alimentary
route, such as microsporidia and Toxoplasma gondii (Casciotti et al., 2002; Moretto et
al., 2004). TH-2 cells are defined by production of IL-4, IL-5 and IL-13 and canonical
expression of the transcription factor GATA-3 (Loots et al., 2000). They elicit an
“alternatively” activated macrophage program that is linked with tissue repair and
mediate protective immune responses against helminths (Maizels et al., 2009; Mosser
and Edwards, 2008). Further, they are commonly associated with allergic responses
(Kim et al.). In contrast to TH-1 development, previous studies have suggested that
normal commensal microbiota derived signals actively constrain steady-state TH-2
development (Mazmanian et al., 2005; Troy and Kasper). Consistent with these reports,
broad-spectrum antibiotic treatment was revealed to trigger oral sensitization to a food
allergen (Bashir et al., 2004). However, a more recent study found that cells from the
terminal ileum of conventionally reared mice readily secreted TH-2 cytokines, including
IL-4 and IL-13, upon polyclonal T cell restimulation (Gaboriau-Routhiau et al., 2009).
Thus, whether the commensal microbiota actively restrains TH-2 cell development is a
matter of debate.

TH-17 cells are associated with the production of the cytokines: IL-17-A, IL-17F,
IL-21 and IL-22 (Khader et al., 2009). While IL-17A and IL-17F are strictly dependent on
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the transcription factor, Retinoic acid receptor-related orphan nuclear receptor gamma
(RORγ) and, to a much lesser extent, RORα, IL-21 and IL-22 can be generated
independently of these transcriptional programs (Ivanov et al., 2006; Korn et al., 2007;
Nurieva et al., 2007; Yang et al., 2008; Zhou et al., 2007). Of interest, IL-22 production
by TH-17 cells is strictly dependent on the environmental toxin-activated, transcription
factor, aryl hydrocarbon receptor (AHR), which was also demonstrated to amplify
production of IL-17A and IL-17F (Veldhoen et al., 2009; Veldhoen et al., 2008a). Shortly
after the discovery of IL-17 (IL-17A, specifically) it became associated with human
autoimmune syndromes, such as Rheumatoid Arthritis and Lupus (Kotake et al., 1999;
Kurasawa et al., 2000; Ziolkowska et al., 2000). In mice, as well, these cells have been
pegged as pivotal instigators of autoimmunity and have an extraordinary capacity to both
stimulate the release and production of inflammatory mediators from myeloid cells and to
recruit innate cells, such as neutrophils to sites of inflammation (Jovanovic et al., 1998;
Ye et al., 2001). This has been amply demonstrated in mouse models of collagen
induced arthritis and, in particular, experimental autoimmune encephalitis, which has
been exploited to great lengths, resulting in an onslaught of molecular insights into the
pathways that control the production of IL-17 (Hirota et al., 2007; Ivanov et al., 2006). As
such, it is now clear that TGF-β signaling in the context of inflammatory mediators, such
as IL-6, IL-1 and IL-21 are critical for TH-17 differentiation, while IL-23 regulates its
effector function in vivo (Ahern et al.; Bettelli et al., 2006; Korn et al., 2007; Mangan et
al., 2006; McGeachy et al., 2007; McGeachy et al., 2009; Nurieva et al., 2007; Veldhoen
et al., 2006; Zhou et al., 2007). Although IL-23 shares an IL-12p40 subunit with IL-12,
which drives TH-1 inflammation, this cytokine regulates distinct pathways (Cua et al.,
2003; Murphy et al., 2003; Trinchieri et al., 2003). Similar to the reciprocal inhibition of
TH-1 and TH-2, both IL-4 and IFN-γ potently suppress TH-17 differentiation (Harrington et
al., 2005). However, pathogenic TH-17 cells, at least, also appear to retain some TH-1
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like features, and can, in fact, morph into IFN-γ producing cells during inflammation (Lee
et al., 2009).

Despite the association of this subset with auto-inflammatory disorders, multiple
studies have revealed that TH-17 cells serve as critical effectors against fungal,
extracellular bacterial, and in some instances, intracellular bacterial infections (AcostaRodriguez et al., 2007; Aujla et al., 2008; Conti et al., 2009; Happel et al., 2005;
Ishigame et al., 2009; Khader et al., 2009; LeibundGut-Landmann et al., 2007; Lin et al.,
2009; Pitta et al., 2009; Saijo et al.; Zheng et al., 2008). Among their protective
functions, IL-17A, IL-17F and IL-22 each have been shown to mediate epithelial cell
production of anti-microbial peptides, including β-defensins (Conti et al., 2009; Ishigame
et al., 2009; Kao et al., 2004; Wolk et al., 2004) and lectins (Sanos et al., 2009; Zheng et
al., 2008). Bearing this in mind, IL-17A secreting TH-17 cells, a proportion of which also
express IL-22 (Ivanov et al., 2009), are typically detected in the small intestinal Lp during
steady-state and express the chemokine receptor, CCR6, which favors their proximity to
IEC (Ishigame et al., 2009; Ivanov et al., 2008; Nagler-Anderson, 2001). Thus, while
clearly in possession of potent inflammatory capacity, in non-inflamed conditions TH-17
cells seem to be well integrated into the intestinal immune system’s microbial
containment strategy. Although not the focus of the work to be described, it is worth
mentioning that other studies that have examined innate cells, such as γδT cells,
lymphoid tissue inducer - like (Lti-like) cells, NK, NKp46+ NK-like cells, and even Paneth
cells have noted their capacity to produce IL-17 (γδT, NK*, Lti-like*, Paneth cells*; *upon
inflammatory stimulation) and/or IL-22 (γδT*, Lti-like*, NKp46+; *upon inflammatory
stimulation) in various contexts, further emphasizing the importance of these cytokines
to mucosal barrier regulation (Cua and Tato). Indeed, innate sources of IL-22 were
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recently revealed to be absolutely required for the early phase of protection against
bacterial pathogens that attach to and efface the IEC barrier (Zheng et al., 2008)

III.	
  Foxp3+	
  Treg/TH	
  populations	
  are	
  in	
  a	
  dynamic	
  equilibrium	
  
The preceding description may lead to the misapprehension that the immune
system protecting the GALT is strictly designed for coping with the everyday stresses
imposed by the commensal microbiota and food antigen; however, this site is also one of
the most convenient ports of entry for foreign pathogen, and, therefore, must also be
equipped with the capacity to stage a swift and simultaneous immune response. One
possibility is that the steady-state immunological landscape in the IEL and Lp
compartments has negligible bearing on how the host will respond to foreign microbial
challenge. However, such an untethered strategy in this region could prove inefficient
and impinge on the capacity of the host to mount a timely and robust immune response.
Further, it could potentially disrupt the sensing mechanisms that are in place to maintain
and/or restore mucosal homeostasis in the event of a pathogenic challenge. Another
consideration, which casts further doubt on this possibility, is that the mucosal immune
system is alerted to the presence of a pathogen via the same pattern recognition
receptors that are engaged by the commensal microbiota (Sansonetti and Di Santo,
2007). Rather, the alternative hypothesis - that the ongoing steady-state immune
response in the GI tract heavily influences the ability of the host to respond to a
pathogenic threat – is more likely.

APC within the Lp compartment express a variety of pattern recognition
receptors, particularly among the TLR family, suggesting that they can receive
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instructive signals directly from the commensal microbiota (Coombes et al., 2007;
Uematsu et al., 2008). The precise nature of these signals and their influence on the
regulation and distribution of Foxp3+ Treg and TH subsets within the Lp remain obscure.
In view of their sensing, migratory, and priming characteristics, LpDC are potentially
strongly equipped for processing and dispatching these cues to CD4+ T cells and, in
turn, influencing the Foxp3+ Treg /TH landscape within the Lp. In Chapter 3 this
possibility will be explored, first, using an in vitro assay to identify potential
components of the microbiota, which impose natural constraints on the Foxp3+
Treg axis in the GALT.

One paradigm that has emerged to provide a basic understanding of the
homeostatic regulation of T cell subsets in this region is the documented reciprocal
nature of Foxp3+ Treg and TH-17 cells. Both are dependent on TGF-β for their induction
and/or survival (Bettelli et al., 2006; Liu et al., 2008; Manel et al., 2008; Mangan et al.,
2006; Ouyang et al.; Veldhoen et al., 2006; Volpe et al., 2008) however, where Foxp3+
Treg cells seem inclined to mediate the suppression of inflammatory cascades, TH-17
cells seem inclined to do just the opposite. Their Janus-like relationship is also apparent
in other contexts. In terms of gene regulation, Foxp3 was shown to sequester RORγ and
to prevent its binding to DNA, while diversion of cells from the Foxp3+ Treg lineage was
shown relieve cells of their inability to produce IL-17 (Gavin et al., 2007; Zhou et al.,
2008). In terms of cytokine regulation, IL-6−/− mice were shown to lack TH-17 cells in their
Lp, but harbored an enhanced frequency of Foxp3+ Treg (unpublished finding) (Korn et
al., 2007). On the other hand, IL-2−/− mice were shown to be unable to sustain Foxp3+
Treg cells in their periphery, but harbored an enhanced frequency of TH-17 cells (D'Cruz
and Klein, 2005; Fontenot et al., 2005; Laurence et al., 2007).
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Taking into account what is known about the intestinal mucosal environment:
abundant TGF-β, a large proportion of Foxp3+ Treg, and the constitutive presence of TH17 cells, these findings suggest that the indigenous microbiota may be able to leverage
this delicate relationship to shape the inflammatory tone of the tissue. Further, when
pathogenic microbial signals converge onto these indigenously derived signals, skewing
away from the Foxp3+ Treg axis of control may be amplified. In this regard, Littman and
colleagues recently demonstrated that a commensal microbial community, which
promotes a steady-state skewing toward the TH-17 subset, can potentiate immune
responses to the TH-17 eliciting bacterial pathogen, Citrobacter rodentium (Ivanov et al.,
2009). This study also identified a microbial species known as segmented filamentous
bacteria (SFB) that was particularly potent at inducing a prominent TH-17 subpopulation
(Ivanov et al., 2009). However, the precise stimulatory pathways utilized by SFB to
promote TH-17 activity were not completely clarified. Indeed, the individual
contributions of discrete signaling pathways, which are engaged by specific
microbial component/pattern recognition receptor interactions, to the regulation
of intestinal homeostasis and mucosal immunity are unclear.

Insofar as this paradigm applies to the Foxp3+ Treg and TH-17 subsets of T cells, it
does not sufficiently encompass the heterogeneity of the microbial communities that are
constitutively present in the GI tract, which also should add to TH diversity and potentially
the functional characteristics of Foxp3+ Treg in the Lp compartment. Indeed germ-free
mice that were reconstituted with a commensal microbiota from naturally colonized mice
displayed dramatic increases in both TH-1 and TH-17 subsets within the ileal Lp
compartment (Gaboriau-Routhiau et al., 2009). Moreover, commensal derived
components, such as the polysaccharide of Bacteroides fragilis, have been shown to
regulate the TH-1/TH-2 balance during steady-state (Mazmanian et al., 2005). Thus the
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commensal microbiota was also demonstrated to affect sensitivity to food borne allergies
(Bashir et al., 2004). Regarding Foxp3+ Treg cells, specific microbial interactions have
been proposed to augment their regulatory activity, including TLR 4 and 5 (Caramalho et
al., 2003; Crellin et al., 2005), while others involving TLR 2, 8 and 9 have been proposed
to restrain their regulatory activity (Larosa et al., 2007; Liu et al., 2006; Pasare and
Medzhitov, 2003; Peng et al., 2005; Sutmuller et al., 2006). Altogether, these data
provide compelling evidence that the composition of the microbiota is able to
exert a strong influence on the T cell landscape of intestinal effector sites, which
in turn may condition the efficiency of the mucosal response to an invasive
pathogen. This concept will be examined in Chapter 3.

Convergence	
  of	
  nutrient	
  metabolism	
  with	
  the	
  mucosal	
  immune	
  system:	
  
The essential function of the GI tract is to digest food and extract nutrients, some
of which are otherwise inaccessible in the absence of the commensal microbiota (Wikoff
et al., 2009). Accumulating evidence reveals that the intestinal immune system has
adapted to this process through utilization of nutrient metabolites. Similar to microbial
driven signals, nutrient metabolite driven signals appear to serve as key moderators of
the immunological conversation taking place at mucosal barrier interfaces. In many
ways, they are also as well tailored as microbial signals to provide the host with a local
immunological advantage. For instance, butyrate, which is a short-chain fatty acid
produced by the commensal microbiota upon metabolism of dietary fiber, was shown to
inhibit the multiplication of pathogenic enteric bacteria and quelled the inflammatory
profile of monocytes, in vitro (Bohnhoff et al., 1964; Saemann et al., 2000). Catabolism
of the essential amino acid tryptophan, which occurs constitutively in the GALT, was
shown to limit basal Ab production to commensal microbiota (Harrington et al., 2008).
Recent data also support the hypothesis that tryptophan catabolism positively regulates
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the Foxp3+ Treg/TH-17 ratio (Favre et al.). Another nutrient that especially bares this
point is vitamin A and, in particular, its metabolic derivative, retinoic acid.

Vitamin	
  A	
  is	
  a	
  critical	
  nutrient	
  for	
  the	
  GALT	
  immune	
  system:	
  
In the early 20th century E.V. McCollum discovered that certain lipids contained a
factor essential for growth, which he termed “fat soluble factor A” or, Vitamin A (Mc,
1952). Mammals and most higher order organisms are dependent on dietary ingestion
for acquisition of this vitamin. Its sources include carotenoids, which are present in fruits
and vegetables and retinyl esters, which are abundant in meats and poultry. These
compounds are broken down into retinol (1) for absorption by the small intestine and
subsequently esterified for storage in the liver (Harrison, 2005; Mc, 1952).

Retinoic	
  acid	
  can	
  be	
  generated	
  or	
  obtained	
  through	
  multiple	
  pathways:	
  
Retinoic acid (RA) is the end product of a series of enzymatic steps in Vitamin
A’s metabolism. When required, retinyl esters are hydrolyzed into retinol and deployed
into circulation along with its chaperone, retinol-binding protein (RBP) (Wolf, 2007). It’s
uptake into cells, including IEC and APC, is mediated by the surface receptor, STRA6,
which binds with high affinity to RBP (Kawaguchi et al., 2007). Once in the cytosol, the
ubiquitously expressed family of alcohol dehydrogenases (ADH) (2) reversibly catalyzes
the oxidation of retinol to retinal (Mic et al., 2003). Retinal dehydrogenases (RALDH) (3)
then bind to retinal and catalyze the final and irreversible step in RA synthesis. In the
GALT, this predominantly results in all-trans RA, which can eventually isomerize to its 9cis form. However, this form has yet to be detected in vivo (Mic et al., 2003). Notably,
RALDH expression is cell and tissue specific, making RA synthesis a controlled process
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(Iwata et al., 2004). While the processes regulating RALDH induction are unclear, it was
recently demonstrated that lipid mediators, which are widely present in the GALT, induce
RALDH2 through the fatty acid binding receptor, PPAR-γ (Szatmari and Nagy, 2008).

As previously mentioned, GALT DC promote lymphocyte homing to intestinal
effector sites through coordinate upregulation of α4β7 and CCR9. The first clue that RA
controlled the induction of these ligands was the finding that adding it exogenously to
APC-free cultures induced their expression on stimulated T cells (Iwata et al., 2004).
Then came the seminal observation that adult mice reared on a vitamin A deficient diet
had a diminished number of T lymphocytes residing in intestinal effector sites (Iwata et
al., 2004). Consistent with their ability to synthesize RA, PpDC and mlnDC expressed
messenger RNA for RALDH1 and RALDH2, respectively. Nevertheless, IEC were also
revealed to prominently express RALDH1. Therefore, GALT DC may also acquire RA
passively from IEC (Iwata et al., 2004). Further, although its physiological significance is
unclear, it should be noted that RA is also detectable in serum, albeit at very low levels
(Kane et al., 2008a; Kane et al., 2008b).

Retinoic	
  acid	
  contributes	
  to	
  lymphocyte	
  function:	
  
Apart from its immunological influence on homing, there are compelling data that
link RA to the functional capacity of lymphocytes, particularly B cells. For example, DC
and stromal derived, follicular DC from Pp were revealed to drive naïve B cell
differentiation into IgA+ B cells and/or to preferentially induce IgA+ class switching in
activated B cells (Mora et al., 2006; Suzuki et al.). RA was demonstrated to be essential
to these processes, since antagonism of RA signaling inhibited the ability of PpDC to
generate IgA+ B cells, while adding RA in conjunction with IL-6 and/or IL-5 dramatically
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enhanced IgA production in peripheral LN DC cocultures (Mora et al., 2006). In concert
with these data, Fagarasan and colleagues reported that activating peripheral LN
follicular DC with RA synergized with TLR 2 and 4 ligands to induce production of active
TGF-β, which is also a critical factor for IgA+ class switching (Cerutti and Rescigno,
2008; Suzuki et al.). Thus, vitamin A metabolism appears to contribute to the generation
of IgA+ B cells through both direct effects on B cells and indirect effects through DC
modulation, although this has not yet been completely resolved.

RA may also exert direct effects on T cells. For instance, RA was shown to
enhance T cell proliferation under mitogenic stimulatory conditions, which was correlated
with a gross increase in IL-2 production (Ertesvag et al., 2002). However, data have also
suggested that RA can inhibit production of IL-2 during naïve T cell activation (Ertesvag
et al., 2009). Notably, these findings were obtained in humans and mice, respectively;
therefore system differences could account for these discrepancies. RA was also
proposed to directly inhibit TH-1 polarization in vitro; however, the effect in these assays
was relatively minor and a clear mechanism for the action of RA was not proposed
(Iwata et al., 2003). Thus, what role RA plays in T cell activation and TH polarization, if
any, is still ambiguous.

Retinoic	
  acid	
  signaling	
  is	
  mediated	
  through	
  nuclear	
  retinoic	
  acid	
  receptors:	
  

RA signals through several families of nuclear hormone receptors in the nucleus.
The best characterized are RA receptors (RAR) which form obligate dimers with retinoid
X receptors (RXR) and in turn, transcriptionally activate RA response elements (RARE)
in the promoter regions of various genes (Chambon, 1996). Recently, RA was also
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shown to be able to signal through PPARβδ; however, the potential importance of this
pathway in immune cell populations awaits further scrutiny and was not examined in the
studies that will be described in the forthcoming sections (Schug et al., 2007). While
RXRs dimerize with several nuclear receptors to transduce signals by other small
molecules, RARs bind exclusively with RA (Ziouzenkova and Plutzky, 2008). Three, in
particular, have been identified - α, β and γ. Underscoring their influence on a score of
genes, as well as their complex regulation, aberrant expression of RARs (positive and
negative) has been strongly linked to metabolic disorders and various cancers (de Lera
et al., 2007; Hua et al., 2009; Walkley et al., 2007; Yang et al., 2005). RA was shown to
mediate TGF-β production in follicular DC via RARβ (Suzuki et al.). However, in contrast
to RARα and RARγ, RARβ is not detectable in lymphocytes (Elias et al., 2008).
Intriguingly, protein expression of RARα was found to increase dramatically upon CD4+
T cell activation in the presence of TGF-β, and as will be highlighted in the forthcoming
chapters, may have a driving influence on Foxp3+ Treg/TH-17 regulation (Schambach et
al., 2007). Furthermore, dysregulation of these receptors has been linked to various
cancers, including leukemias. The prevalence of vitamin A metabolism occurring in
the GALT, suggests that RA/RAR interactions may bear significance in the
regulation of T cell homeostasis and immunity in this region. Work to be
described in Chapter 2 and Chapter 4 will start to address this possibility.

A	
  role	
  for	
  retinoic	
  acid	
  in	
  infection	
  and	
  immunity	
  
On a typical western diet, retinol absorption exceeds the body’s homeostatic
requirements. This results in the accrual of retinyl esters in the liver. However, in
developing countries, where malnutrition and diarrhea are common, Vitamin A intake
and absorption are reduced. When combined with pregnancy, which increases Vitamin A
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metabolism, the risk of Vitamin A insufficiency (VAI) both to mother and unborn infant
increases dramatically. According to the most recent WHO estimate, there are
approximately 250 million children presenting with subclinical and/or clinical signs of VAI
at this precise moment (informational website).

VAI has long been linked to increased prevalence of diarrheal diseases and
mortality from gastrointestinal infection (Duggan et al., 2002; Villamor and Fawzi, 2000).
While numerous studies indicate that Vitamin A supplementation mitigates the incidence
and severity of these infections, determining the impact of RA mediated mechanisms on
these outcomes has proven difficult (Long et al., 2006a; Long et al., 2007a; Long et al.,
2007b; Long et al., 2006b). Complicating this task is the variability in degree of VAI and
preexisting disease states within single cohorts. Rodent models of VAI, which prevent
these complications, have shed some light on the role of RA in GALT immunity to
infection. For example, RA signaling was required for the development of a proper TH-2
response in mice infected with the helminth, Trichinella spiralis, whereas VAI resulted in
an aberrant TH-1 response to this infection (Cantorna et al., 1994; Carman et al., 1992).
However, another report demonstrated that RA administered concomitantly during
infection with Mycobacterium tuberculosis enhanced TH-1 responses in vivo and
facilitated bacterial clearance (Yamada et al., 2007). VAI mice were found to be
significantly more susceptible to rotavirus than their WT counterparts. However, while
this study compared architectural changes in various tissues, including the gut, immune
responses were not assessed in these mice (Ahmed et al., 1990). Thus, the impact of
RA mediated signaling on TH responses is still unclear and may depend on the local site
of infection. To date, there has been a paucity of studies that have considered the
role of RA, in situ, during intestinal immune responses. Moreover, the precise
mechanisms that underlie exacerbated enteric infections during VAI remain
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undefined. Studies in Chapter 4 will tackle this question and help define how in situ Lp
responses are impacted by VAI.

Models	
  of	
  infection:	
  
To gain mechanistic insight into the questions that have been raised in this
section the following challenge models will be employed:

Encephalitozoon	
  cuniculi	
  (E.	
  cuniculi):	
  
Microsporidia are spore forming obligate intracellular parasites that have recently
been classified as fungi (James et al., 2006). They infect a wide range of hosts, primarily
through oral transmission (Didier et al., 2004). Species that infect humans, such as E.
cuniculi, tend to induce a sub-clinical chronic infection accompanied with mild or acute
symptoms, most typically diarrhea. Upon ingestion, spores infect the epithelia of the
duodenum and replicate in parisotophorous vacuoles (Mathews et al., 2009).
Importantly, E. cuniculi can infect a variety of other cells, including APC (Orenstein et al.,
1992), and can readily disseminate to other tissues in the body. As such, these
infections are particularly severe and problematic in immunocompromised individuals
(Farthing, 2006; Ferreira et al., 2001; Mertens et al., 1997; Wanachiwanawin et al.,
1998).

E. cuniculi is also a natural mouse pathogen (Keeble, 2001). Studies in

laboratory animals have shed light on the course of infection and the immunological
requirements for control of this pathogen, which include both CD4+ and CD8+ T cells
during the natural route of infection (Moretto et al., 2004; Salat et al., 2006). In order to
address how enteric commensal driven signals influence host ability to respond to
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infection, mice will be infected with this pathogen. The results obtained from these
studies will be described in Chapter 3.

Toxoplasma	
  gondii	
  (T.	
  gondii):	
  

Toxoplasma gondii (T. gondii) is a protozoan parasite naturally acquired through
the oral route that infects up to a third of the world’s population (Montoya and Liesenfeld,
2004). While primary infection manifests in a subclinical response, unless treated, T.
gondii establishes a chronic phase of infection in the host, which is exemplified by the
formation of Bradyzoite cysts in the muscle and brain tissue whose pathological
consequences are limited by a multitude of host regulatory and inflammatory factors
(Stumhofer et al., 2007; Wilson et al., 2005). Extensive mouse studies have established
the critical importance of both CD4+ and CD8+ T cells and a controlled TH-1 response in
the development and maintenance of immunity to this parasite (Combe et al., 2005;
Gazzinelli et al., 1992; Gazzinelli et al., 1996; Liesenfeld et al., 1996). Consequently, T.
gondii can have fatal consequences in immunocompromised individuals upon
reactivation of the chronic phase (Israelski and Remington, 1988). Based on virulence in
mice, T. gondii has been classified into 3 strains. Type I are acutely lethal, regardless of
the dose of pathogen administered, while Type II and type III strains are generally
considered non-lethal, depending on the strain of mice and dose administered (Bradley
and Sibley, 2007). For the studies that will be highlighted in Chapter 4, a clone of the
type II strain, ME-49 will be utilized.
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Summary:	
  

The immune system of the gastrointestinal tract has adapted in close apposition
with the commensal microbiota, food protein and environmental antigens. As such, it
maintains a dynamic presence of both effector and regulatory lymphocyte populations.
Yet, the mechanisms in place to orchestrate this balanced dichotomy have not been well
defined. To gain insight into this broad question, the studies, which will be discussed
herein, were focused particularly on understanding CD4+ T cell regulation within the
intestinal Lp compartment as a model of homeostasis. Chapter 2 explores the
convergence of potentially redundant regulatory pathways in this region, specifically,
Foxp3+ Treg generation and presents data that identifies retinoic acid as a cofactor in the
extrathymic development of Foxp3+ Treg. Chapter 3 then examines how commensal
components intersect with host regulatory strategies to favor the development of
mucosal immune responses. Finally, Chapter 4 inspects more closely the role of vitamin
A metabolism in immunity.
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CHAPTER	
  2:	
  GALT	
  Foxp3+	
  Treg	
  development	
  is	
  critically	
  dependent	
  on	
  
vitamin	
  A	
  metabolism	
  
Abstract:	
  
The gastrointestinal tract is a home to a broad reservoir of regulatory T cells,
including those which express the transcription factor, Foxp3. Although, most studies
and differentiation models mark the origin of these cells as the thymus, recent evidence
has showcased their potential to arise from naïve precursors and/or in the absence of a
thymically generated pool. In this study, the GI tract and its associated lymphoid tissues
(GALT) were studied as potential nucleating sites for the generation of extrathymic
Foxp3+ Treg. The following findings emerged:

1.

Antigen introduced through the oral route robustly induced naïve T cell
upregulation of Foxp3 protein in the GALT.

2.

Dendritic cells from the intestinal lamina propria (Lp) and those draining
into the mesenteric lymph nodes (mln) uniquely promoted in vitro Foxp3+
Treg generation via active TGF-β signaling and the synthesis of retinoic
acid (RA).

3.

RA enhanced TGF-β induced Foxp3+ Treg generation via retinoic acid
receptor alpha.

4.

Vitamin A metabolism was essential for GALT Foxp3+ Treg induction.
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Rationale:	
  
Previous studies have demonstrated that TCR stimulation of naïve CD4+ T cells in
the presence of TGF-β could promote the induction of Foxp3 (Chen et al., 2003; Fantini
et al., 2004). Further, sub-immunogenic (Kretschmer et al., 2005) or chronic exposure to
antigen (Apostolou and von Boehmer, 2004; Knoechel et al., 2005) was also shown to
lead to long-lasting adoption of this transcription factor in extra-thymic naïve CD4+ T cells.
Therefore, the immune system protecting the GI tract and associated lymphoid tissues
(GALT) was hypothesized to serve as a candidate environment for peripheral Foxp3+ Treg
development. Indeed, the small intestinal tissue was shown previously to constitutively
express large amounts of TGF-β (Barnard et al., 1993) and is continuously exposed to
gut commensal microbiota or dietary antigens in what is largely deemed a nonimmunogenic manner.
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Results:	
  

De	
  novo	
  generation	
  of	
  Foxp3+	
  Treg	
  cells	
  can	
  occur	
  in	
  the	
  GALT	
  	
  
In order to address if the gastrointestinal tract and its associated lymphoid
tissues (GALT) could favor de novo production of Foxp3+ Treg from naïve T cells, Ly5.2+
T cells from RAG1–/– OT-II Tg mice, which are specific for the peptide sequence 323-339
of chicken ovalbumin (OVA) protein, were adoptively transferred into Ly5.1+ replete
recipients. Because these cells bear a TCR that does not recognize endogenous
antigen, they retain a naïve phenotype and are devoid of regulatory features, including
CD25 (Jordan et al., 2001) and Foxp3 (Walker et al., 2003). Following transfer, the
Ly5.1+ recipients were fed OVA antigen dissolved in drinking water for 5 consecutive
days. This feeding regimen was previously demonstrated to suppress airway
inflammation if implemented prior to immunization and intra-nasal challenge with OVA
antigen, and was associated with upregulated Foxp3 mRNA expression in CD25+ CD4 T
cells (Mucida et al., 2005). A recent study by the same group demonstrated that Foxp3
was essential for this effect (Curotto de Lafaille et al., 2008).

After 5 days of OVA administration, Ly5.2+ OVA-specific T cells had expanded
and were readily detectable in the GALT, spleen, and even in distal lymph nodes, such
as the sub-mandibular (subLN) (Figure 3A). However, in spite of the broad
dissemination of transferred cells, Foxp3+ expressing T cells were only appreciably
detected in the GALT, including the mesenteric lymph nodes (mln), small intestinal
lamina propria (Lp) and the Peyer’s Patches (Pp) (Figure 3B). Although the highest
frequency of Foxp3+ converted OVA-specific T cells was consistently found in the Lp,
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with a mean frequency of 16.8 ± 6.5%, it is important to note that these mice were
sacrificed only 24 hrs post-feeding and that longer resting periods may have led to the
redistribution of the cells to other tissues. Nevertheless, these findings argue that in
response to oral exposure to antigen, the GALT environment can promote the
emergence of Foxp3+ T cells from a naïve population in an antigen dependent manner.
Importantly, feeding irrelevant antigen, such as bovine serum albumin was shown to not
be able to induce Foxp3+ upregulation in a similar setting (Coombes et al., 2007).

Figure 3. Acquisition of Foxp3 in CD4+ T cells responding to orally delivered
antigen.
On day 6 after transfer, donor T cells were assessed flow cytometrically for Foxp3
expression via intracellular staining in cell suspensions from the sub-mandibular lymph
nodes (subLN), spleen (Sp), mesenteric lymph nodes (mln), Peyer’s patches (Pp), and
small intestinal lamina propria (Lp). (A) Top dot plots were gated on total CD4+ cells.
Ly5.2 was used to identify the transferred population. Bottom contour plots show Foxp3
expression by Ly5.2 gated cells (B) Summary of the percentage of Ly5.2+ RAG1-/- OT-II
T cells expressing Foxp3. Each dot represents a single mouse. Data were combined
from 2 individual experiments (3 mice each). Statistical comparisons were performed
using the Student’s T test, with Sp tissue serving as the baseline comparison for each
tissue. ns = not significant,, P < 0.001.
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Characterization	
  of	
  lamina	
  propria	
  dendritic	
  (LpDC)	
  cells	
  	
  
The observations above suggest that the GALT microenvironment is particularly
poised for the peripheral generation of Foxp3+ Treg. As detailed in Chapter 1, tissue
resident dendritic cells (DC) constitutively migrate from the Lp into the mesenteric lymph
nodes (Huang et al., 2000); this property is essential for the polarization of antigen
specific T cells in the draining mln upon antigen feeding (Johansson-Lindbom et al.,
2005). It was plausible, therefore, that Lp derived DC may play a dynamic role in the
generation of Treg. Examining the dual expression of CD11c and MHC II, which are the
two surface antigens typically used to denote DC, in unfractionated Lp tissue
suspensions indicated that these cells accounted for typically 25% of the hematopoietic
cells within the Lp. As illustrated in Figure 4A, CD11c+ MHC II+ cells comprised a
heterogeneous population, where two dominant subpopulations emerged: one (I)
expressed higher levels of CD11c and slightly less MHC II, while the second (II) stained
slightly lower for CD11c, but higher for MHC II. A third subpopulation has also been
characterized by another laboratory, which stains much dimmer for CD11c and very
bright for MHC II. Recent findings have identified these cells as the serosal
macrophages (Bogunovic et al., 2009). As a side note, this population was not sorted in
assays in which LpDC were isolated. Consistent with previous reports, when
CD11c+MHC II+ cells were assessed for surface integrins, virtually all were CD11b+
(Niess and Reinecker, 2005), while up to 30% expressed αE, also known as CD103
(Figure 4A) (Johansson-Lindbom et al., 2005). The majority of CD103+ LpDC coexpressed CD11b. Unlike their counterparts in the Lp, SpDC were almost uniformly
CD103–, although in some experiments a portion of the CD11b– subpopulation
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expressed this marker, albeit it dimly (Figure 4A and data not shown). Moreover, while
these observations were made in C57BL/6 mice, for unclear reasons, the CD11b–
CD103+ SpDC subpopulation is known to be more prominent in BalbC strains (Annacker
et al., 2005). Thus, the basal status of activation within the host may affect the
constitutive presence of this population in the spleen. Upon cell sorting, Giemsa staining
revealed that LpDC displayed the characteristic features of conventional DC with a
stellar shape comparable to freshly sorted SpDC (Figure 4B). Analysis of costimulatory
molecules on LpDC indicated comparable levels of CD80 and CD86 to SpDC, while
CD40 was enhanced (Figure 4C). MHC II was also more highly expressed in LpDC. In
concert with these findings, LpDC were shown to be at least as efficient as SpDC at
inducing T cell proliferation when pulsed with peptide (Johansson-Lindbom et al., 2005).
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Figure 4. Phenotypic traits of small intestinal lamina propria DC (LpDC).
(A) Lp and Sp cell suspensions were labeled with αMHCII, αCD11c, αCD11b and
αCD103 mAb. Higher panels indicate the percentages of CD11c+MHCII+ cells. Lower
panels, gated on CD11c and MHCII, show CD103 versus CD11b expression. Numbers
represent the percentage of events in each quadrant. (B) * Giemsa staining of sorted Lp
(left) and Sp (right) CD11c+MHCII+ DC. (Magnification X 1000) (C) * Histograms depict
the expression levels of CD40, CD80, CD86, and MHC II on LpDC (red) and SpDC
(black). Isotype controls are shown in grey (Stained with pooled Lp and Sp samples).
*Performed by Cheng Ming Sun, Ph.D.
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LpDC	
  preferentially	
  induced	
  Foxp3-‐	
  T	
  cells	
  to	
  become	
  Foxp3+	
  Treg	
  cells	
  in	
  Treg	
  
polarizing	
  conditions	
  
LpDC were next assayed for their capacity to induce Treg generation. To this end,
DC from the Lp or spleen were isolated, co-cultured with purified Foxp3 negative CD4 T
cells, and stimulated with polyclonal αCD3 mAb. In order to isolate live Foxp3– CD4 T
cells, we used a transgenic reporter mouse in which an IRES eGFP construct was
inserted downstream of the Foxp3 coding sequence (Bettelli et al., 2006). While αCD3
was unable to efficiently induce Foxp3, provision of exogenous TGF-β resulted in the
production of Foxp3+ T cells in both cultures, as determined by intracellular cytokine
staining (Figure 5A). However, under the same conditions and at several T cell to DC
ratios, the frequency of Foxp3+CD4+ T cells was typically 3 fold greater in LpDC cultures
(Figure 5B). Notably, the intensity of Foxp3 expression was higher when induced in the
presence of LpDC than with SpDC (mean fluorescence intensity (MFI): 90.9 vs. 57.4,
Figure 5A). These findings were recapitulated in an antigen specific setting, in which
OVA peptide was used to stimulate OT-II transgenic T cells in DC cocultures (data not
shown). To test the functionality of the induced Foxp3+ T cells, eGFP expressing cells
were isolated from cocultures and their suppressive capacity was tested in vitro
(Thornton and Shevach, 1998). Foxp3+ T cells obtained from both LpDC and SpDC

cocultures were as capable as freshly isolated, ex vivo, Foxp3+ Treg at curbing the
proliferation of Foxp3- responder T cells upon stimulation, suggesting that these induced
cells have regulatory capabilities (Figure 6).
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Figure 5. Small intestinal LpDC induce Foxp3+ Treg at a significantly higher rate of
efficiency than SpDC.
(A-B) 105 sorted, Foxp3– CD4+ T cells were cocultured with 104 – 2.5x103 Sp or LpDC
for 5 days, with αCD3 mAb alone or in concert with TGF-β. Viable cells were then
assessed for intracellular Foxp3 expression. (A) Contour plots show the percentage of
CD4+ T cells that express Foxp3. MFI = mean fluorescence intensity. DC:T cell ratio 
1:10 (B) Bar graphs illustrate the frequency of Foxp3+ T cells detected upon termination
of culture for each condition. Error bars indicate the high and low values (average of
triplicate wells) from two experiments.
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Figure 6. Induced Foxp3+ T cells
behave similar to ex vivo isolated
Foxp3+ Treg.
5 x 104 eGFP–CD4+ T (Teff) cells were
mixed with graded doses of eGFP+ T cells
that were sort purified from day 5 SpDC or
LpDC cocultures and then stimulated with
irradiated splenocytes and αCD3 mAb (0.5
mg/ml). Proliferation was measured by the
incorporation of 3H-Thymidine during the
last 6 hr of culture. eGFP+ T cells sorted
ex vivo (nTreg) were used for comparison.
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The induced Foxp3+ Treg expressed high levels of CD25 and GITR (data not shown)
regardless of the origin of the stimulating DC, while CD103 expression was consistently
enhanced when induced by LpDC (MFI: 594 vs. 275, Figure 7A). Since CD103
expression was previously shown to be upregulated by TGF-β signaling (El-Asady et al.,
2005), the influence of the dose of TGF-β on Foxp3 T cell generation was examined in
DC cocultures. Significantly, the ability of SpDC to induce Foxp3 was much more
sensitive to the dose of TBF-β, where lowering the dose led to a precipitous reduction in
the frequency of this induced population. Conversely, the ability of LpDC to induce a
sizable Foxp3+ population remained robust across various TBF-β concentrations (Figure
7B). These findings raised the possibility that TGF-β signal transduction is augmented in
T cells stimulated by LpDC. Though not part of these studies, it would be intriguing to
investigate the kinetics and degree of smad phosphorylation, which is downstream of
TGF-β receptor signaling (Li and Flavell, 2008), in T cells during stimulation with Lp vs.
SpDC.

CD103 expression by DC is required for suppression of T cell mediated colitis in
the adoptive transfer model, suggesting that this subset possesses regulatory function in
vivo (Annacker et al., 2005). Therefore, it was important to test whether the CD103+
subset was the subpopulation of LpDC that was promoting preferential Foxp3+ Treg
induction. To address this, LpDC were further sort purified based on CD103 expression.
Strikingly, CD103+ LpDC, were uniquely able to induce Foxp3 expression in the absence
of exogenous TGF-β (Figure 8). Moreover, in the presence of TGF-β they consistently
induced a higher frequency of Foxp3+ cells, though this was not very dramatic,
especially when compared with SpDC. Purification of the CD103+ DC subpopulation
from the intestinal draining mln indicated that these cells shared the same competency
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to induce Foxp3+ Treg as their counterparts in the Lp. This held true both in absentia and
in the presence of exogenous TGF-β (Figure 8). On the other hand, even with
exogenous TGF-β, the CD103– subpopulation still induced less than half of the Foxp3
frequency when compared to the CD103 expressing subset (Figure 8). These findings
suggest that the CD103+ DC subset in the mln originates from the intestinal Lp, while the
CD103– subset likely does not. Consistent with this idea, an elegant study demonstrated
that, although DC were readily detected, the CD103– subset was selectively excluded
from lymph vessels draining the intestine (Schulz et al., 2009).

Figure 7. TGF-β responsiveness is enhanced in the presence of LpDC
(A) eGFP–CD4+ T cells were cocultured at a 10:1 ratio with SpDC or LpDC in Treg
polarizing conditions. On day 5, eGFP+ T cells were assessed for CD103 expression via
flow cytometry. Red = SpDC, Black = LpDC. (B) As in A; however, the amount of TGF-β
in coculture was tested at several concentrations.
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Figure 8. CD103+ Lp and mln DC are specialized to induce Foxp3+ Treg in the
absence of exogenous factors.
eGFP–CD4+ T cells were cocultured at a 10:1 ratio with CD103+ or CD103– DC purified
from Lp or mln tissues and stimulated with αCD3, in the presence or absence of TGF-β.
Cells were harvested 5 days later, and eGFP expression was assessed on viable CD4+
T cells as a surrogate for Foxp3.
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The relative paucity of converted Treg in SpDC cocultures may have been due to
a lower viability or a reduced proliferative potential of cells that acquired Foxp3. To
determine the potential contribution of these elements, the survival of in vitro activated T
cells was measured. In both SpDC and LpDC cocultures, Foxp3+ T cells remained
significantly more viable than the Foxp3 null population. Thus, the lower yield of Treg cells
in SpDC cocultures was not the result of increased cell mortality (Figure 9A). T cell
proliferation in cocultures was explored next. Since eGFP and CFSE share overlapping
emission spectra, naïve CD4+ T cells (Foxp3 contamination was < 0.5%) were isolated
from non-transgenic mice (However, in subsequent experiments it became clear that
eGFP is not retained when fix/permeabilized with the Foxp3 staining buffer kit offered by
eBioscience). Consistent with findings using CD4+ T cells from reporter mice, the
proportion of converted Treg continued to dominate in LpDC co-cultures (54.5% vs.
14.9%, Figure 9B). CFSE dilution profiles indicated that CD4+ T cells proliferated
vigorously regardless of the origin of DC during the length of incubation. While the
Foxp3+ Treg lineage is typically distinguished by its hypoproliferative characteristics (Ref),
this observation may in part be explained by the polarizing system used, in which IL-2, a
potent growth factor for Treg in these stimulating conditions, was added at 24 hrs and 72
hrs post-culture. Importantly, even at late division cycles the proportion of Foxp3+ Treg
remained high in LpDC cocultures (Figure 9C). These data suggest an initiation of a
more stable Foxp3+ Treg program in the presence of LpDC.
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Figure 9. Maintenance of Foxp3 contributes to higher frequency of Foxp3+CD4+ T
cells in the presence of LpDC.
(A) eGFP–CD4+ T cells were co-cultured with purified DC at a 5:1 ratio in Treg polarizing
conditions. At indicated time points, cells were harvested, and stained with 7AAD (dead)
and annexinV (apoptotic). Foxp3 expression was determined based on eGFP
fluorescence. The percentage of 7AAD– annexinV– cells is depicted by white bars for
LpDC and black bars for SpDC. Data are from one of 2 independent experiments. (B)
CFSE labeled naive CD4+ T cells were co-cultured with purified DC as described above.
On day 5, cells were harvested and stained for CD4 and intracellular Foxp3. Dot plots of
Foxp3 versus CFSE are illustrated. The percentage of Foxp3+ cells and the MFI was
defined as the bordered population. (C) The proportion of Foxp3+ cells among CD4 T
cells is plotted as a function of the number of cell divisions. LpDC () of SpDC ().

45

LpDC	
  are	
  equipped	
  to	
  metabolize	
  vitamin	
  A	
  derivatives	
  in	
  retinoic	
  acid	
  

	
  

Prior to this work, a number of studies have attributed several unique functional
properties to GALT DC. Specifically, these studies found that lymphocytes activated in
the presence of GALT DC, including those from the Lp, selectively up-regulate the gut
homing surface molecules CCR9 and α4β7, which as mentioned in Chapter 1 results in
their preferential migration into intestinal tissue (Johansson-Lindbom et al., 2005;
Johansson-Lindbom et al., 2003; Mora et al., 2003; Mora et al., 2006). This upregulation
was recently shown to depend on retinoic acid (RA) (Iwata et al., 2004; Mora et al.,
2006). Corresponding to this feature, GALT DC from Pp and mln were found to uniquely
express high levels of messenger RNA for certain retinaldehydrogenases (RALDH),
which are the enzymes that irreversibly catalyze the metabolism of the vitamin A
derivative, retinal, into RA (Mic et al., 2003).

In order to assess for the functional

expression of this family of enzymes in LpDC, a cell-membrane-penetrating probe that
fluoresces upon binding to active RALDH was incubated with Sp and Lp tissue cell
suspensions, and then examined flow cytometrically. Strikingly, only LpDC displayed
high levels of functional RALDH; more specifically, these high levels were restricted to
the CD103+ LpDC population (Figure 10A). Nevertheless, inhibition of RALDH activity
using the alcohol dehydrogenase inhibitor, diethylaminobenzaldehyde (DEAB), during
incubation with the RALDH probe indicated that both CD103– LpDC and SpDC have
marginal, albeit detectable RALDH activity. Consistent with more RALDH activity in
LpDC, upregulated α4β7 expression was consistently observed on induced Foxp3+ T
cells in LpDC but not in SpDC cocultures (Figure 10B).
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Figure 10. LpDC synthesize retinoic acid, which can enhance Foxp3+ Treg
generation in cooperation with TGF-β.
(A) Sp and Lp cell suspensions were incubated with a RALDH substrate possessing a
fluorescent indicator. Where indicated, cell suspensions were concomitantly treated with
a RALDH inhibitor, DEAB. RALDH activity was assessed by flow cytometry, with gating
strategy showed. (B) In vitro cocultured cells were stained for α4β7 and assessed for
eGFP fluorescence (Foxp3) by flow cytometry. (C) The dose responsiveness of eGFP
(Foxp3) expression by CD4 T cells cocultured with SpDC was determined by flow
cytometry. Error bars represent the standard error of the mean (s.e.m.) of 3 individual
samples from one experiment. Statistical significance was determined using the
Student’s T test. , P < 0.05; , P < 0.01; , P < 0.001.
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To proceed with the previous findings, the capacity of RA to enhance the
generation of Foxp3+ T cells in Treg polarizing conditions was tested. To this end,
SpDC/T cell cocultures were prepared with αCD3 and TGF-β in the presence of
increasing doses of the synthetic RA, all-trans RA, which is the predominant
physiologically detectable form of retinoic acid (Mic et al., 2003). While RA alone did not
induce Foxp3 expression, RA in the presence of TGF-β enhanced the frequency of
Foxp3+ Treg recovered in culture in a dose dependent manner, also leading to
upregulated α4β7 on these cells (Figure 10C and data not shown). The enhanced
generation of Foxp3+ T cells was markedly significant at RA concentrations of 1nM and
above, and plateaued at 10nM, with the percentage of Foxp3+ cells reaching 40-55%
(Figure 10C). Since exogenous RA in the absence of TGF-β was unable to induce Treg
generation in vitro, the effects of this molecule seem to require TGF-β. In this regard, RA
was recently shown to enhance smad3 phosphorylation and its nuclear translocation in
Treg polarizing conditions (Nolting et al., 2009; Xiao et al., 2008). Nevertheless, RA was
capable of augmenting the frequency of Foxp3+ cells in the absence of smad3 (Nolting
et al., 2009). Therefore, although RA may influence other aspects of TGF-β signaling in
the absence of smad3, another plausible explanation is that RA signals complement the
effect of TGF-β signals. Regardless of these interpretations, TGF-β appears requisite for
the establishment of a baseline level of Foxp3 differentiation, in vitro, at least.

To determine the signaling pathway utilized by RA to induce this outcome, naïve
CD4+ T cells deficient in retinoic acid receptor alpha (Rara), beta (Rarb), or gamma
(Rarg), respectively, were incubated with WT SpDC in Treg polarizing conditions, with or
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without RA. Strikingly, only in the absence of RARα did RA fail to enhance the frequency
of Foxp3+ T cells recovered in cocultures (Figure 11A). Indicative that RARα was an
important transcriptional effector of RA driven pathways, α4β7 upregulation was also
attenuated in the absence of this gene (Figure 11B). Not examined in these
experiments was whether the effect of other isoforms, such as 9-cis RA, was also
diminished in the absence of RARα. This form of RA, although not readily detected in
vivo, was also shown to enhance Foxp3 generation (Mucida et al., 2007).

Figure 11. RA signaling through RAR-alpha enhances Foxp3+ Treg generation.
(A) Naïve CD4+ T cells from Rara, Rarb, or Rarg deficient mice and their WT littermates
were cocultured at a 10:1 ratio with WT SpDC in Treg polarizing conditions, ± RA (10nM).
Intracellular Foxp3 expression was assessed on day 5. Bars depict the average percent
increase (of duplicate samples) in the proportion of Foxp3+ T cells recovered when
cultured with RA. Percent increase was calculated based on the average frequency of
Foxp3+ T cells recovered from duplicate wells cultured w/o RA. Error bars mark the high
and low values. (B) α4β7 expression was measured on total CD4+ T cells after coculture.
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Exogenous RA in the presence of TGF-β in LpDC cocultures also increased the
proportion of Foxp3+ T cells generated and diminished the intrinsic differences between
CD103+ and CD103– subsets’ abilities to induce Treg (Figure 12A). Notably, in LpDC
cultures containing the CD103+ subset, in which the frequency of Foxp3+ cells was
already high, RA exerted a more dramatic effect on α4β7 than on Foxp3 expression. This
suggested that the signaling pathways evoked by RA for the generation of Foxp3 and
upregulation of α4β7 may differ, independent of their dependency on RARα, and that the
effects of RA on the regulatory pathway is saturated at smaller concentrations of RA.
Interestingly, addition of RA to CD103+ LpDC cocultures stimulated without TGF-β, in
which a small frequency of Foxp3+ T cells was already induced, did not lead to the
expansion of this population (data not shown), indicating that the endogenous level of
RA is not the limiting component in these conditions.
The accumulating data suggested that the capacity of LpDC to synthesize RA
was, in part, responsible for Foxp3+ Treg induction observed in these cocultures. To
address this hypothesis the synthetic RA receptor antagonists LE540 and LE135 (RAi)
were added to LpDC cocultures in an attempt to block RA mediated signaling.
Remarkably, the addition of 1µM each of these inhibitors inhibited Treg conversion by
67% and 57% in CD103+ and CD103– LpDC cocultures, respectively (Figure 12A).
Drawing from these data, we hypothesized that RA signals conveyed by LpDC
synergized with TFG-β to favor Treg induction. In support of this, either blockade of TGFβ or RA receptor signaling resulted in a significant decline of spontaneous αCD3 induced
Treg induction by CD103+ LpDC, (87%, P < 0.0005 and 73%, P < 0.001, respectively)
(Figure 12B).
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Figure 12. RA production by LpDC is requisite for optimal Foxp3+ Treg induction.
(A) Foxp3– CD4+ T cells were cocultured with both CD103± LpDC at a 10:1 ratio in Treg
polarizing conditions. However, in some wells, RA (100nM), or the RA receptor
antagonists (RAi), LE540 and LE135 were added. Cells were subsequently stained and
assessed for α4β7 and eGFP fluorescence (Foxp3) by flow cytometry. (B) Foxp3– CD4+
T cells were cocultured with CD103+ DC and stimulated with αCD3 ± TGF-β neutralizing
antibody (isotype IgG1) or LE540 and LE135. Error bars depict the s.e.m. of three
independent experiments. Statistical significance was determined using the Student’s T
test. ns = non significant; , P < 0.001.
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Although RA receptor blockade prevented Treg generation in vitro, it remained
unclear whether vitamin A metabolism was an essential mediator of Treg induction in the
GALT upon antigen feeding. To begin to address this, a natural model of diet-induced,
vitamin A insufficiency (VAI) was employed, in which mice no longer received vitamin A in
their diet starting at day 14.5 in utero (Smith et al., 1987). At 10 weeks of age, these
mice, which displayed normal gut histology and thymic T cell development (data not
shown), were deficient in vitamin A and its derivative metabolites as evidenced by
diminished α4β7 expression on CD44hi CD4+ T cells (Figure 13A). Moreover, the capacity
of LpDC to synthesize RA, based on assessment of functional RALDH, was abrogated
during VAI (Figure 13B). These data suggested that the metabolism of vitamin A in LpDC
is controlled by a positive feedback loop. Further, they indicated that even in the event
that residual vitamin A/metabolites lingered in the VAI host, LpDC would be unable to
induce RA mediated signals during polarization.
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Figure 13. RA synthesis is abolished in vitamin A deficient diet fed mice at 10 wks
of age.
(A) Cell suspensions from Sp, mln and Lp of Ctl and VAI mice were stained for T cell
markers, α4β7, and CD44 and analyzed flow cytometrically. α4β7 expression was then
assessed on gated CD44hi CD4+ T cells. Bars depict the average values (n = 4 per
group). Error bars depict the standard deviation (s.d.). , P < 0.001. (B) Lp cell
suspensions from Ctl and vitamin A insuffient (VAI) mice were pooled (2 per group) and
incubated with the functional RALDH probe. RALDH activity on LpDC was assessed by
flow cytometry. The RALDH inhibitor, DEAB, shows the specificity of the probe.

53

To determine whether VAI mice retained the capacity to promote GALT Treg generation
upon antigen feeding, Foxp3–Ly5.2+ T cells from Foxp3eGFP X OT-II Tg mice were
adoptively transferred into Ly5.1+ VAI recipients. As expected, after 5 days of OVA
feeding, an appreciable frequency of transferred cells adopted Foxp3 in the Lp of mice
fed a vitamin A sufficient diet (control – Ctl) (Figure 14A). In contrast, transferred cells
failed to upregulate Foxp3 in any of the tissues analyzed in VAI hosts, including the Lp,
Sp and mln (Figure 14A-C). This outcome was unlikely due to a defect in antigen
presentation, as CFSE labeling indicated that OVA specific cells readily divided in
response to OVA feeding. Nevertheless, despite the breakdown of this pathway, thymic
Foxp3+ Treg development appeared grossly unimpaired in VAI animals (Figure 15A-B).
Taken together, these results unequivocally reveal a requirement for vitamin A in GALT
Treg induction in vivo.
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Figure 14. Vitamin A insufficiency results in diminished GALT Foxp3+ Treg
induction.
(A) CD45.1+ WT and VAI mice were intravenously injected with CFSE labeled, sorted
CD45.2+ Foxp3– OTII transgenic T cells and fed OVA antigen in their drinking water for 5
consecutive days. Transferred cells were assessed in the Sp, mln, and Lp for de novo
expression of intracellular Foxp3 via flow cytometry. Representative dot plots gated on
CD45.2+ CD4+ T cells show Foxp3 as a function of CFSE. (B) Summary of the
frequency Foxp3 expression in transferred cells. (C) Summary of the absolute number of
induced Foxp3+ Treg. Error bars illustrate the s.d. Statistical comparisons were performed
using the unpaired Student’s t test , P < 0.05; , P < 0.01; , P < 0.001, ns = not
significant. n = 3-4 mice per group.
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Figure 15. CD4+ T cell development appears normal in VAI mice.
(A) Thymic CD4 and CD8 profile of Ctl and VAI mice at 10 wks of age. Absolute number
of CD4 single positive cells is displayed above each dot plot. n = 4 mice per group. (B)
Cells were fixed and intracellularly stained for Foxp3. Dot plots illustrate CD25 versus
Foxp3 expression upon gating on viable CD4+ cells. The frequency of Foxp3+ cells is
summarized on the right-hand side. Each dot represents and individual mouse.
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Discussion	
  
The data herein demonstrate that the GALT environment is able to promote the
de novo generation of Foxp3+ Treg. Specifically, the findings described reveal that DC
from the small intestinal lamina propria are uniquely endowed with the capacity to induce
Foxp3+ Treg in vitro via a mechanism that, in addition to TGF-β, is dependent on the
vitamin A metabolite, retinoic acid. Underscoring the relevance of this pathway for the
development of peripheral Treg in vivo, mice devoid of RA are unable to induce Treg in
the GALT upon antigen feeding.

The induction of oral tolerance has been linked to a number of immunoregulatory
processes, including: the polarization of TGF-β (TH-3) and IL-10 (TR-1) producing T cells,
clonal deletion in the periphery, and more recently, the upregulation of Foxp3+ mRNA,
which is essential for the programming of Foxp3+ Treg cell function (Chen et al., 1995;
Chen et al., 1994; Gavin et al., 2007; Lin et al., 2007; Mucida et al., 2005). It is now clear
that Foxp3 protein expression is acquired, as well, during this process (Coombes et al.,
2007; Sun et al., 2007). The high frequency of Foxp3+ Treg, sometimes exceeding 20%,
detected within the small bowel Lp suggests that this site may serve as a niche for this
population of cells. Lending support to this hypothesis, this lab has demonstrated using a
lymphopenic transfer model that induced Foxp3+ Treg preferentially accumulate in the Lp
(Sun et al., 2007).

Based on the capacity of LpDC to induce Foxp3+ Treg, compounded with the high
frequency of these cells that was recovered from the Lp, one interpretation is that de
novo Foxp3 production occurs in situ. However, this possibility is unlikely for several
reasons:
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1. Naïve cells are rarely present in the intestinal tissue (<5% based on CD44
and CD62L staining, data not shown).
2. Though not tested on naïve T cells per se, Foxp3 could not be induced in
CD4+ T purified from the Lp. Regardless, it would be worthwhile to repeat
this experiment with Lp T cells that were isolated based on expression of
naïve surface markers.
3. From a kinetic standpoint, impressive Foxp3 induction initially occurred in
the mln and Pp. One caveat of these findings, however, is that the
adoptive transfer system that was used for these experiments involved
the injection of 1x106 OT-II T cells or less. As such, it was difficult to
identify transferred OTII cells within the Lp shortly after transfer (i.e. within
36 hrs).
4. Removal of the mesenteric lymph nodes or genetic disruption of the
ability of LpDC to migrate into them was previously demonstrated to
abrogate oral tolerance induction (Worbs et al., 2006).

It was recently revealed that the CD103+ LpDC population is the predominant migratory
subset of CD11c+MHCII+ cells within the intestinal Lp and is much more efficient than the
CD103– subset at polarizing T cells (Bogunovic et al., 2009; Schulz et al., 2009). Thus,
whether the CD103– subset plays a physiological role in GALT Foxp3+ Treg generation
and maintenance of oral tolerance is unclear. Based on their capacity to promote Treg in
vitro in the presence of exogenous TGF-β, as well as their capacity to efficiently take-up
antigen (Schulz et al., 2009), it’s plausible that these cells could act to maintain or
propagate de novo generated Foxp3+ cells. Arguing in favor for such a role,
F4/80+CD11c+CD11b+ cells, i.e. surface markers, which correspond to the CD103–
subset, were shown to prevent T cell mediated transfer colitis via IL-10 production and
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the maintenance of the Foxp3 Treg (Murai et al., 2009). Intriguingly, another study
described a macrophage-like subset, which expressed low/negative levels of CD11c,
and potently induced Foxp3+ Treg generation in vitro via IL-10 (Denning et al., 2007).
These cells were also found to express message for RALDH2 enzyme.

Although the antigen-feeding model employed in these assays favors the
emergence of Treg in the GALT, this protocol in other studies has been shown to limit
airway inflammation in a Foxp3 dependent manner (Curotto de Lafaille et al., 2008),
underscoring the circulatory capacity of these induced regulatory cells. Moreover,
suggestive that a similar tolerogenic process occurs in tissues that are in contact with
other natural sites of opportunistic entry, such as the nasal cavities, intranasal
administration of antigen also was revealed to curb airway inflammation. It would be
interesting to examine whether Foxp3+ Treg induction in this system also depends on
vitamin A metabolism. Interestingly, RA was recently demonstrated to limit airway
responses in a model of allergic asthma; however, the cellular-source of RA responsible
for these effects was not clear, nor was the dependency on Foxp3+ Treg induction
(Goswami et al., 2009).

Indeed, the capacity to synthesize RA is not restricted to GALT DC. For example,
epithelial cells are also endowed with this feature (Iwata et al., 2004). More recently, it
was revealed that the stroma of the mesenteric lymph nodes also share this capability
(Hammerschmidt et al., 2008). In fact, in elegant surgical experiments, this capacity was
demonstrably essential for the effective upregulation of α4β7 and CCR9 on newly
activated T cells upon antigen feeding. This finding indicates that, rather than merely
serving as a collecting reservoir for migrating LpDC, the mln may actively participate in
the fates of activated T cells. In this regard, it would be of interest to test how selective
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ablation of RA synthesizing capacity in the mln stroma would effect Foxp3+ Treg induction
and development of oral tolerance.
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While the potential participation of other sources of RA in the induction and
regulation of GALT Foxp3+ Treg generation remains enigmatic, the importance of
vitamin A metabolism in this process is unequivocal. Thus, VAI mice that are devoid of
vitamin A and its metabolites were unable to support the differentiation of Foxp3+ Treg in
response to antigen feeding. Based on this finding, a reasonable question to test is
whether oral tolerance is also hindered in these animals. Nevertheless, the manifold
problems that accompany VAI may confound the interpretation of such experiments.
Rather, with consideration to the importance of RA/RARα driven signals in Foxp3+ Treg
generation in vitro, it may be more straightforward to test the requirement of RARα by T
cells in this process in vivo and its significance in oral tolerance induction. However, this
experiment would first require crossing Rara–/– mice to OTII transgenic mice.

Although vitamin A metabolism is essential for GALT Foxp3+ Treg generation, it is
not sufficient. TGF-β signaling was also critical for the capacity of LpDC to induce Foxp3
in CD4+ T cells in vitro. This point was illustrated in experiments using αTGF-β mAb.
This finding, however, was not altogether surprising, as virtually every report detailing
the peripheral requirements for the generation of CD25+ or Foxp3+ Treg, both in vitro and
in vivo, has noted the critical involvement of TGF-β (Chen et al., 2003; Fantini et al.,
2004; Kretschmer et al., 2005; Wan and Flavell, 2005). Nevertheless, this is the first
demonstration that LpDC and their mln counterparts are capable to produce and/or
process active TGF-β (Coombes et al., 2007; Sun et al., 2007). Indeed, in comparing DC
subsets in the mln, Powrie and colleagues found that the CD103+ mlnDC subset was
uniquely capable of expressing TGF-β related genes (Coombes et al., 2007). Further
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highlighting the potential importance of this finding, it was recently demonstrated that the
ability of DC to activate TGF-β on their surface via integrin alpha(v) is vital to the
maintenance of intestinal homeostasis (Lacy-Hulbert et al., 2007; Travis et al., 2007).
Assimilating these findings and putting them into context with the data reported above
tempts speculation that the CD103+ LpDC population is selectively armed with this
integrin. Importantly, CD103 expression on DC is important for protection against T cell
transfer mediated colitis(Annacker et al., 2005), yet LpDC from animals genetically
deficient in this marker are still capable of synthesizing RA (Jaensson et al., 2008).
Thus, one possibility is that CD103 expression regulates the expression of alpha(v)
integrins, potentially via cellular crosstalk, as CD103’s chief binding partner is Ecadherin, which is broadly expressed throughout the GI tract.

It is still unclear why RA acts merely as a cofactor with TGF-β to enhance Foxp3
generation in vitro, yet seems absolutely required for Treg generation in the GALT.
Perhaps this discrepancy could derive from alterations to the endogenous LpDC
population in VAI mice that transcend a deficit in RA production. Related to this
possibility, deficiency in vitamin A has been shown to alter the intestinal epithelial
landscape, as well as mucous production (Cha et al.). Additionally, TGF-β activity may
also be disrupted during VAI. Consistent with this possibility, a recent study showed that
TGF-β production was impaired in follicular DC - which do not share their origin with
hematopoietic DC - from Pp of VAI mice (Suzuki et al.).
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Figure 16. TSLP signals are not
required for the ability of LpDC
to induce Foxp3+ Treg.
Foxp3– cells were cultured with Sp
or LpDC and stimulated in Treg
polarizing conditions at a 10:1
ratio for 5 days. Dot plots are
gated on CD4+ cells and the
percentages of Foxp3+ cells are
shown.

Importantly, changes in epithelial homeostasis may have broad implications on
the conditioning of DC within the Lp. For instance, intestinal epithelial production of the
cytokine, thymic stromal lymphopoietin (TSLP), was revealed to promote IL-10 secretion
by DC and diminish their capacity to polarize a TH-1 response (Rimoldi et al., 2005)
(Zaph et al., 2007). TSLP was also found to promote Treg induction in human thymic T
cells via effects on DC maturation (Watanabe et al., 2005). In light of these discoveries,
a potential role for TSLP in controlling the ability of LpDC to preferentially induce Foxp3+
Treg was evaluated. However, LpDC from TSLP receptor deficient (TSLPR–/–) mice were
as competent as their WT counterparts at promoting high frequencies of Foxp3+ T cells
in coculture (Figure 16). Moreover, these animals displayed no alterations in the
frequency and absolute number of Foxp3+ Treg across several lymphoid and nonlymphoid tissues (data not shown). Yet, it is still possible that other conditioning factors
produced by epithelia contribute to the capacity of LpDC to drive a Foxp3 program.
Highlighting this possibility, RA and TGF-β released from an intestinal epithelial line were
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shown to confer RA synthesizing capacity, CD103 and active TGF-β in conditioned bone
marrow DC (Iliev et al., 2009). Alternatively, LpDC may receive environmental cues from
other cells within the lamina propria. For example, GM-CSF secreted from an F4/80
(macrophage like) population was proposed to potentiate RA synthesizing capacity in
LpDC (Yokota et al., 2009).

In summary, the data provided here suggest that the intestinal immune system,
through the simultaneous production of TGF-β and RA, has evolved a self-contained
strategy to promote Foxp3+ Treg induction. The dual necessity for these factors would
likely restrict this process to lymphatic sites draining tissues that reside in close contact
with opportunistic points of entry, such as the gastrointestinal, nasopharyngeal, and
possibly the urogenital tract. Notably, in response to antigen feeding, Foxp3+ induced
cells were found to preferentially accumulate in the Lp tissue and were detected less
commonly in the draining mln. This may be a reflection of the sentinel role played by
these cells, which could facilitate their rapid deployment into tissue. In this regard, it
deserves mention that a recent and elegantly conducted study, which compared TCRα
sequences across various CD4+ T cell subsets in an effort to correlate TCR specificity
with peripherally versus thymically generated Foxp3+ Treg, concluded that the frequency
of peripherally generated Foxp3+ Treg was quite low (Lathrop et al., 2008). However,
several caveats in this study may have led to an underestimation of the contribution of
peripherally induced Foxp3+ T cells to the Foxp3+ Treg repertoire. First, the mice used for
analysis possessed a fixed TCRβ chain, so only alpha rearrangements could occur.
Second, the authors did not evaluate Foxp3+ Treg and non-Treg repertoires in tissue sites,
where the data described here would predict most of the induced Treg reside. Thus,
based on a high probability that the thymus and gut, as well as other tissues exposed to
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non-sterile environments maintain a degree of non-overlapping antigen repertoires, it is
plausible that peripheral Foxp3+ Treg generation potentially expands the Foxp3+ Treg
repertoire.
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Abstract:	
  
The intestinal tract is in intimate contact with the commensal microbiota. Yet, how
commensal signals communicate with cells in this tissue to ensure immune homeostasis
is still unclear. In addition, the importance of these signals in the regulation and
generation of mucosal immune responses has not been amply investigated. Continuing
from findings described in Chapter 2, this study begins with an assessment of the
influence of commensal components on the Foxp3+ Treg polarizing capacity of DC from
the intestinal lamina propria. Remarkably, only TLR9 engagement was found to have a
significant impingement on the induction of Foxp3+ Treg. Pairing these findings with work
initiated by Dr. Nicolas Bouladoux, resulted in a collaborative effort (each figure that was
a collaboration is indicated by an (*)), which produced the following data:

1. TLR9 stimulation of LpDC limited Foxp3+ Treg generation in favor of the
generation of Teff equipped with mucosal homing capacity.
2. Commensal microbiota derived DNA (gfDNA) was a natural TLR9 ligand
that impaired Foxp3+ Treg generation
3. TLR9−/− mice experienced dysregulated Treg/TH homeostasis in the GI tract,
and displayed an expansion of Foxp3+ Treg that contributed to impaired
mucosal

T

cell

responses

following

oral

Encephalitozoon cuniculi.
4.

gfDNA was a natural adjuvant of mucosal TH responses.
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Rationale:
The ability of the gastrointestinal tract and its associated lymphoid tissues to
support the induction Foxp3+ Treg may help curb untoward responses to dietary, floral
and environmental antigens, which otherwise put the host at risk for allergic
hyperresponsiveness and tissue damage (Curotto de Lafaille et al., 2008).

Yet this

mode of regulation, as well as others that are constitutively supported in this tissue must
be tempered in order to avoid compromising effective immunity. Commensal and
pathogenic microbes routinely reveal and radio their presence to the host immune
system through conserved ligands that are cardinal features of microorganisms, which
commonly signal through the toll like family of receptors (TLR) and subsequently through
the adaptor protein, Myd88 (Sansonetti and Di Santo, 2007) (Medzhitov et al., 1998).
These signals positively regulate the sampling of luminal content by DC in the underlying
Lp tissue (Chieppa et al., 2006; Niess and Reinecker, 2005), indicating that LpDC
constitutively “sense” commensals and dietary antigen. Indeed, the constant exposure of
the intestinal immune system to flora and its constituent ligands provides a rationale to
consider the physiological impact of TLR signaling not just on GALT Treg generation,
maintenance and regulation, but more broadly in the control of T cell homeostasis in this
region. Such an understanding will be critical to unraveling how regulatory thresholds are
set and overcome in the control of host tissue immunity.
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To begin to address how the commensal flora may influence peripheral Foxp3+ Treg
induction in the GALT, LpDC were cocultured with naïve CD4+ T cells in Treg polarizing
conditions and exposed to various purified and synthesized TLR ligands. With intent to
avoid direct responses of the T cells to TLR stimulation, T cells from Myd88 deficient
mice were used for these experiments. LpDC were revealed to express weak to
undetectable levels of TLRs 2 and 4, yet readily expressed message for TLRs 5 and 9
(Uematsu et al., 2008). Thus, the addition of peptidoglycan (PGN), or lipopolysaccharide
(LPS), which engage TLRs 2 and 4, respectively, only marginally affected the outcome
of Foxp3+ T cell generation in coculture (Figure 17A). The addition of flagellin (Flgn),
which engages TLR5 (Uematsu et al., 2006), also had no obvious effect on Foxp3+ Treg
induction even at a high input concentration, raising the possibility that TLR5 expression
may vary depending on the animal facility in which the mouse is reared. Conversely, the
addition of ODN1826 (CpG), which stimulates cells through TLR9, resulted in a potent
reduction in the frequency of Foxp3+ Treg recovered at the end of coculture (Figure 17AB). This inhibition was observed at CpG doses equal to or exceeding 100ng/ml (Figure
17A-B). Analysis of α4β7 revealed that rather than being inhibited, the expression of this
retinoic acid signaling dependent integrin was increased, most notably on the Foxp3
negative population (Figure 17C). Consequently, the tolerogenic and homing effects of
RA are decoupled in the presence of a strong adjuvant, such as CpG.

Cells that failed to up-regulate Foxp3 had potentially outgrown Treg cells in CpG
stimulated cocultures. To assess this, naïve TLR9−/− T cells were CFSE labeled prior to
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culture. However, gating on the Foxp3– cells indicated that they proliferated comparably
in both CpG stimulated and non-stimulated cocultures (Figure 17D). The next question
was whether TLR9 signaling could inhibit naïve T cell up-regulation of Foxp3 during
differentiation. In fact, even before Foxp3 cells had undergone a single division, their
frequency was reduced 50% in cocultures containing CpG.
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Figure 17. TLR9 signaling inhibits LpDC induced Foxp3+ Treg generation.
(A) FACS-sorted naïve CD4CD25–CD44lo T cells isolated from myd88–⁄– mice were
cultured in Treg polarizing conditions with WT LpDC at a 10:1 ratio in the presence of the
indicated TLR ligand for 5 days. PGN (TLR2), LPS (TLR4), Flgn (TLR5) or CpG (TLR9)
was added at a starting concentration of 2 µg/ml, 10 µg/ml, 1 µg/ml or 10 µg/ml,
respectively. Two subsequent five-fold dilutions of each ligand were tested (wedge).
Results were then normalized to the frequency of Foxp3+ T cells generated in Treg
polarizing conditions without TLR ligands Cross bars indicate the high and lows of
duplicate cultures. (B) Dosage effect of CpG on LpDC induced Foxp3+ Treg generation.
(C) Same as in A. Dot plots are gated on viable CD47-AAD– T cells and illustrate α4β7
versus Foxp3 expression following culture with or without CpG (10 µg/ml). (D) Naïve
CD4CD25 CD44lo T cells were isolated from TLR9−/− mice, labeled with CFSE, and
cultured as in A. CFSE dilution was assessed as a function of Foxp3 at the indicated
time points. Histogram overlay of CFSE dilution profiles for CD4Foxp3– T cells,
indicated in the boxed in regions (solid line: control; dotted line: in presence of CpG).
−
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CpG stimulation of LpDC was found to induce their production of proinflammatory
cytokines, including: IL-6, IL-12p40, and TNF-α (Figure 18A). The IL-12p40 subunit can
form a heterodimer with IL-12p35 to comprise IL-12 or with IL-23p19 to comprise IL-23;
however, these cytokines were not examined in these experiments. IL-27 was also not
examined, although it deserves mention that LpDC have been shown to express both of
the subunits comprising this cytokine, EBI3 and IL27p28 at steady-state (Oldenhove et
al., 2009). Nevertheless, in comparison to other TLR stimuli, CpG was the only one that
induced a strong proinflammatory cytokine profile by LpDC (Figure 18B). Consequently,
in place of Foxp3, TLR9 activated LpDC differentiated naïve T cells into TH capable of IL17A, IFN-γ as well as IL-4 secretion (Figure 19). Thus, coupled with its ability to induce
α4β7, TLR9 stimulation of LpDC may help shape Treg/TH composition throughout the
GALT.
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Figure 18. TLR9 stimulation of LpDC promotes robust pro-inflammatory cytokine
production.
(A) 5x104 FACS purified LpDCs were stimulated over night in the presence or absence
of CpG (1 µg/ml) in complete media supplemented with 40 ng/ml of GM-CSF.
Supernatants were assessed for cytokines by ELISA. (B) Lp cell suspensions were
stimulated with the indicated TLR ligands (1µg/ml) for 4 hrs and subsequently surface
stained with CD11b, CD11c, Class II, F4/80, and fixable live/dead dye. Upon
fixation/permeabilization, cells were stained intracellularly for IL-6, IL-12p40 and TNF-α.
Counter plots are gated on CD11chi and CD11chi CD11b+ cells.
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Figure 19. TLR9 stimulated LpDC induce Teff
programs in Foxp3+ Treg polarizing conditions.
CD4 CD25–CD44loFoxp3– T cells from Tlr9–⁄–
Foxp3eGFP mice were cultured in Treg polarizing
conditions in the presence or absence of CpG for
5 days and then restimulated with PMA +
ionomycin for assessment of intracellular cytokine
production. Cytokine percentages in bordered
regions are expressed as a percentage of viable
CD4 cells.
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Among the innate cytokines, IL-6 and IL-27 were previously reported to potently
inhibit Foxp3+ Treg generation in vitro (Bettelli et al., 2006; Korn et al., 2007). Depending
on the conditions and source of costimulation, IL-12 was shown to have a marginal to
moderate negative impact on Treg polarization (Bettelli et al., 2006; Wei et al., 2007),
while IL-23, had a minimal influence (Izcue et al., 2008). To test the relative significance
of TLR9-induced IL-6 production on the subversion of Foxp3+ Treg induction, IL-6
signaling was blocked with anti-receptor and neutralizing Abs (αIL-6) or bypassed with
LpDC genetically deficient for IL-6 (Il-6−/−). While both of these measures curbed IL-17A
production, neither was sufficient to reverse the effect of TLR9 stimulation on Treg
inhibition (data not shown and Figure 20A). Additional blockade with antibody against
IL-27p28 also failed to induce any appreciable rebound; nevertheless it is important to
note that the efficacy of this mAb was not confirmed for these assays (Figure 20A).
Assuming that αIL-27 reduced IL-27 signaling in the assays described, these data
indicated that TLR9 signaling hindered the capacity of LpDC to induce Foxp3+ Treg
through complex innate pathways. In this regard, the group that showed that IL-23 was
unable to inhibit Foxp3+ Treg induction in vitro more recently showed that the IL-23R was
a cell intrinsic regulator of the differentiation/accumulation of Foxp3+ Treg in vivo (Ahern et
al.).

As

such,

IL-23

signaling

may

negatively

regulate

Foxp3+

differentiation/accumulation in concert with other cytokines. Although further addition of
an Ab directed against IL-12p40, which has been validated to block both free IL-12p40
and the IL-12 heterodimer, in cocultures containing Il-6−/− LpDC also failed to relieve
Foxp3 inhibition, the efficacy of this Ab against IL-23 has not yet been tested (Figure
20A). In light of the effectiveness of Abs directed against αIL-6/αIL-6R, it may be
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worthwhile in the future to perform these experiments with LpDC obtained from
IL12p40−/− mice.

Intriguingly, blockade of IL-6 treatment consistently enhanced IFN-γ, IL-4, and IL-10
production (Figure 20B). While IL-10 was recently demonstrated to only slightly reduce
the frequency of Foxp3+ T cells generated in Treg polarizing conditions (Bettelli et al.,
2006), IFN-γ and especially IL-4, were revealed to antagonize Foxp3+ Treg generation in
a Stat1 and Stat6 dependent manner, respectively (Wei et al., 2007). Moreover,
enforced expression of TH-1 and TH-2 transcription factors was sufficient to effect this
inhibition in the absence of these cytokines. These findings coupled with the cytokine
modulation that occurred in the face of IL-6 blockade indicated that deviation towards TH1 and TH-2 programs, in addition to TH-17, was potentially complicit in TLR9-induced
Foxp3 inhibition. In accord with this hypothesis, the addition of neutralizing Abs against
both IL-4 and IFN-γ, in addition to αIL-6, resulted in a ~70% rebound in the frequency of
Foxp3+ Treg cells (Figure 21A and B). IL-4 neutralization drove a greater rebound in the
frequency of Foxp3+ T cells at the end of culture than IFN-γ neutralization.
Complementing these data, addition of each of these cytokines blocked LpDC-induced
Foxp3 development in a dose dependent fashion, where IL-6 exerted the most potent
inhibition at all concentrations tested. Notably, suppression was further enhanced when
the cytokines were combined (Figure 21C). These data demonstrated that TLR9
activation overrode preferential Treg induction via non-specific TH programming.
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Figure 20. TLR9 stimulated LpDC redirect polarization of T cells in Foxp3+ Treg
polarizing conditions via multiple innate pathways.
(A) CD4CD25–CD44loFoxp3– T cells from Tlr9–⁄– Foxp3eGFP mice were cocultured with
LpDCs purified from WT or IL-6−/− mice for 5 days. In wells where CpG (10µg/ml) was
added, the effect of various cytokine blocking Abs was assessed, including: αIL-27p28
and αIL-12p40/p70. Each condition was tested in triplicate. (B) Supernatants from
cocultures in A were assayed for IL-4, IFN-γ and IL-10 by ELISA. Error bars depict the
s.e.m. (#, sample was tested in duplicate; , P <0.01; , P <0.001).
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Figure 21. Partial rescue of Foxp3 development in the face of TLR9 activated
LpDCs.
(A) Naïve CD4CD25–CD44lo T cells from Myd88 / mice were cultured in Treg polarizing
conditions for 5 days in the presence or absence of CpG (10µg/ml). In wells containing
CpG, antibodies to IL-6 and IL-6 receptor α (αIL-6), IL-4 (αIL-4) and IFN-γ (αIFN-γ) were
added at the start of culture as indicated. Bracketed areas indicate the percentage of
Foxp3 cells. (B) Summary of results in A normalized to baseline Treg induction.
Crossbars represent the high and lows of conditions cultured in duplicate. (C) Blockade
of LpDC induced Foxp3+ Treg generation by IL-6, IL-4 and IFN-γ. Naïve CD4CD25–
CD44lo T cells were cocultured with LpDCs in Treg polarizing conditions. Various doses of
IL-6, IL-4, IFN-γ or a combination of all 3 cytokines were added at the start of culture.
Cytokine concentration is shown on the x-axis. In wells containing cytokine
combinations, the same concentration of each cytokine was used.
− −
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TLR9 recognizes unmethylated CpG dinucleotides, which are abundant in the DNA
of various prokaryotic species populating the GI tract (Dalpke et al., 2006). To test
whether physiological ligation of TLR9 influenced LpDC in a manner similar to CpG,
DNA was extracted from the gut content of caeca (gfDNA) and colons in naïve C57BL/6
mice and added to LpDC cocultures in Foxp3+ Treg polarizing conditions. In the absence
of a defined sequence length for gfDNA, a control condition to guarantee cellular uptake
was also included. In this condition, gfDNA was complexed to the monocationic lipid
transfection reagent, DOTAP, prior to stimulation (Bucci et al., 1992). Notably,
cathelicidins, which are a family of cationic antimicrobial peptides secreted by intestinal
epithelial cells, and innate cells, including neutrophils and macrophages, may serve a
physiologically analogous role to DOTAP, by virtue of their ability to package DNA
(Lande et al., 2007), Regardless of whether DOTAP was present, gfDNA consistently
and significantly reduced the frequency of Foxp3+ Treg recovered from culture, and
upregulated α4β7 on Foxp3− cells (Figure 22A-B). This effect was abolished when
purified LpDC from Tlr9−/− mice were used, demonstrating that gfDNA targeted TLR9.
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Figure 22. DNA enriched from the gut flora prevents Foxp3+ Treg production in a
TLR9 dependent manner.
(A) Naïve CD4CD25–CD44lo T cells isolated from WT or Tlr9–⁄– mice were cultured in
Treg polarizing conditions with LpDC from WT or Tlr9–⁄– mice, respectively. In some
culture wells, CpG (10µg/ml), DNA enriched from murine gut flora (gfDNA) or gfDNA
formulated with the cationic liposome, DOTAP, was added (DO_gfDNA). (A) Foxp3 and
α4β7 expression was analyzed on day 5. Dot plots are gated on viable CD4+ cells. (B)
Summary of results from A (normalized to the baseline Treg frequency. Error bars
represent the s.e.m. of triplicate cultures (, P <0.01; , P <0.001).
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The preceding data suggested that gfDNA/TLR9 signaling contributed to T cell
homeostasis in the GALT. To test this hypothesis, Foxp3+ Treg populations were first
assessed in various tissues of naïve Tlr9−/− and WT mice. Strikingly, Tlr9−/− mice
displayed greater percentages and absolute numbers of Foxp3+ Treg cells than their WT
counterparts throughout the GALT, including the intestinal epithelial lymphocyte (IEL),
small intestinal Lp, and Peyer’s patch (Pp) compartments (Figure 23A-C). This trend did
not extend to the mesenteric lymph nodes (mln), nor was it observed outside of the small
intestinal compartment. To exclude the possibility that these findings arose due to
distinct commensal populations residing within these animal strains, these differences
were assayed and reconfirmed in animals that were co-housed for several weeks (data
not shown). Importantly, the selective expansion of Foxp3+ Treg in the GALT was
observed in chimeric WT mice reconstituted with Tlr9−/− bone marrow, while it was
reversed in chimeric Tlr9−/− mice reconstituted with WT bone marrow (Figure 23D).
These data demonstrated that the hematopoietic compartment controlled Foxp3+ Treg
homeostasis in the GALT. Further, based on the previous in vitro experiments, it was
plausible that this likely occurred, at least in part, via constitutive gfDNA/TLR9
interactions in LpDC.
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Figure 23. (*) Hematopoietic derived TLR9 signals regulate Foxp3+ Treg
homeostasis in the gastrointestinal tract during steady-state.
(A) Comparative assessment of CD4Foxp3 Treg cells in the spleen (Sp), mesenteric
lymph node (mln), intestinal epithelium lymphocyte (IEL), intestinal lamina propria (Lp)
and Peyer’s patch (Pp) compartments of age-matched naïve WT and Tlr9–⁄– mice. Cells
gated on CD4 and TCR-β were analyzed for expression of Foxp3 and CD25 by flow
cytometry. Numbers in quadrants refer to the percentage of each subset. (B) Summary
of Treg frequencies in naïve WT (closed circle) and Tlr9–⁄– (open circle) mice. cLp = colon
lamina propria. Each dot represents the results from one experiment (three mice pooled
per group). Crossbars depict the mean of three independent experiments. (C) Same as
B, but a summary of the absolute number of Treg. (D) Frequency of Foxp3 Treg was
analyzed in various tissues of BM chimeric mice, in which the hematopoietic or the nonhematopoietic compartment lacked TLR9 expression. CD45.1+ cells were gated on CD4
and TCR-β, and then analyzed for Foxp3 expression. (, P <0.05; , P <0.01; , P
<0.001)

To further probe how constitutive TLR9 signaling shaped the T cell landscape in the GI
tract, Lp tissue cell suspensions, in which most conventional αβ T cells are of the CD4+
lineage, and IEL tissue cell suspensions, in which a majority are of the CD8+ lineage,
from both WT and Tlr9−/− mice were restimulated with phorbol 12-myristate 13-acetate
(PMA) and ionomycin, and then analyzed for cytokine production. In Tlr9−/− mice, a
significant reduction in both the frequency and absolute number of IL-17A and IFN-γ
producing cells was observed in the Lp compartment, while IL-10 was less affected
(Figure 24A-B). A similar reduction in the frequency and absolute number of IFN-γ
producing cells was also observed in the IEL of Tlr9−/− mice (Figure 24A-B). Thus, the
loss of TLR9 signaling in the GI tract resulted in disequilibrium of T cell subset
distribution within this tissue, culminating in an expansion of Foxp3+ Treg cells and a
concomitant reduction in TH cells.
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Figure 24. (*) TLR9 signaling contributes to the basal TH tone of the GI tract.
(A) Thy 1.2 enriched cells from the Lp and IEL compartments were stimulated with
PMA+ionomycin, and then stained intracellularly for IL-10, IL-17 and IFN-γ. Cytokine
percentages in bordered regions are expressed as a percentage of CD4 cells. (B) A
summary of the absolute numbers of CD4 and/or CD8α T lymphocytes expressing
IFN-γ and IL-17 in naïve WT (closed circle) and Tlr9 / (open circle) mice. Each dot
represents a single mouse and each bar delineates the mean. (, P <0.05; , P <0.01;

, P <0.001).
− −
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The profound influence of constitutive TLR9 signaling on the activation status of
T cells within the GI tract suggested that gfDNA/TLR9 interactions played a potential role
in establishing and amplifying protective immunity to pathogenic encounters in the
GALT. To test this, Tlr9−/− and WT mice were infected with the obligate intracellular
fungal parasite, Encephalitozoon cuniculi, (E. cuniculi), which naturally infects its host
through the alimentary tract and belongs to the microsporidia phylum (Didier, 2005). In
addition to the oral route, E. cuniculi induces a productive TH-1 response following
intraperitoneal (IP) challenge (Khan and Moretto, 1999; Moretto et al., 2004). To assess
whether any systemic priming defects were present in Tlr9−/− mice, animals were first
inoculated with E. cuniculi IP Measurement of the cardinal TH-1 cytokine, IFN-γ, following
in vitro antigen recall on day 11 of infection demonstrated that Tlr9−/− mice mounted
immune responses that were comparable to their WT counterparts (Figure 25A).
Parasite burdens were also similar between knockout and WT animals (Figure 25B).
Together, these data indicated that systemic priming did not require TLR9 signaling.
They further implied that TLR9 recognition of E. cuniculi was dispensable for triggering
immunity to this parasite.
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Figure 25. (*) Systemic priming and immunity to E. cuniculi is independent of
TLR9 signaling.
WT and Tlr9–⁄– mice were infected with 5×106 freshly isolated E. cuniculi spores i.p.
(A) On day 11 of infection, pooled, single cell suspensions from various tissues were
incubated in triplicate with uninfected (DC) or E. cuniculi-infected BMDC (inf. DC).
ELISA was performed on supernatants 72 hrs later. Histograms depict the mean
cytokine concentration ± s.d. (B) Measurement of parasite load in the duodenum and
liver using quantitative real-time pcr. Each dot represents an individual mouse. n = 5 per
group. Bars indicate the means.
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In contrast to IP inoculation, oral inoculation with E. cuniculi produced a significantly
different picture in Tlr9−/− and WT mice. Specifically, antigen specific IFN-γ and IL-17A
production were severely impaired in the IEL and LP of Tlr9−/− mice, manifesting in
defective parasite clearance both in the primary (duodenum) and dissemination (liver)
sites of infection (Figure 26A-B). Consequently, systemic immune impairments,
determined by splenocyte recall of IFN-γ and IL-17A production, were also observed
(Figure 26A). There are numerous instances illustrating that inefficient control of
parasitic infection can be a consequence of improper T cell polarization (Else et al.,
1994; Scott, 1991; Zaph et al., 2007). Nevertheless, although impaired TH-1 and TH-17
responses were accompanied with higher systemic concentrations of IL-10 and IL-4,
deviation towards a (TH-2) response was not observed in the GALT of Tlr9−/− mice
(Figure 26C and data not shown).
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Figure 26. (*) Immunity to oral infection with E. cuniculi is dependent on TLR9
signaling.
WT and Tlr9–⁄– mice were infected by gavage with 5×106 freshly isolated E. cuniculi
spores. (A) On day 11 of infection, pooled, single cell suspensions from various tissues
were incubated in triplicate with uninfected (DC) or E. cuniculi-infected BMDC (inf. DC).
ELISAs for IFN-γ and IL-17 were performed on supernatants 72 hrs later. Histograms
depict the mean cytokine concentration ± s.d. (B) Measurement of parasite load in the
duodenum and liver using quantitative real-time pcr. Bars indicate the means. (C) Same
as in A measuring IL-10 and IL-4. (# = not detected; n.s. = not significant; , P <0.01;

, P <0.001). Each dot represents an individual mouse. n = 5 per group.
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Increased Foxp3+ Treg cell frequencies within the intestinal tissue persisted in
orally infected Tlr9−/− mice (Figure 27A). These cells have the capacity to negatively
modulate the effector stages of infectious immunity through both antigen specific and
non-specific means (Belkaid and Tarbell, 2009; Oldenhove et al., 2009; Shafiani et al.).
Thus, it was possible that the enhanced number and frequency of Foxp3+ Treg in the GI
tract contributed to the impaired TH response that ensued following oral inoculation with
E. cuniculi. To address this hypothesis, WT and Tlr9−/− animals were treated with an
antibody against CD25 (clone PC-61), an activation marker mainly restricted to Foxp3+
Treg during steady-state conditions (Fontenot et al., 2003; Khattri et al., 2003). This
antibody was previously shown to reduce the absolute number of Foxp3+ Treg by as
much as 50% in vivo and inhibit CD25 expression (Couper et al., 2007). Although CD25
is also a hallmark of activated T cells, the depletion protocol employed for these assays
consistently enhanced pro-inflammatory TH-1 cytokine production in both WT and Tlr9−/−
mice, suggesting that bystander loss of TH cells did not pose a significant confounding
element to consider in the interpretation of infectious outcomes in treated animals
(Figure 27B). Strikingly, α-CD25 treatment markedly improved parasite clearance in the
duodenum and liver of infected Tlr9−/− mice, while having no discernible effect in WT
mice, in which parasite burdens were already relatively low (Figure 27C). While these
data argue that the elevated proportion of Foxp3+ Treg (in the GI tract of Tlr9−/− mice)
constituted a barrier to efficacious mucosal immunity upon oral challenge, Lp IFN-γ
production was still reduced in α-CD25 treated Tlr9−/− animals in comparison to isotype
Ab treated WT animals post-infection. Based on the low expression of CD25 on Treg in
the Lp, one explanation was that α-CD25 failed to trigger sufficient depletion of these
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cells in this tissue. The implication of this type of scenario could be that Foxp3+ Treg
negatively regulate the amplitude and/or maintenance of TH responses in situ. However,
a previous report demonstrated that TLR9 signaling in DC made TH resistant to Treg
regulation (Pasare and Medzhitov, 2003), indicating that gfDNA/TLR9 interactions may
also promote TH responses independent of Treg.

Figure 27. (*) The expansion of Treg in the GI tract contributes to impaired mucosal
immunity in the absence of TLR9.
WT and Tlr9–⁄– mice were infected by gavage with 5×106 freshly isolated E. cuniculi
spores. (A) On day 11 of infection, the percentage of CD4Foxp3 Treg cells in various
tissues was assessed via flow cytometry. (B-C) Mice 3 days preceding and on day 0 and
day 7 of infection were injected i.p. with αCD25 or isotype control Ab (Isot). (B) In vitro
recall was performed as described in Figure 26A. Histograms depict the mean cytokine
concentration ± s.d. (C) Measurement of parasite load in the duodenum and liver using
quantitative real-time pcr. Each dot represents an individual mouse. n = 5 per group.
(, P <0.05; , P <0.01; , P <0.001).
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Gut	
  flora	
  DNA	
  from	
  conventional	
  gut	
  flora	
  is	
  a	
  natural	
  adjuvant	
  of	
  intestinal	
  
immune	
  responses	
  
Taken together, the preceding in vitro and in vivo data suggested that
commensal gfDNA engagement of TLR9 provided pro-inflammatory cues during both
steady-state and pathogenic challenge, thereby promoting mucosal immunity. To test
this, the impact of other gut floral signals in the GI tract were minimized by placing mice
on a cocktail of antibiotics (ATB) (Rakoff-Nahoum et al., 2004), while LPS, CpG, or
gfDNA was provided orally once per week. 6 wk into treatment, mice were orally infected
with E. cuniculi. While the frequency and absolute number of CD4 and CD8 T cells
remained comparable between all different treatment groups (data not shown), ATB
treated mice mounted noticeably impaired IFN-γ and IL-17A responses in both the IEL
and Lp compartments (Figure 28A). Paralleling these impairments, parasite burden was
consistently elevated in ATB treated animals (Figure 28B). These data demonstrated
that the commensal flora were required to promote and sustain mucosal immune
responses. Providing back LPS (a TLR4 ligand) led to a restoration of the systemic
immune response to E. cuniculi in ATB treated animals, based on the IFN-γ recall
response in the spleen. However, this commensal product failed to boost the immune
response in the small intestinal Lp (Figure 28C). As such, the parasite burden in LPS
treated mice remained elevated and comparable to mice receiving ATB alone (Figure
28B). In contrast, the addition of CpG induced a significant rebound in systemic cytokine
production and propelled mucosal IFN-γ and IL-17A cytokine production to levels
observed in control (Ctl) mice, which did not receive any ATB (Figure 28A and C).
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Figure 28. (*) Gut floral DNA restores immune responses in commensally depleted
mice orally infected with E. cuniculi.
3 wk old mice received a commensal depleting antibiotic cocktail (ATB) in their drinking
water for 6 weeks and, in tandem, received oral weekly treatments of PBS vehicle or
100 µg of CpG, 500 µg gfDNA, or 25 mg/kg of lipopolysaccharide from Escherichia coli
(LPS). Control mice received no ATB treatment. Mice were infected orally with
E. cuniculi after 6 weeks of treatment. (A) On day 11 of infection, pooled IEL and Lp
suspensions from each group were restimulated as previously described. Supernatants
were assessed for IFN-γ and IL-17 by ELISA. Histograms depict the mean cytokine
concentration ± s.d. (B) 8 wk-old mice were treated and infected as described in A.
Parasite burden was evaluated in the duodenum and liver on day 11 of infection by
quantitative real-time PCR. Each dot represents one mouse and each bar the mean of
three or four mice analyzed (C) Cell suspensions from B were in vitro restimulated and
IFN-γ production was measured by ELISA. n.s. = not significant; , P <0.05; , P <0.01;

, P <0.001.

This recovery of the mucosal response in CpG treated animals was also associated with
a reduced parasite burden (Figure 28B). These data suggest that flora derived TLR9
signaling is a significant driver of mucosal immunity. Nevertheless, ATB treating Tlr9−/−
mice also resulted in a reduction in the mucosal immune response, confirming that other
commensally derived components can amplify mucosal immune responses, either
normally or through compensatory mechanisms when TLR9 signaling is deprived or
disrupted (data not shown). Strikingly, gfDNA restored the mucosal response to E.
cuniculi in WT ATB treated mice, but not in Tlr9−/− mice (Figure 28-B and data not
shown). Thus, gfDNA functions as a natural TLR9 specific adjuvant of mucosal immune
responses.
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Discussion	
  
The tissues of the GI tract are constantly exposed to TLR ligands harbored by
the commensal gut flora (Pamer, 2007); yet how these interactions factor into the
regulation and development of immunity in this region have not been investigated in
depth. The data revealed in this study, demonstrated that TLR9 stimulation, via gfDNA,
antagonizes the Treg polarizing capacity of LpDC. As such, in the absence of natural
TLR9 signals in vivo, the GI tract harbored an expanded frequency of Foxp3+ Treg and a
concomitant reduction in TH, which in turn subdued the development of an efficient
protective response upon mucosal challenge. Loss of TLR9 signaling in the
hematopoietic compartment recapitulated this homeostatic dysregulation.

Strikingly,

orally introduced gfDNA potently adjuvanted the mucosal response to infection with E.
cuniculi, when signals from other gut floral compents were diminished. Altogether, these
data highlight the importance of in situ signaling from gut floral components in the
generation of protective immune responses at sites of mucosal challenge.

Stromal	
  vs	
  hematopoeitic	
  TLR9	
  engagement	
  	
  -‐	
  controlling	
  injury	
  vs	
  immunity	
  
In contrast to hematopoeitic cells, which recognize TLR9 intracellularly (AhmadNejad et al., 2002; Latz et al., 2004), epithelia in the GI tract basally express TLR9 on
their surface (Ewaschuk et al., 2007; Lee et al., 2006). Although intracellular
compartmentalization was revealed as a prerequisite for TLR9 activation in antigen
presenting cells (Ewald et al., 2008), physiologically acidic environments may confer
functional activity to TLR9 expressed on epithelial surfaces. In this regard, epithelial
driven TLR9 signals were shown to promote the expression of proteins that drive Paneth
cell maturation and have the potential to regulate flora composition, thereby linking
lumenal signals from gfDNA to intestinal homeostasis (Lee et al., 2006). Accordingly, the
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absence of TLR9 led to exacerbated colitis induced by oral administration of the
polysaccharride, DSS, which disrupts epithelial integrity and facilitates bacterial
translocation (Lee et al., 2006; Okayasu et al., 1990). These findings were reminiscent of
an earlier study, which revealed that commensal sensing by the intestinal epithelial
compartment was essential for recovery from DSS induced colitis (Rakoff-Nahoum et al.,
2004).

Coupled with a study demonstrating the MyD88 dependece of Paneth cell

mediated barrier protection (Vaishnava et al., 2008), these findings suggest that
gfDNA/TLR9 interactions on the intestinal epithelia promote barrier protection and
facilitate recovery from acute intestinal epithelial injury.

While intestinal epithileal sensing of gfDNA appears to drive mucosal
homeostasis through barrier repair and maintenance of tissue integrity, this function is
distinct from gfDNA‘s impact on steady-state T cell equilibrium within the GI tissue. Thus,
the absence of TLR9 expression in the hematopoeitic compartment was sufficient to
promote Foxp3+ Treg expansion within the GI tract. Further, although the data were not
presented here, this absence resulted in an attenuated immune response to oral
infection with E. Cuniculi (Hall et al., 2008). The question then to arise from these
findings is which hematopoeitic cells does gfDNA signal through to drive robust mucosal
immune responses. In this study, LpDC were singled out: first, for their known function in
initiating primary immune responses (Banchereau and Steinman, 1998); second, for
their capacity to sense luminal bacterial components (Chieppa et al., 2006). Indeed,
engaging LpDC with TLR9 ligands, including gfDNA, hindered their capacity to promote
a Foxp3+ Treg program in Treg polarizing conditions, and instead could promote T cell
differentiation into TH-17, TH-2 or TH-1 cells. This in vitro finding remarkably paralleled
the differences in ex vivo activation statuses that was observed between CD4+ T cells
isolated from the Lp of WT versus Tlr9−/− mice. Consistent with a role for LpDC in the
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effector status of T cells in the GI tract, temporary ablation of LpDC via oral
administration of diptheria toxin (DT) to mice expressing a Diptheria toxin receptor
transgene under the control of the CD11c promotor (CD11c-DTR) was shown to reduce
constitutive TH-17 production in the Lp (Denning et al., 2007).

TLR9	
  signaling	
  on	
  other	
  immune	
  cells	
  
Nevertheless, gfDNA signaling may act on other immune cell populations
besides DC within the GI tract, which in turn could contribute to the promotion and
maitenance of mucosal immune responses. In this regard, DT administration to CD11cDTR mice would likely ablate resident macrophages in addition to DC in the Lp, since
they also express CD11c. Indeed, based on the current controversy and difficulty
associated with discerning Lp macrophages from classical LpDC (Varol et al., 2009);
Schulz, 2009 #1360}, it is possible that the LpDC preperations used in the experiments
described above contained some proportion of contaminating macrophages. As such,
TLR9 ligands may also act directly on macrophages, which themselves or indirectly via
effects on LpDC could provide inflammatory cues to naive T cells in culture or to already
activated cells in situ. Plasmacytoid DC also reside within the intestinal Lp (Yrlid et al.,
2006a) and their activation in situ can direct the migration and maturation of CD103+
LpDC (Yrlid et al., 2006b). Thus, it would be interesting to assess whether gfDNA can
induce pDC activation, which may facilitate antigen transport into the draining mln.
Based on their potent capacity to produce type I IFNs upon stimulation, secretion of
these cytokines upon stimulation in vitro could first be examined to address this
possibility (Theofilopoulos et al., 2005).
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Recent studies have indicated that MyD88 intrinsic signals promote sustained T
cell responses in various infection models (LaRosa et al., 2008; Rahman et al., 2008).
Along these lines, TLR9 expression has been reported in naive and activated CD4+ T
cells (Gelman et al., 2004). Further, TLR9 activation via CpG was shown to directly
enhance T cell proliferation and Teff survival (Gelman et al., 2006). Based on these
findings, one could speculate that gfDNA also provides survival/activation cues directly
to T cells in the GI tract. This possibility could be investigated with the generation of
50:50 (Tlr9−/−/WT) mixed bone marrow chimeras.

TLR9	
  signaling	
  –	
  polarization	
  versus	
  amplification	
  	
  
The implication that other immune cell populations are directly affected by the
sensing of gfDNA and that these TLR9 interactions contribute to the efficacy of mucosal
immune responses raises another important question, at what step of the immune
response is gfDNA sensing the mucosal response? The evidence that the ability of
LpDC to polarize a regulatory respnse is abrogated upon TLR9 engagement would
suggest that gfDNA sensing plays a role in polarization. However, this has not been
confirmed in vivo, and is difficult to do in an infection for which immunodominant
peptides are not known, such as E. cuniculi.

Although not described in the data section, the importance of TLR9 stimulation in
the GI tract was also verified using the mucosal adjuvant, LT(129G) (a non-toxic mutant
of the E. coli labile toxin) (Chong et al., 1998), which was administered in conjuntion with
OVA as a model antigen. This vaccination protocol is typically administered several
times prior to assessment of the immune response; however, if the vaccine were
introduced into WT or Tlr9−/− mice that were adoptively transferred with CD4+ T cells
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expressing the OT-II transgene, then a potential contributing role of gfDNA/TLR9
interactions to Teff polarization could be better investigated. A role for gfDNA/TLR9
interactions in GALT Teff polarization notwithstanding, the sensing of gfDNA may also
amplify mucosal immune responses directly in situ. While this possibility could still
implicate LpDC, gfDNA interactions with resident macrophages, resident plasmacytoid
DC, TH, as well as Foxp3+ Treg, would need to be considered.

In	
  situ	
  regulation	
  of	
  immune	
  responses	
  via	
  Foxp3+	
  Treg	
  
The selective expansion of Foxp3+ Treg in the GI tract of Tlr9−/− mice strongly
correlated with the specificity of the immune impairments in response to the mucosal
route of challenge. Moreover, partial Treg depletion with αCD25 during infection led to a
resurgence both in mucosal cytokine production and parasite clearance. Together, these
data argue that the expansion of these cells was complicit in the suboptimal
development/maitenance of mucosal immune responses in the absence of gfDNA
sensing. In addition to augmented numbers, there is also recent evidence that the
absence of TLR9 increases Foxp3+ Treg suppressive function in a cell intrinsic manner.
This is based on unpublished data from Dr. Nicolas Bouladoux of the lab as well as a
recent report showing that CpG hindered Treg suppressive capacity in vitro (data not
shown) (Larosa et al., 2007). As there have been multiple recent demonstrations of the
ability of Foxp3+ Treg to inhibit a variety of innate processes, including: DC differentiation
from immediate precursors (Liu et al., 2009), DC migration from tissues (Zhang et al.,
2009a), not to mention inflammatory chemokine production from multiple cell sources,
such as DC, NK cells and stroma (Lund et al., 2008), the impact of augmented Treg
proportions in the GI tract of Tlr9−/− mice could be two-fold.
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gfDNA/TLR9	
  intreactions	
  and	
  T	
  cell	
  homeostasis	
  in	
  the	
  GI	
  milieu	
  	
  
Although their steady-state increase is likely one of the root causes of impaired
mucosal immunity, the mechanisms that drive Foxp3+ Treg expansion in the absence of
TLR9 signals within the GI tract are still unclear. Based on the in vitro data presented
here, one potential explanation is that gfDNA/TLR9 interactions place natural constraints
on extrathymic GALT Treg generation. Indeed TLR9 engagement of LpDC drove multiple
proinflammatory signals, including: IL-6, IL-12/23p40, and likely IL-27 (although not
investigated in these studies), which alone or in concert have been shown to impede the
development of Foxp3+ Treg in vitro and/or in vivo (Bettelli et al., 2006; Korn et al., 2007)
(Ahern et al.; Wei et al., 2007). IL-6−/− mice, in particular, display several features that are
reminiscent of Tlr9−/− mice. First, they lack TH-17 cells in the intestinal Lp during steadystate (Ivanov et al., 2006). Second, they fail to mount robust immune responses, on
account of an inability to overcome Treg suppression (Korn et al., 2007; Pasare and
Medzhitov, 2003). Thus, the effect of IL-6 blockade on LpDC induction of Foxp3+ Treg
was tested during TLR9 stimulation in vitro. Rather than restoring Foxp3+ cell
generation, both antibody blockade and coculture with IL-6−/− LpDC resulted in enhanced
TH-1 and TH-2 cytokine production, while impeding TH-17. These data emphasize that
TLR9 sensing induces an inflammatory cytokine profile with the potency to induce a
diversity of Teff programs, which are indeed observed in the GI tracts of WT mice during
steady-state. While further attempts at innate cytokine inhibition also failed to rescue
Foxp3+ Treg generation (suggesting that a microarray screen of TLR9 engaged LpDC
versus an unstimulated control may be useful, to acquire a full sense of the inflammatory
signature that results), antibodies against IL-4 and IFN-γ in addition to IL-6 led to a
significant restoration. Both IL-4 and IFN-γ were recently revealed to inhibit Treg
development in vitro (Wei et al., 2007). Further, IL-4 in conditions containing TGF-β was
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shown to induce IL-9 secretion by T cells (TH-9) (Dardalhon et al., 2008; Veldhoen et al.,
2008b), a cytokine whose role in intestinal homeostasis is not clear and which was not
examined in these experiments. The transcription factor, interferon regulatory factor -4
(IRF-4) is essential for TH-2, TH-17, and TH-9 development (Brustle et al., 2007; Staudt et
al.). In light of these findings, it would be interesting to assess how steady-state IRF-4
expression in T cells within the GI tract is affected by gfDNA sensing.

Controll	
  of	
  extrathymic	
  Foxp3+	
  Treg	
  generation	
  	
  
If extrathymic GALT Foxp3+ Treg generation is controlled by gfDNA sensing, an
important consideration is the stage at which this inhibition is occurring. The two
scenarios that are known to induce Foxp3 in T cells within the GALT are lymphopenia
and oral exposure to antigen in the absence of pathogenic signals (Coombes et al.,
2007; Lathrop et al., 2008; Sun et al., 2007; Zheng et al.). Mice are obviously in a state
of lymphopenia immediately after birth and the time after weaning might also represent a
time of dynamic change within the GI tract upon loss of maternal antibodies. Thus, it
would be worthwhile to measure the number and frequency of Foxp3+ Treg within the GI
tract of WT and TLR9−/− mice as a function of age, which would offer insight into when
gfDNA sensing limits the de novo generation and/or expansion of these cells. Foxp3+
Treg induction in response to exposure to antigen traversing the gut is also likely a
dynamic process. As such, these cells may turn over very fast and their acquisition of a
Foxp3 program may at early time points be subject to destabilizing factors, such as
gfDNA, both at sites of priming and in Lp tissue itself. Therefore, the absense of TLR9
signals may promote an induced Foxp3+ Treg that is longer lived. An alternative possibility
with a similar outcome is that in the absence of TLR9 signaling, signaling by other TLRs
can gain precedence. TLR2 signaling, for example favors Treg cell expansion through

99

both cell intrinsic (Liu et al., 2006; Sutmuller et al., 2006) and cell extrinsic means. The
latter being regulated via the induction of retinoic acid synthesizing capacity in DC
(Manicassamy et al., 2009). Accordingly, Foxp3+ Treg cell frequencies are decreased in
TLR2−/− mice (Liu et al., 2006; Sutmuller et al., 2006). Altogether, these findings suggest
that TLR ligands can discretely influece T cell homeostasis in the GI tract, which may
explain why MyD88−/− and MyD88−/− Trif−/− mice have no apparent gross changes in the
frequency of Foxp3+ Treg or TH-17 cells in this tissue (Atarashi et al., 2008; Cha et al.;
Ivanov et al., 2008; Min et al., 2007).

Not	
  all	
  TLR	
  ligands	
  are	
  created	
  equal	
  
Minimization of gut floral signals with broad-spectrum antibiotic treatment
(ATB) also impaired the mucosal immune response to infection with E. Cuniculi and
resulted in a concomitant increase in parasite burden. TLR9 but not TLR4 activation was
sufficient to rescue immune responses in ATB treated animals, illustrating both the
discrete functions of individual TLR ligands in the promotion and regulation of immunity
and the potency of TLR9 engagement as an adjuvant. Intriguingly, TLR4 activation with
LPS, while failing to improve parasite control and immune responses within the GI tract,
elicited a complete rebound in the systemic cytokine response to oral E cuniculi
infection. This finding is consistent with recent reports illustrating that peripheral TLR4
signals, which occur upon floral translocation, can enhance the activation status of T
cells (Brenchley et al., 2006; Paulos et al., 2007). Despite these findings, however, TLR4
signals may also operate in other ways, specifically within the GI tract. In this regard,
exposure of the intestinal epithelia to LPS during birth was found to result in tolerance of
this tissue to subsequent LPS stimulation (Lotz et al., 2006). More recently, LPS
engagement of TLR4 was also revealed to temper T cell activation via enhancement of
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phosphatase activity in a cell intrinsic manner (Gonzalez-Navajas et al.). This may be
especially relevant in sites where T cell interactions with LPS are likely, such as the
GALT.

The experiments in this study illustrated that DNA purified from the entire gut
flora exerted an adjuvant effect on mucosal immune responses; yet it is important to
bear in mind that gut flora bacteria possess differential capapacities to stimulate TLR9
(Dalpke et al., 2006). Moreover, some DNA motifs may, in fact, exert inhibitory effects on
TLR9 activation or actively promote regulatory features, which are still dependent on
TLR9 (Trieu et al., 2006). As such, experiments are currently underway by other
members of the laboratory to address whether gfDNA derived from different commensal
species imparts specific effects on the development, control and maintenance of
mucosal immune responses and whether these effects can be extrapolated to the types
DNA motiffs present in these species.

TLR9	
  in	
  other	
  infections	
  
In contrast to sterile sites, mucosal sites in the body are in ritual contact with
commensals and their byproducts. The finding that Tlr9−/− mice exhibited a specific
mucosal defect in response to infection, in this instance the fungal parasite, E. cuniculi,
suggested that gfDNA/TLR9 interactions in the GI tract shape mucosal immune
responses through release of immunoregulatory elements. One in particular that was
showcased in these findings was immunosuppression via Foxp3+ Treg. Previous
immunological studies of infections that are initiated at mucosal sites, such as
Toxoplasma gondii and Herpes simplex virus, have also defined a role for TLR9 in the
regulation of mucosal inflammation and viremia, respectively (Lund et al., 2006; Minns et
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al., 2006). Although TLR9 is clearly important in the recognition of these microbes, it is
also plausible that the absence of gfDNA/TLR9 interactions at these sites of challenge
both during steady-state and infection could have additional bearing on the phenotype
observed.
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CHAPTER	
  4:	
  Essential	
  role	
  for	
  retinoic	
  acid	
  in	
  the	
  promotion	
  of	
  CD4+	
  T	
  cell	
  
effector	
  responses	
  via	
  retinoic	
  acid	
  receptor	
  alpha	
  
	
  
Abstract:	
  
The data presented in Chapter 2 along with numerous recent reports indicate
that the vitamin A metabolite, retinoic acid (RA), promotes Foxp3+ Treg induction in vitro
and in vivo. However, incorporation of the data from Chapter 3 into these findings also
suggested that RA signaling, rather than suppressing the differentiation of Teff cells,
could also promote their migration into the intestinal mucosa. While an initial
interpretation of these findings could suggest context dependent roles of RA during
tolerance and infection, they also could imply that RA possesses a more fundamental
function in the regulation of T cell activation/differentiation. To begin to address this
hypothesis, immune responses to the parasite, T. gondii, and the mucosal adjuvant,
LT(R129G), were examined in mice reared on a vitamin A deficient diet. Unexpectedly,
these studies led to the following insights:

1. TH-1 and TH-17 immunity were abrogated in the absence of vitamin A
metabolites.
2. Retinoic acid rescued TH-1 and TH-17 immune responses in the absence of
vitamin A.
3. RA receptor alpha expression was necessary for CD4+ T cell immunity and
homeostasis.
4. RA receptor driven signals maintained the ability of T cells to properly
respond to TCR/CD3 stimulation in a cell intrinsic manner.
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Rationale:	
  
In Chapter 2, LpDC and their migratory counterparts in the mesenteric lymph
nodes were revealed to be specially equipped with the capacity to induce Foxp3+ Treg
(Coombes et al., 2007; Sun et al., 2007). This feature was dependent on their ability to
convey both TGF-β and retinoic acid mediated signals to T cells. At approximately the
same time that these findings emerged, other groups demonstrated that exogenous RA
was able to: reduce TH-17 polarization via inhibition of IL-6 and IL-23 receptors (Elias et
al., 2008; Mucida et al., 2007; Xiao et al., 2008); facilitate Foxp3 induction in the face of
high levels of costimulation (Benson et al., 2007), and negatively modulate cytokine
production by effector/memory T cells during restimulation (Hill et al., 2008). Prior to
these reports, RA was also shown to promote IgA-secreting plasma B cell differentiation
(Mora et al., 2006). Altogether, these findings reinforced an emerging perception that RA
drove anti-inflammatory programs and synchronized with the paradigm of mucosal
tissues as hypo-responsive environments during steady-state conditions. Nevertheless,
in the event of pathogenic exposure, overcoming these regulatory hurdles is essential
and how RA is integrated into this framework is unclear. In Chapter 3, adjuvant
activated LpDC were revealed to lose their capacity to induce Foxp3+ Treg; however, this
effect was likely not a consequence of impaired RA signaling, as the RA-inducible
integrin heterodimer, alpha4beta7 (α4β7) was strongly upregulated on Foxp3– T cells.
Indeed, α4β7 upregulation is a well-appreciated hallmark of T cells activated in the GALT,
which in turn drives their migration into the GI tract (Johansson-Lindbom et al., 2003).

Deficiency in vitamin A, which is the precursor of RA, is known to manifest in
susceptibility to mucosal infections (Sommer, 2008; Underwood, 2004). Although this
susceptibility, in part, may be driven by impairments in epithelial barrier protection
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(Biesalski and Nohr, 2004; Stephensen, 2001), to date, the in situ regulation of mucosal
CD4+ T cell responses via RA and/or other retinoids has not been investigated. Gaining
an understanding of these pathways will help unravel how vitamin A metabolism
contributes to host protective immunity.
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Results:	
  
Retinoic	
  acid	
  mediated	
  signaling	
  occurs	
  during	
  systemic	
  inflammation	
  
To address the role of vitamin A metabolism in immunity, the induction of
mucosal homing markers was evaluated during oral infection with Toxoplasma gondii (T.
gondii). This parasite induces a strong inflammation and a robust systemic TH-1
response (Gazzinelli et al., 1992; Suzuki et al., 1988). Mice were inoculated with 10
cysts of the type II avirulent T. gondii strain, ME-49, and CD4+ T cells were examined
during the acute stage of infection, at which time they are the predominant responding T
cell subset. Accordingly, a large proportion of activated cells within the small intestinal
lamina propria, the draining mesenteric lymph nodes, and the spleen expressed the
transcription factor, T-bet, which mediates interferon gamma (IFN-γ) production (Figure
29A). Expression of, α4β7 and CCR9, which are indicative of retinoic acid signaling
(Iwata et al., 2004; Svensson et al., 2008), were also observed on a proportion of
activated CD4+ T cells in each of these tissues (Figure 29A and data not shown).
Notably, expression of these markers was mainly confined to T-bet+ cells (Figure 29A).
To determine whether α4β7 induction was unique to the oral route of infection with T.
gondii animals were next inoculated intraperitoneally (IP). Strikingly, a large proportion of
activated CD4+ T cells expressed α4β7, and, again, most of these coexpressed T-bet
(Figure 29B). These results suggested that RA signaling was sustained and occurred
systemically during inflammatory responses.

An alternate scenario compatible with these findings was that signaling
molecules, other than RA, contributed to α4β7 expression in response to infection. To
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address this possibility, vitamin A insufficient (VAI) mice at 10 wks of age were
inoculated with T. gondii.
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Figure 29. Vitamin A metabolite dependent signaling is sustained and systemic
during T. gondii infection
(A) C57BL/6 mice were infected per-orally with 10 bradyzoite cysts of ME-49 clone C1.
On day 8 post-infection (p.i.), single cell suspensions prepared from the spleen (Sp),
mesenteric lymph nodes (mln) and small intestinal lamina propria (Lp), were stained with
fluorochrome labeled antibodies and assessed for a4b7 and T-bet expression by flow
cytometry. Dot plots are gated on Foxp3- CD44hi CD62Llo CD4+ T cells and
representative of 3 mice per group. (B) C57BL/6 mice were infected intraperitoneally
with 10 bradyzoite cysts of ME-49 clone C1. On day 8 p.i., single cell suspensions
prepared from the Sp were stained and assessed as described in A (C) Ctl and VAI
mice were infected per-orally with T. gondii. On day 8 single cell suspensions were
stained for α4β7. Bar graphs summarize the average frequency of Foxp3- CD44hi CD4+ T
cells expressing α4β7, n = 3-4 mice per group. (D) Ctl and VAI mice were infected
intraperitoneally with T. gondii and assessed as described in part c. n = 6-8 mice. For C
and D, error bars illustrate the s.d. Statistical comparisons were performed using the
unpaired Student’s t test , P < 0.001, ns = not significant.
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Significantly, 8 days post infection, α4β7 remained virtually absent on activated CD4+ T
cells in VAI mice infected either by the oral or IP route with T. gondii, strongly suggesting
that its upregulation was strictly dependent on RA during both steady-state and
inflammatory conditions (Figure 29C and D). Thus, RA signaling was sustained during
infection and exerted a systemic influence on CD4+ T cells regardless of the route of
infection, an indication that vitamin A metabolism may imprint features that exceed
homing potential during infection.

Mucosal	
  and	
  systemic	
  CD4+	
  T	
  cell	
  immunity	
  is	
  impaired	
  in	
  the	
  absence	
  of	
  
vitamin	
  A	
  metabolites	
  
To explore the functional consequence of vitamin A insufficiency during infection,
the acute-phase TH-1 response in VAI mice was evaluated following oral inoculation with
T. gondii. To this end, magnetically enriched T cells from mice on day 8 post-infection
were restimulated with soluble T. gondii antigen (STAg) in the presence of BMDC in
vitro. 48hrs later, IFN-γ in supernatants was measured. Strikingly, T cells enriched from
the mln, Lp, as well as the Sp of infected VAI mice produced significantly smaller
amounts of IFN-γ than their control counterparts upon recall (Figure 30A). The reduction
in TH-1 responsiveness was reflected in the enhanced parasite burden observed both
systemically (Sp) and in the Lp of VAI mice (Figure 30B). IP infection with T. gondii
yielded similar findings, in which, CD4+ T cells removed from VAI animals and
rechallenged with STAg produced lower levels of IFN-γ on a per cell basis (MFI =
1800±380 in VAI versus 5300±870 for Ctl, p < 0.003). Enhanced parasite burdens in the
peritoneal exudates (Pecs) and Sp of these animals were also observed (Figure 30C),
emphasizing that impaired TH-1 immunity to T. gondii during vitamin A insufficiency is not
solely a consequence of defective responsiveness in the GALT. These data suggested a
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direct or indirect role for vitamin A metabolites in the capacity of CD4+ T cells to acquire
effector function during infection.

T. gondii infects all nucleated cells and triggers multiple innate pathways that
synergize to induce a strong adaptive TH-1 response. Therefore, the influence of vitamin
A metabolism on mucosal immunity was also tested in a non-infectious system with a
model antigen. To this end, mice were orally vaccinated with a mixture of OVA and the
mucosal adjuvant, LT (R129G), a non-toxic mutant of the heat-labile enterotoxin of
Eschericia coli. This regimen previously was demonstrated to induce a TH-1 and robust
TH-17 response (Hall et al., 2008); the latter distinguished by expression of the
transcription factor, ROR(γ)t, in T cells (Ivanov et al., 2006). After two rounds of
vaccination one week apart, abundant IFN-γ and IL-17A were detected in the
supernatants of in vitro restimulated Lp and Peyer’s patch (Pp) tissues from control
mice, while less was detected in the mln (Figure 30D). Coincident with IL-17A protein,
flow cytometric analysis revealed substantial expression of ROR(γ)t in Foxp3– CD4+ T
cells from the Lp (44.8±6.4%) and Pp (9.3±0.4%) (Figure 30E-F). Yet, GALT cells from
VAI mice secreted only marginal amounts of IFN-γ and IL-17A. This reduction in IL-17A
corresponded with diminished ROR(γ)t expression in both the Lp (13.7±5.9%) and Pp
(1.7±0.8%). Moreover, the frequency of CD4+ T cells expressing the nuclear proliferation
antigen, Ki-67 (Gerdes et al., 1983), was significantly reduced, indicating decreased
activation/proliferation in response to vaccination in VAI mice (Figure 30E-F).
Collectively, these results suggest that vitamin A is critical for optimal T cell responses.
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Figure 30. TH-1 and TH-17 immune responses are impaired in the absence of
vitamin A metabolites
(A-B) Ctl and VAI mice were infected per-orally with T. gondii (A) At day 8 p.i., pooled
tissue suspensions were enriched for T cells and cultured with irradiated BMDC +/soluble T. gondii antigen (STAg) for 48 hr. IFN-γ was measured in triplicate supernatants
by ELISA. n = 4-5 mice per group. (B) Parasite burdens in Sp and Lp of individual mice
from A were determined by plaque assay. Results are expressed as plaque forming
units (PFU). Each dot represents an individual mouse (C) Ctl and VAI mice were
infected intraperitoneally with T. gondii. Parasite burden was assessed day 8 p.i. as
described in B. n = 6-8 mice per group. (D-F) Ctl and VAI mice were immunized orally
with a mixture of OVA and the mutant E. coli labile toxin, LT(R129G), once per week. On
day 14, pooled cell suspensions from mln, Pp and Lp were cultured with BMDC infected
with recombinant vaccinia virus expressing OVA (iDC) for 72 hours. Triplicate
supernatants were assayed for IFN-γ and IL-17A by ELISA. n = 3-4 mice per group. (EF) Lp (E) and Pp (F) suspensions from individual mice were assessed for intracellular
RORγ(t) and Ki-67 by flow cytometry. Representative dot plots from Lp of WT and VAI
mice gated on viable Foxp3– CD4+ T cells are shown. Bar graphs summarize the
frequency of Ki-67+ and RORγ(t)+. Error bars in A and D depict the s.e.m.; error bars in E
and F depict the s.d. , P < 0.05; , P < 0.01; , P < 0.001.

RA	
  restores	
  CD4+	
  T	
  cell	
  immunity	
  in	
  the	
  absence	
  of	
  vitamin	
  A	
  
Impaired TH-1 and TH-17 responses in VAI mice could also emerge from a
developmental defect in these animals, and not reflect a genuine role for vitamin A
metabolites on TH-1 and TH-17 development (Mora et al., 2008; Ziouzenkova et al.,
2007). Vitamin A metabolism produces several derivatives with signaling capacity in the
host. RA, in particular, has been shown previously to induce strong effects on a variety
of immune cell populations in vitro (Geissmann et al., 2003; Mora et al., 2008) and in
vitamin A-replete settings in vivo (Mucida et al., 2007; Xiao et al., 2008). However, the
effect of RA on T cell immunity in the absence of other vitamin A metabolites, which may
exert confounding influences, has never been interrogated. To test if RA could restore
protective immunity in vivo, VAI mice were prophylactically treated with RA every other
day. On day 5 of treatment, they were innoculated orally with T. gondii. Administration of
RA or the vehicle control continued every other day until day 8 of infection, when the
animals were analyzed. In contrast to vehicle treated animals, T. gondii infected VAI
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mice that received short-term RA displayed a striking recovery in ex vivo T cell IFN-γ
responses to STAg, both in the Sp and Lp (Figure 31A). Assessment of intracelular IFNγ further revealed that Lp CD4+ T cells responded as potently as their control
counterparts to antigen restimulation (Figure 31B). Importantly, this rebound culminated
in functional immunity to toxoplasmosis, enhancing parasite clearance so that parasite
burdens mirrored those observed in control infected animals (Figure 31C-D). The effect
of RA was also examined on TH-17 responses via oral vaccination with LT(R129G) and
OVA. For these experiments, mice were treated with the same drug regimen. To
accommodate this, the vaccination schedule was performed four days apart, rather than
one week. Significantly, Lp Foxp3– CD4+ T cells from RA treated animals regained their
capacity to produce IL-17A, in some instances to a degree that exceeded what was
observed in control animals (Figure 31E). This capacity was coupled to a rebound in
RORγ(t) expression and markedly enhanced T cell proliferation, as measured by
intracellular Ki-67 (Figures 31E-F). The efficacy of short-term treatment with RA, argued
that rather than a developmental deficit causing impaired CD4+ T cell immunity in VAI
mice, this metabolite provided essential signals to mediate TH-1 and TH-17 responses.

113

114

Figure 31. Retinoic acid is required for CD4+ T cell immunity
(A-D) Ctl and VAI mice treated with RA or vehicle were infected orally with T. gondii. n =
3 mice per group. (A) At day 8 p.i., pooled cell suspensions from Sp or Lp were enriched
for T cells and cultured with irradiated BMDC +/- STAg for 48 hr. Bar graphs present the
average amount of IFN-γ in duplicate or triplicate supernatants. (B) Lp samples treated
as described in A were incubated for 14 hrs with STAg, and analyzed for intracellular
IFN-γ via flow cytometry. Stacked histograms are gated on viable, Foxp3– CD4+ T cells.
(C) Parasite burden in Sp and Lp of individual mice was measured by PFU. (D)
Visualization of parasite localization in duodenal-jejunal sections of individual mice on
day 9 p.i. (E-F) Ctl and VAI mice treated with RA or vehicle were immunized orally with a
mixture of OVA and LT(R129G) on day 0 and 4. n = 3 mice per group. (E) On day 7,
suspensions pooled from Lp were enriched for T cells and cultured with SpDC +/– OVA
for 14 hr and examined for intracellular IL-17A and IFN-γ. Contour plots are gated on
viable, Foxp3– CD4+ T cells. (F) Lp cells from individual mice were analyzed for
intracellular RORγ(t) and Ki-67 by flow cytometry. Bar graphs depict Ki-67 and RORγ(t)
as a frequency of Foxp3– CD4+ T cells. (A-F), RA treated groups received 250mg RA
intraperitoneally 5 days prior to infection or vaccine and every other day thence until
takedown. Error bars in A depict the s.e.m.; Error bars in C and F depict the s.d. , P <
0.05; , P < 0.01; , P < 0.001; ns = not significant.

RARα	
  regulates	
  CD4+	
  T	
  cell	
  immunity	
  and	
  homeostasis	
  	
  
As mentioned in Chapter 1, RA signals through several families of nuclear
hormone receptors. The best characterized are RA receptors (RAR) α, β and γ, which
transcriptionally regulate gene expression in partnership with retinoid X receptors
(Chambon, 1996). Previously, TGF-β was shown to induce RARα expression
(Schambach et al., 2007). Accordingly, it was also shown in Chapter 2 that this receptor
was required for RA to enhance Foxp3+ Treg differentiation in vitro (Hill et al., 2008;
Nolting et al., 2009). Using real time quantitative PCR, naïve CD4+ T cells were found to
readily express mRNA for RARα. RARγ was also detected. Similar to observations in
activated cells, RARβ was not detectable (#) (Figure 32A) (Elias et al., 2008). To
deduce whether RARα played a role in RA directed immunity, RARα deficient (Rara−/−)
mice were orally vaccinated with LT (R129G) and OVA. Unlike VAI mice, which after 16
weeks begin to succumb to a wasting disease, these animals display no overt
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impairments as adults (Lufkin et al., 1993). Notably, this vaccine regimen was unable to
induce an antigen specific TH-17 response in mice on this mixed 129 background (data
not shown). Nevertheless, relative to WT littermates, CD4+ T cells from Rara−/− mice
expressed attenuated levels of the TH-1 driving transcription factor, T-bet, after
vaccination and secreted virtually no IFN-γ upon antigen recall (data not shown and
Figure 32B), Thus, abrogation of Rara impaired CD4+ T cell immunity.

In Chapter 2, disruption of RA/RAR signaling, either by antagonism in vitro or by
loss of RA in vivo was shown to inhibit peripheral Foxp3+ Treg generation. Other
laboratories corroborated in vitro inhibition of Foxp3+ Treg generation using RAR
antagonists, as well (Coombes et al., 2007; Mucida et al., 2007). Despite the inability to
generate GALT Foxp3+ Treg upon oral feeding (Figure 14), a paradoxical increase in the
frequency of Foxp3+ Treg was observed within the Lp of VAI mice (Figure 32C). As noted
previously, a parallel increase was also observed in the frequency of Lp Foxp3+ Treg in
Rara−/− mice (Hill et al., 2008). However, in both VAI and Rara−/− animals, thymic
production of Foxp3+ Treg was unperturbed (Figure 15 and data not shown). Thus,
upon loss of RA or RARα mediated signaling, impaired GALT Foxp3+ Treg generation
was coupled with an aberrant increase in the frequency of thymically derived Foxp3+ Treg
in the Lp. Based on their potential to raise the threshold of immune activation, which was
demonstrated in Chapter 3 (Figure 27), the relative increase in thymically derived
Foxp3+ Treg in this region was considered a potential cause of impaired CD4+ T cell
responses. In order to test this, VAI DEREG mice were generated (Lahl et al., 2007), in
which Foxp3+ Treg could be selectively depleted upon injection of diphtheria toxin (DT).
Oral vaccination in conjunction with DT treatment readily depleted Foxp3+ Treg and
restored Foxp3- CD4+ T cell proliferation in the Lp (Figure 32D). However, TH-1 and TH17 cells remained undetectable in VAI mice after this treatment (Figure 32E).
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Figure 32. The RA/RARα signaling axis regulates CD4+ T cell immunity and
homeostasis.
(A) mRNA from sort-purified naïve CD4+ T cells (Foxp3– CD25– CD44lo) was assessed
for RARs: α, β, and γ via quantitative RT-PCR and normalized to the house-keeping
gene, hypoxanthine phosphoribosyltransferase. # = not detected. (B) Rara−/− and
littermate control WT mice were immunized orally with a mixture of OVA and the mutant
E. coli labile toxin, LT(R129G), once per week. On day 21, suspensions pooled from Sp
were enriched for T cells and cultured with BMDC infected with recombinant vaccinia
virus expressing OVA (iDC) for 72 hours. IFN-γ was quantified in triplicate supernatants.
Results are representative of 2 independent experiments. (C) Lp cell suspensions from
VAI, Rara−/− and their respective control counterparts were assessed for Foxp3+ Treg via
flow cytometry. Results are expressed as a proportion of viable TCRβ+ CD4+ T cells. (DE) Ctl, VAI and VAI DEREG mice immunized orally with a mixture of OVA and
LT(R129G) on days 0 and 4 were treated with 1mg of diphtheria toxin72 and 24 hrs prior
to vaccination and every subsequent 48 hrs through termination of experiment. (D) On
day 7, suspensions from individual mice were assessed for intracellular Foxp3 and Ki-67
by flow cytometry. Data are gated on CD4+ T cells. Each dot represents an individual
mouse. (E) Suspensions pooled from the Lp were enriched for T cells and cultured with
purified SpDC +/– OVA for 14 hr, then assessed for intracellular IL-17A and IFN-γ via
flow cytometry. Contour plots are gated on viable Foxp3– CD4+ T cells. n = 3-4 mice per
group (F) Summary of the absolute number of Foxp3+ and Foxp3– CD4+ T cells in the Lp
of mice. (G) Vehicle or RA treated mice were orally infected with T. gondii or vaccinated
as described in Figure 3. A summary of the frequency of Lp Foxp3+ Treg ± s.d. as a
proportion of viable CD4+ T cells is shown. n = 3 mice per group. Data are representative
of 2-3 experiments. Error bars in A and B depict the s.e.m. , P < 0.01; , P < 0.001;
ns = not significant.

Thus, the enhanced frequency of Foxp3+ Treg in the Lp was not a primary cause of
impaired mucosal immune responses upon loss of vitamin A dependent signaling.

The increase in the frequency of Lp Foxp3+ Treg revealed that GALT T cell
homeostasis was perturbed in both Rara−/− and VAI mice. Quantification of CD4+T cell
subsets indicated that in both these animals, the increase in Lp Foxp3+ Treg frequency
was due to a 2 to 4 fold selective reduction in the number of Foxp3- CD44hi CD4+ T cells
within the Lp (Figure 32F). Importantly, treating VAI mice with RA during T. gondii
infection and vaccination restored GALT T cell equilibrium in addition to TH responses
(Figure 32G). These findings demonstrated that deficiency in RARα alone could
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recapitulate the effects of vitamin A insufficiency on T cell homeostasis. Further, they
identified a crucial contribution of RA/RARα signaling to vitamin A dependent CD4+ T cell
homeostasis and protective immunity.

RARα	
  regulates	
  T	
  cell	
  activation	
  	
  
Although RA mediated enhancement of protective immunity could involve
multiple cellular targets, expression of RARα in naïve CD4+ T cells, combined with
impaired T helper immunity in Rara−/− mice, suggested a potential cell intrinsic
requirement for this receptor in T cell responses. To address this, magnetically isolated
naïve WT or Rara−/− CD4+ CD62Lhi T cells were stimulated in an APC-free system under
TH-1 and TH-17 polarizing conditions, in vitro. After 48hrs in culture, relative to WT T
cells, significant reductions of IFN-γ and IL-17A were detected in supernatants from TH-1
and TH-17 polarized Rara−/− T cells (Figure 33A). However, these cultures contained
significantly fewer cells than WT cultures, indicating that differences in cytokine levels
were potentially secondary to impaired cell proliferation. Confirming this hypothesis,
intracellular cytokine staining revealed that surviving Rara−/− T cells were as capable as
WT T cells to produce cytokine (data not shown). Indeed, T cells lacking RARα failed to
proliferate as efficiently as their WT counterparts upon polyclonal T cell receptor (TCR)
activation with anti-CD3. The lack of proliferation persisted in the presence of costimulation and upon exogenous provision of IL-2 (Figure 33B), suggesting that the loss
of RARα signaling may cause a fundamental activation and/or survival defect. A
potential defect in activation was explored first. After 16 hrs of stimulation, there was less
upregulation of the activation markers: CD69, CD25 and the iron transferrin receptor,
CD71, on Rara−/− T cells (Figure 33C). Expression of CD71 was recently shown to
depend on activation of the mammalian target of rapamycin kinase (mTOR) (Zheng et
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al., 2007), which regulates cell growth, proliferation, survival and differentiation pathways
via two distinct complexes, mTORC1 and mTORC2 (Guertin et al., 2006; Loewith et al.,
2002; Wullschleger et al., 2006); (Delgoffe et al., 2009; Lee et al.). mTORC1 activity
regulates protein translation via activation of the ribosomal S6 kinase (S6K1) (Holz et al.,
2005), while mTORC2 activity regulates cell growth, proliferation and survival via
activation of AKT (kinase mediated phosphorylation of serine 473) and additional
pathways. In accord with a reduction in CD71, phosphorylation of the S6K1 target, 40S
ribosomal protein S6, (pS6) was decreased by as much as 50% in Rara–⁄– T cells relative
to WT T cells, indicating a reduction in mTORC1 activity (Figure 33D). Suggesting a
global reduction in mTOR activity, short stimulation with plate-bound anti-CD3 and antiCD3 + anti-CD28 resulted in less efficient Akt phosphorylation at serine position 473, in
Rara–⁄– T cells (Figure 33E).
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Figure 33. Role of RARα signaling for T cell activation
(A) CD4+ CD62Lhi T cells purified from Sp and lymph nodes of Rar−/− and
littermate/WT mice were activated with plate-bound α-CD3 + soluble α-CD28, in TH-1
or TH-17 polarizing conditions for 48 hrs. IFN-γ and IL-17A ± s.e.m. in culture
supernatants were measured by ELISA. ***, P < 0.001 (B) CD4+ T cells were plated
for 48 hrs in the following conditions: I. unstimulated II. α-CD3 III. α-CD3 + α-CD28
IV. α-CD3 + α-CD28 + IL-2. After 48 hrs, cells were rested overnight in IL-2 and
assayed for CFSE intensity by flow cytometric analysis. Histograms are gated on
viable CD4+ T cells. (C) CD4+ CD62Lhi T cells were isolated and activated with α-CD3
+ α-CD28 + IL-2 for 16 hrs, then assessed for the activation markers: CD69, CD25,
and CD71. (D) Naïve T cells were activated as described in C and stained for pS6.
Roman numerals indicate same conditions used in B. (E) CD4+ T cells (5x106) were
stimulated with plate-bound α-CD3 (2µg/ml) and/or α-CD28 (10µg/ml) for the
indicated times and then lysed. Total cell lysates were immunoblotted for
phosphorylated (Ser473) and total Akt.
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Basal	
  RARα	
  activity	
  regulates	
  responsiveness	
  to	
  signaling	
  via	
  TCR/CD3	
  complex	
  	
  
TCR engagement results in the orchestration of signaling pathways, which
promote naïve T cell transition into effector T cells. The observed decrease in activation
markers at 16hrs suggested that an upstream defect might impair signal transduction
pathways in Rara−/− T cells. Ca2+ mobilization is a critical biochemical mediator of early T
cell activation events, which is initiated upon stimulation through the T cell receptor
(TCR)/CD3 complex. To determine whether RARα signaling was involved in the
regulation of these events, the rate and magnitude of cytoplasmic Ca2+ flux was

% (Cell
divided)
II
III
IV

WT
51
74.8
76.4

Rara-/8
15.8
15.4

Prolif
Index
II
III
IV

WT
2.2
3.4
3.5

Rara-/1.5
2.1
2.2

Table 1. Impaired proliferation of Rara–⁄– T cells upon activation
The percent of cells that underwent proliferation and calculated
proliferation index are indicated.
assayed. Strikingly, upon anti-CD3 crosslinking, Ca2+ mobilization was dramatically
reduced in Rara–⁄– CD4+ T cells relative to WT counterparts (Figure 34A). As RA and its
metabolic precursors are constitutively present in serum (Kane et al., 2008a; Kane et al.,
2008b), we could not exclude the possibility that that deficiency in Rara may result in a
long-lasting metabolic defect that may also impair T cell activation. As such, we also
incubated WT cells with the pan-RAR antagonist, LE540, prior to T cell activation.
Treatment with this antagonist recapitulated the Rara–⁄– phenotype, manifesting in
impaired Ca2+ mobilization upon anti-CD3 crosslinking (Figure 34B). Supporting the idea
that RARα exerts a function downstream of the TCR/CD3 complex, Ca2+ mobilization
was unaffected in LE540 treated cells stimulated with the Ca2+ ionophore, ionomycin (Liu
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and Hermann, 1978). These findings imply that transient blockade of RARα signaling is
sufficient to impede signal transduction events upon TCR recognition. Consequently,
RARα is a crucial regulator of T cell responses.

123

Figure 34. Loss of basal RARa signaling impairs responsiveness to TCR/CD3
engagement
(A) Analysis of Ca2+ fluxes in Rara–⁄– (grey line), and WT mice (black line). Cells are
gated on total CD4+ T cells. (B) Vehicle treated (black line) versus LE540 (grey line,
2.5µM) treated cells. Black-tipped arrow denotes the addition of biotin α-CD3
(10µg/ml). White-tipped arrow denotes the addition of streptavidin (20µg/ml). White
arrowhead denotes addition of ionomycin. Cells are gated on total CD4+ T cells.
Histograms depict the median ratio of DAPI-A/Indo-1-A of Ca2+ fluxing cells as a
function of time (sec = seconds).
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Discussion:	
  
Although vitamin A insufficiency has long been linked to impaired immunity to
pathogens, the role of vitamin A metabolism in the regulation of CD4+ T cell responses
remains poorly understood. The experiments detailed herein indicate that the retinoic
acid/RARα signaling axis is essential for adaptive CD4+ T cell immunity. Specifically,
mucosal TH-1 and TH-17 responses to oral infection and vaccination were compromised
upon loss of vitamin A. These impairments were unlikely to be manifestations of a
developmental defect propagated upon loss of vitamin A, as RA rapidly restored
mucosal TH-1 and TH-17 responses. This finding, in particular, suggested that this
metabolite is the cardinal mediator of vitamin A dependent immunity in vivo. Strikingly,
genetic ablation of Rara was sufficient to recapitulate the phenotype of VAI mice, both at
steady-state and during infection. Furthermore, T cells lacking RARα or subjected to RA
receptor antagonism display early activation defects and proliferate less efficiently in
response to T cell stimulation. Thus, the RA/RARα axis controls the fate of adaptive
immunity, at least in part, via cell autonomous effects on CD4+ T cells and reveals one
potential explanation for the broad control of this pathway over various T cell fates.

RA	
  does	
  not	
  impair	
  adaptive	
  TH-‐1	
  responses	
  	
  
RA has been proposed to foster the reciprocal development of Foxp3+ Treg and
TH-17 cells (Mucida et al., 2007); however, the findings described here suggest that on
some fundamental level RA is a physiological mediator of TH-17 responses, as well as
TH-1 responses. Importantly, the majority of CD4+ T cells that displayed a RA signature
(based on α4β7), co-expressed T-bet, the transcription factor required for TH-1
commitment (Szabo et al., 2000). Further, in vivo add-back experiments demonstrated
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that RA was capable of restoring TH-1 responses in VAI mice. These data are somewhat
in conflict with previous reports that have suggested that RA is a negative regulator of
TH-1 inflammation (Cui et al., 2000). For instance, VAI mice produced abnormally high
levels of IFN-γ during infection with the nematode, Trichinella Spiralis and failed to elicit
a proper and robust TH-2 response (Carman et al., 1992). In this system, RA was shown
to decrease IFN-γ production when added to in vitro restimulated cell suspensions and
was, hence, as a TH-1 suppressor (Cantorna et al., 1994). However, this type of “addback” experiment is difficult to interpret physiologically, especially when considering that
the cells treated in culture were likely of a heterogeneous activation status. In this
regard, RA was shown to be able to inhibit effector/memory T cell cytokine production
(Hill et al., 2008). Integrating these data into a working model suggests that RA signaling
is potentially biphasic - driving T cell activation/differentiation during the early stages of
an immune response, but regulating the amplitude at later stages. In terms of tissue
immunity, this could be a particularly effective strategy to minimize tissue damage.

RA	
  may	
  potentiate	
  TH-‐17	
  through	
  a	
  multitude	
  of	
  effects	
  in	
  the	
  intestinal	
  mucosa	
  	
  
TH-17 cells are elicited via the actions of multiple cytokines, including TGF-b, and
any combination of IL-6, IL-21, IL-23 and/or IL-1 (Korn et al., 2009). The data described
here demonstrate that diminished vitamin A prevented the acquisition of a robust TH-17
response in vivo. The ability of RA to restore TH-17 responses in VAI mice was also
unexpected in light of recent studies that have reported negative effects of RA on IL-17
production in vitro (Elias et al., 2008; Mucida et al., 2007) and in certain animal models of
autoimmune disease (Xiao et al., 2008). Nevertheless, in systems that have scrutinized
the effects of RA at low doses (Wang et al.) and in conjunction with microbial stimuli,
such as TLR5 ligands (Uematsu et al., 2008), TH-17 generation was shown to be
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unaffected or enhanced, respectively. Thus, in physiological settings and microbial rich
environments, RA may favor the generation of TH-17 cells. Compatible with this idea, two
recent studies revealed that TH-17 cells were virtually ablated in the Pp and Lp of VAI
mice during steady-state (Cha et al.; Wang et al.). In one of these studies, the authors
attributed this result to impeded migration of TH-17 cells into the gut; however, deficiency
did not result in their increase elsewhere(Wang et al.). Therefore, at the minimum, the
intestinal mucosal environment is requisite for promoting TH-17 development and/or
maintenance. Moreover, the other study, which observed TH-17 depletion, detected this
defect while the mice were young and TH homing capacity to mucosal sites would have
been intact (Cha et al.). Strikingly, this study also reported large shifts in the commensal
microbial phyla that were present within the intestinal ileum when mice were reared on a
vitamin A deficient diet. Not only was the total amount of bacteria decreased in these
animals, but SFB, which was present in the control diet fed mice, was also completely
missing. This finding indicates that RA may be able to influence both the density and the
composition of the commensal microbiota, which when considered alongside the
findings described in Chapter 3, could also explain, in part, the attenuation of TH
responses in VAI mice. Supposing that the influence of RA and TLR ligands on follicular
DC can extend to LpDC, another possibility is that RA may foster TH-17 development via
promotion of TGF-β production (Suzuki et al.). Importantly, these potential modes of TH17 generation are consistent with the proposed biphasic model of RA on T cell
activation, where RA could provide a source of active TGF-β in situ.

Potential	
  roles	
  of	
  RA/RARα	
  in	
  the	
  regulation	
  of	
  T	
  cell	
  activation	
  	
  
Rara−/− mice complemented VAI mice on multiple levels. First, the number of Lp
effector T cells was reduced in both animals compared to their control counterparts (~3
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fold for VAI; ~2 fold for Rara−/−). These findings suggest that RARα is critical for
upregulation of homing receptors, which fits with the data presented in Figure 11 of
Chapter 2. In that experiment, Rara−/− T cells failed to upregulate α4β7, when cultured in
the presence of RA, albeit in Foxp3+ Treg polarizing conditions. Remarkably, transient
provision of RA restored both T cell equilibrium and the CD4+ T cell response within the
Lp of VAI mice. Since RA restored both of these parameters, it is difficult to comment on
the relative contribution of homing versus effects on T cell activation to the restoration of
immunity in this tissue. However, suggesting that RA/RARα signals impart more than
merely homing features to T cells, systemically infecting VAI mice with T. gondii still
resulted in a markedly impaired TH-1 response. This outcome could be the product of
both direct and indirect actions of RA/RARα signaling on T lymphocytes.

Nevertheless, indicative that this pathway can function directly through T cells,
RARα was observed to mediate signal transduction events downstream of TCR
recognition, which governed T cell activation. In the absence of RARα CD4+ T cells
failed to respond efficiently to T cell stimulation and growth factors. While this deficiency
could potentially reflect a T cell developmental defect in Rara−/− mice, retinoic acid
receptor antagonism of WT cells also impaired Ca2+ mobilization upon TCR activation,
which was similarly observed in RARα deficient T cells. Prolonged Ca2+ mobilization
induces the dephosphorylation and subsequent translocation of a series of transcription
factors collectively referred to as the nuclear factor of activated T cells (NFAT), into the
nucleus (Winslow et al., 2003). Transcriptional events mediated by NFAT result in a host
of genetic changes, culminating in cell growth, proliferation and effector function (Feske
et al., 2001). Thus, one possibility is that loss or antagonism of RARα results in delayed
translocation of NFAT.
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Recent findings indicate a role for nutrient metabolism in T cell activation. For
instance, vitamin D/vitamin D receptor (VDR) signaling was shown to promote the
proliferation of human T cells in response to TCR stimulation via the induction of
PLCγ (von Essen et al.). The DNA binding capacity of VDR presumably mediates this
induction via transcription. RARα is also recognized to regulate gene expression in the
same fashion (Chambon, 1996). As RA, as well as other retinoids, are present in the
serum and tissues of mice (Kane et al., 2008a; Kane et al., 2008b), it is intriguing to
speculate that these compounds exert constitutive effects on the phosphorylation status,
localization and/or conformation of RARα in T cells, which may in turn regulate this
protein’s function. Short-term incubation (< 1 hr) with a pan-RAR antagonist impaired T
cell Ca2+ mobilization in a manner similar to that observed in the absence of RARα. One

explanation for this finding is that nuclear RARα regulates the expression or kinase
activity of a mediator of T cell activation through its function as a transcription factor.
Another possibility is that extra-nuclear RARα molecules facilitate TCR dependent signal
transduction. Indeed, unconventional roles for RARα in mitogen-activated protein kinase
as well as PI3K regulation have been reported in non-hematopoietic cells (Rochette-Egly
and Germain, 2009). In line with these activities, RARα was shown to localize to the
plasma membrane of a neuroblastoma cell line in an RA dependent manner (Masia et
al., 2007).

It is also worth noting that RARα expression is not necessarily restricted to
expression in T cells and may also affect the function of APC, including DC. In this vein,
RARα ligands were shown to synergize with inflammatory mediators and enhance the
activation of human Langerhans cell-type dendritic cells (Geissmann et al., 2003).
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Therefore, it is possible that altered APC function also contributes to impaired adaptive
CD4+ T cell responses in VAI and Rara−/− mice.

In summary, the GI tract must be able to tolerate constant exposure to food
antigen and commensals, while maintaining the capacity to rapidly respond to
encounters with pathogen. These conflicting pressures confront the host immune system
defending the GI tract with a unique challenge. One would predict that the most judicious
strategy to respond to this spectrum of recurring challenges would involve a conserved
pathway that can readily adjust to environmental cues. Here we identify the RA/RARα
signaling pathway as fitting this mode of host control, promoting Foxp3+ Treg generation
and likely tolerance during steady-state conditions, while adaptive T cell responses in
the face of pathogen. As such, we propose that RA regulates adaptive immunity in a
manner that is symmetrical to TGF-β, where accompanying signals dictate whether a
response ultimately becomes regulatory in nature or inflammatory. An important
consideration is that adaptive immune responses often involve multiple waves of antigen
presenting cell recruitment. Based on the systemic RA mediated signals that we observe
during infection, it will be interesting to examine how newly recruited APC contribute to
the RA/RARα signaling axis during inflammation. Finally, the requirement of RARα for T
cell activation suggests that this pathway may have evolved early with the development
of adaptive CD4+ T cell responses to coordinate host protection.
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CHAPTER	
  5:	
  Conclusion	
  
Vitamin	
  A	
  metabolism	
  drives	
  Foxp3+	
  Treg	
  generation	
  in	
  vitro	
  and	
  in	
  response	
  to	
  
oral	
  antigen,	
  in	
  vivo	
  
The ability of the GI tract to provide a nutrient source to the body is dependent on
maintaining homeostasis in the face of constant exposure to the external environment
and the intestinal microbiota. To adapt to the constant level of stimulation in this
environment, the intestinal immune system has evolved a multitude of regulatory
strategies. In Chapter 2, one of these regulatory strategies, the local generation of
Foxp3+ Treg, was revealed to depend on a specialized population of migratory GALT
dendritic cells, which was able to synthesize retinoic acid from vitamin A derivatives. RA
receptor antagonism was shown to hinder LpDC-induced Foxp3+ Treg generation, while
RA was shown to enhance SpDC-induced Foxp3+ Treg generation, thus, highlighting the
potential importance of this metabolite in GALT Foxp3+ Treg development (Sun et al.,
2007). Reinforcing this idea, the induction of Foxp3+ Treg in the GALT was abrogated in
mice, which lacked vitamin A and its associated metabolites (VAI mice). Studies on VAI
mice further revealed that vitamin A was required for LpDC to retain the capacity to
synthesize RA. This finding indicates the intestinal immune system has adapted to take
advantage of the abundant intake and remarkable storage capacity of vitamin A. Indeed,
RA is also an important mediator of IgA+ class switching in B cells (Mora et al., 2006;
Suzuki et al.), and the upregulation of intestinal-homing surface markers on lymphocytes
(Iwata et al., 2004).

At the time that the findings in Chapter 2 were published (Sun et al., 2007),
several other groups reported similar data with mesenteric lymph node DC, particularly
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the CD103+ subset, which derived from the intestinal lamina propria (Coombes et al.,
2007; Mucida et al., 2007). A host of other groups also reported that RA could enhance
Foxp3+ Treg generation in vitro under a variety of circumstances, including: during high
costimulatory activity, in the presence of TH cytokines, and in otherwise non inhibitory
conditions (Benson et al., 2007; Elias et al., 2008; Hill et al., 2008; Nolting et al., 2009).
Despite several demonstrations that RARα was required for RA to be able to enhance
Foxp3+ Treg induction, the molecular mechanism by which RA/RARα signaling stimulates
Foxp3 activity remains unclear (Hill et al., 2008; Nolting et al., 2009). One interesting
conjecture is that RA mediates these effects through the inhibition of the transcriptional
complex, activation protein – 1 (AP-1), in T cells (von Boehmer, 2007). Rao and
colleagues recently demonstrated that NFAT partnering to Foxp3 rather than AP-1
favors the development of Foxp3+ Treg in lieu of effector T cells (Wu et al., 2006).
Therefore, inhibition of AP-1 may promote Foxp3+ Treg generation. Indeed RA/RARα has
been shown to inhibit several aspects of the AP-1 pathway, including: upstream
activation of JNK (Lee et al., 1999; Xu et al., 2002), subunit expression (Fisher et al.,
1998; Talmage and Lackey, 1992), and DNA binding (Schule et al., 1991).

TLR9	
  /	
  Commensal	
  microbial	
  DNA	
  interactions	
  are	
  requisite	
  for	
  mucosal	
  T	
  cell	
  
homeostasis	
  and	
  immunity	
  
While GALT mediated Foxp3+ Treg induction may represent a default pathway to
promote tolerance to food antigen and commensals, data presented in Chapter 3
suggested that this process is tightly controlled by components of the commensal
microbiota. Specifically, engagement of TLR9 by microbiota derived DNA strongly
inhibited the capacity of LpDC to promote the generation of Foxp3+ Treg and instead
drove the formation of TH cells, including TH-17, TH-1 and TH-2. Complementing this
finding, Tlr9–⁄– mice were found to have an increased ratio of Foxp3+ Treg / TH within
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intestinal effector sites. Although this shift had no bearing when Tlr9–⁄– mice were
infected systemically with E. cuniculi, the adaptive immune response in these animals
was dramatically impaired upon infection through the oral route. Together, these findings
suggest that commensal DNA sensing is a critical mediator of adaptive immune
responses to pathogens that gain access to the host through the gastrointestinal tract.
Previously, Nod2 was shown to affect immune responses to bacterial infection in a
similar manner, i.e. Nod2–⁄– mice were susceptible specifically to the oral route of
challenge (Kobayashi et al., 2005). However, the data described in Chapter 3 also
illustrate that perturbation of the Foxp3+ Treg / TH ratio can markedly influence adaptive
immune responses at mucosal sites of challenge. This finding may have significant
bearing on oral vaccination strategies and also provides a framework for thinking about
how the composition of the microbiota could influence the ability of the host to respond
to intestinal challenge. In particular, more comprehensive analyses of the commensal
microbiota may facilitate the identification of immuno-stimulatory/regulatory DNA motifs
that can be utilized in oral vaccine design.

Around the time that the TLR9 findings were published (Hall et al., 2008), Littman
and colleagues demonstrated that TH-17 cells were strongly diminished in the absence
of the commensal microbiota (Ivanov et al., 2008). Another study showed that TH-1 cells
were also strongly diminished in germ-free conditions (Gaboriau-Routhiau et al., 2009).
The fact that TH-1 and TH-17 cells are not altogether ablated in these conditions may be
due to residual TLR ligands present in the diet fed to these animals (Hill et al.).
Surprisingly, Littman and colleagues also noted in their study that the frequency of TH-17
cells was unaffected in mice lacking both MyD88 and TRIF. However, Chapter 3
showed that both the frequency and absolute number of TH-1 and TH-17 cells were
decreased in mice deficient in Tlr9, which is known to signal through MyD88 (Hemmi et
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al., 2000). One possibility is that discrete microbial components, via signaling through
distinct canonical pattern recognition receptors (TLR, Nod, and C type lectin)
differentially contribute to the induction, proliferation and/or maintenance of TH-1, TH-17
and Foxp3+ Treg cells. It is also possible that combinatorial signals through these
receptors influence the composition of these cells in intestinal effector sites.

In regard to toll like receptor signaling, microbial sensing and the type of
response that it evokes are dependent not only on the nature of the microbe, but also on
the cellular compartmentalization of the TLR in question. Surface TLRs, especially those
expressed on intestinal epithelial surfaces are in direct apposition to the commensal
microbiota, and are thus more inclined to experience receptor engagement. With the
exception of industrialized countries and areas with access to water sanitation, IECs are
also commonly in apposition with intestinal dwelling parasites. These pressures have
likely compelled tissue adaptations, which regulate the ability of surface TLRs to
promote signal transduction cascades that terminate in pathological situations. For
example, TLR4 signaling in IEC results in the down-regulation of IRAK1, and thereby
prevents the induction of an inflammatory program (Chassin et al.). TLR9 is also readily
present on the surface of IEC (Lee et al., 2006); however to what extent these receptors
are functional is unclear, as environmental pH plays a critical role in regulating functional
TLR9 activity (Engel and Barton). Other mechanisms to avoid gross activation of the
epithelial barrier upon recognition of luminal derived TLR ligands also likely exist.

Hematopoietic cells in the intestinal lamina propria have also evolved
mechanisms to sustain constitutive TLR engagement in the absence of an undue
pathological response. For instance, expression of the ubiquitin-editing enzyme, A20, in
APC prevents spontaneous reactivity to the commensal microbiota (Turer et al., 2008).
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Such a pathway illustrates the importance of having regulatory mechanisms in place to
modulate the activation status of APC within the intestinal tract and also demonstrates
that

these

cells

constitutively

receive

commensal

dependent

signals.

This

notwithstanding, constitutive recognition of commensal DNA via TLR9 endows APC with
the capacity to elicit TH responses in intestinal effector sites in the absence of overt
pathology. Given that TLR9/bacterial DNA interactions are predicated on an active
sensing mechanism in these cells, it stands that the ability of this pathway to drive an
inflammatory response is conserved in the event of pathogen encounter.

Vitamin	
  A	
  metabolism	
  promotes	
  TH-‐1	
  and	
  TH-‐17	
  adaptive	
  immune	
  responses	
  via	
  
retinoic	
  acid/RARα	
  
A summary of the data in Chapter 2 and Chapter 3 indicates that signals
dependent on vitamin A metabolism and TLR9 engagement contribute to T cell
homeostasis in the GI tract, which in turn, shapes host responsiveness to mucosal
pathogens. Although vitamin A metabolism in LpDC appears to favor Foxp3+ Treg
development and/or maintenance in the GALT, while commensal DNA interactions with
TLR9 in LpDC appear to favor TH development and/or maintenance, how the signaling
pathways downstream of these cues converge and regulate one another in T cells is
unclear and merits further investigation. Studies in this regard will also help to further
clarify findings in Chapter 4, which demonstrate that vitamin A metabolism is required
for GALT Foxp3+ Treg differentiation and optimal TH-1 and TH-17 responses. Previous
studies have demonstrated the importance of RA precursors, such as retinol and retinal
in the maintenance of energy homeostasis (Acin-Perez et al.; Ziouzenkova et al., 2007).
However, work here suggests that these precursors are dispensable for adaptive
immune responses. In support of this, administration of RA to VAI mice orally challenged
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with T. gondii or vaccinated with a mutated E. coli labile toxin, completely restored CD4+
T cell responses to levels observed in WT animals.

RA signals are transduced by at least four known nuclear receptors including:
RARα, RARβ, RARγ, and PPARβδ, which are expressed differentially in multiple cell
types (Mora et al., 2008). Given the nature of the add-back experiments performed in
Chapter 4, it is difficult to propose a precise and all-inclusive mechanism for the
coordinated activities of RA, which would account for the restoration of adaptive immune
responses. One receptor that appeared particularly important was RARα, which has in
fact been shown to facilitate accessibility to other genes involved in vitamin A
metabolism, including RARβ2, which also controls other inducible RA responsive genes
(Corlazzoli et al., 2009; Ren et al., 2005). An examination of the GALT in Rara–⁄– mice
indicated that they shared several overlapping immunological defects with VAI mice. In
addition to a disrupted T cell equilibrium in GALT effector sites, the immune response
upon oral vaccination was similarly impaired in Rara–⁄– animals. But, perhaps, the most
unexpected finding in Chapter 4 was the importance of RA/RARα signaling in T cell
activation and proliferation.

RARα	
  regulates	
  the	
  acquisition	
  of	
  effector	
  T	
  cell	
  function	
  in	
  a	
  cell	
  intrinsic	
  
manner	
  
In the absence of RARα, T cell activation, proliferation, and survival were
impaired as a result of a cell intrinsic defect. Mammalian TOR activation, which regulates
multiple pathways essential for cell growth, proliferation, survival and differentiation
(Wullschleger et al., 2006), was noticeably reduced. Further, Ca2+ mobilization in
response to TCR/CD3 engagement was impaired in Rara–⁄– T cells, as well as, WT T
cells exposed to the pan RAR antagonist, LE540, prior to activation. As retinoids are

136

constantly present in the serum (Kane et al., 2008a; Kane et al., 2008b), and naïve T
cells were observed to actively transcribe Rara, it is possible that steady-state RA/RARα
signals constitutively modulate protein expression and/or kinase activity to facilitate T
cell activation upon TCR engagement. In this regard, it may be worthwhile to examine
steady-state RA activity in T cells, which could be performed using mice that have been
engineered with a transgenic RA-responsive element reporter (Svensson et al., 2008).
Although these findings would theoretically impact the development of all TH subsets,
including Foxp3+ Treg, it is important to note that the foregoing studies did not assess TH2 responses in VAI mice nor in Rara–⁄– mice. Therefore, it is still not clear precisely how
defects in RA/RARα signals contribute to TH-2 development.

Previously, it was demonstrated that the strength of signal through the TCR could
function as a crucial determinant in TH-1 versus TH-2 polarization. In particular, weaker
stimulation achieved with a low-dose of cognate peptide or an altered peptide ligand
favored the development of TH-2 cells, both in vitro and in vivo (Constant et al., 1995;
Hosken et al., 1995; Pfeiffer et al., 1995). Conversely, increasing the antigen dose or
strength of peptide/MHC interactions with TCR favored the development of TH-1 cells.
These findings set the stage for more recent data highlighting that TH-1 and TH-2 cell
induction may have different signaling requirements. For instance, altered peptide
ligands, which skew T cell polarization in the TH-2 direction, were observed to induce
sustained reductions and more transient spikes in Ca2+ mobilization (Brogdon et al.,
2002). Pharmacological inhibition/reduction of extracellular signal-related kinase (ERK)
activity was also shown to sensitize cells for TH-2 polarization under normally TH-1
polarizing circumstances (Yamane et al., 2005). As for a TH-2 polarizing antigen,
Schistosoma mansoni egg antigen was recently shown to contain a ribonuclease that
specifically impaired conjugate formation between dendritic cells and CD4 T cells,
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presumably lowering the strength of TCR signaling (Steinfelder et al., 2009). Based on
these findings, it is tempting to speculate that the activation defects observed in the
absence of RA/RARα may have a less pronounced impact on in vivo TH-2 responses.
Nevertheless, there is a notable correlation between the incidence of worm infection,
which requires a TH-2 response for effective expulsion (Paul and Zhu), and micronutrient
deficiencies, particularly in vitamin A (Koski and Scott, 2001). Importantly, epithelial cells
and accessory cells, such as basophils, often play critical roles in the initiation and
amplification of TH-2 responses in vivo (Anthony et al., 2007; Paul and Zhu). The
function of these cells may be dysregulated in the absence of RA/RARα signaling.
Multipotent progenitors and innate lymphoid cells, which are also important mediators of
TH-2 responses (Moro et al.; Neill et al.; Saenz et al.), may also be affected in these
conditions.

Based on the data reported above, a tentative model for the influence of
RA/RARα

in

mucosal

immunity

may

be

constructed.

Antigen

derived

from

food/environmental constituents, commensals or invasive pathogens is captured in the
lamina propria by antigen presenting cells, which include both migratory and resident
subsets. The migratory APC that captures antigen is the CD103+ lamina propria DC,
which is able to synthesize RA. The resident APC that captures antigen is CD103– and is
less capable to synthesize RA. How antigens captured by these cells end up being
transferred to and presented by the migratory CD103+ subset remain unclear, though it
may involve a mechanism such as exosomal transfer and apoptosis (Thery et al., 2009;
Trombetta and Mellman, 2005). Upon entry into the draining mesenteric lymph nodes,
CD103+ LpDC may form a cognate interaction with a naïve T cell constitutively
expressing RARα. RA secreted by LpDC may influence the phenotype of the T cell
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during activation, including the upregulation of mucosal homing markers and the
acquisition of Foxp3. Ultimately, however, the cytokines and costimulatory signals
elicited by the antigen and environment shape the polarity of the response (Figure 35, 1
versus 2). There is also a possibility that autocrine/paracrine interactions with RA
influence cytokine production by LpDC and contribute to the polarity of the response. For
instance, RA was shown to enhance TGF-β production by follicular DC, and may
potentially exert similar effects on LpDC (Figure 35, 3). As TGF-β is critical for the
development of both Foxp3+ Treg and TH-17 cells, this could explain why the induction of
both of these subsets is impaired in VAI mice. Nevertheless, these aspects are
secondary to the role of RA/RARα signals in controlling early T cell activation and
proliferation. The data in Chapter 4 also suggest that RA/RARα plays a role in
regulating tonic T cell signal transduction. Therefore, other sources of RA, including the
serum and stroma may be critical for the coordination of early T cell activation events
(Figure 35, 4).

Understanding	
  the	
  localization	
  of	
  RARα	
  will	
  provide	
  clues	
  into	
  how	
  it	
  regulates	
  
T	
  cell	
  activation.	
  
RARα is a complexly regulated protein, making it difficult to draw any immediate
conclusions on how precisely it regulates signaling events involved in T cell activation
and proliferation. In addition to it’s clear function as a transcriptional modifier, extranuclear activities of RARα have previously been noted in non-hematopoietic cells
(Rochette-Egly and Germain, 2009). For example, RARα has been described to interact
with the p85 subunit of phosphoinositide 3-kinase (PI3K) (Masia et al., 2007), which is
involved in activating the Akt pathway. Although, little is known about the steady-state
regulation and localization of RARα in T cells, a mechanism on par with this is at least
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consistent with the reduction of Akt phosphorylation observed upon activation of Rara–⁄–
T cells in Chapter 4. Of course, RARα has also been linked to other pathways involved
in T cell activation, most notably the AP-1 pathway. In particular, RARα has been shown
to induce expression of the phosphatase, MKP-1, which negatively regulates JNK
activity through both transcriptional dependent and independent means (Lee et al., 1999;
Xu et al., 2002). This in part explains the inhibitory effect of RA on AP-1 activity.
Although it is unclear whether RA/RARα positively regulates MKP-1 in T cells, loss of
this protein was shown to impair T cell activation, as well as TH-1 and TH-17 responses in
vivo (Zhang et al., 2009b). Importantly, proper regulation of JNK activity has also been
demonstrated to be crucial for T cell proliferation, where early over-activation promotes
cell death, while lack of activation promotes proliferation (Berger et al.; Dong et al.,
2000). Future studies on the role of RA/RARα in T cell function will benefit by a better
understanding of the localization and regulation of RARα, in addition to the target
molecular pathways.

Influence	
  of	
  RA	
  on	
  T	
  cell	
  responses	
  in	
  situ:	
  
The potential inhibitory effect of RA/RARα signaling on AP-1 activation in T cells
coupled with recent data showing that RA can curb cytokine production by
effector/memory T cells suggest that RA may down-modulate T cell activity in situ
(Figure 36, 1). RA may support yet another regulatory circuit, as previously discussed,
via activation of TGF-β in this tissue environment. In these ways, RA may contribute to
the preservation of tissue integrity and barrier protection. These regulatory effects may
promote the maintenance, functional differentiation, and/or expansion of Foxp3+ Treg and
also counter the risk of excessive responsiveness to bacteria lying in close apposition to
the epithelial barrier, such as SFB, the presence of which also depends on vitamin A
(Figure 36, 2 and 3). Although a recent report pointed out that deficiency in vitamin A
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can result in perturbations to the commensal microbiota, including the loss of SFB, a
comprehensive metagenomic analysis of the differences between commensal microbial
communities in vitamin A replete versus deficient hosts has not been undertaken. From
an evolutionary perspective, the model proposed here argues that vitamin A metabolism
may not only permit the propagation and survival of commensal bacterial species with
more immunostimulatory features, but also facilitates host evolutionary mechanisms to
tolerate these species.

Closing	
  Remarks:	
  

The experiments described in this thesis highlight the importance of commensal
DNA and retinoic acid in the promotion of mucosal immunity. Constitutive signals derived
from both of these cues were essential to the maintenance of T cell homeostasis in the
GI tract, without which adaptive mucosal immune responses could not proceed
efficiently. Although TLR9 signaling was revealed to possess a non-redundant function
in the GI tract, it was dispensable for immune responses to systemic challenge. In
contrast, RA was required for both mucosal and systemic adaptive immune responses
and was revealed to regulate the acquisition of effector T cell responses in a cell intrinsic
manner. Evolutionarily, these findings correspond with the compartmentalization of these
elements: where commensal DNA is typically restricted to the GI tract; while RA, through
robust storage and chaperone mechanisms, is able to traverse the entire body. Given
this ubiquity, the capacity of RA to induce both regulatory and inflammatory responses
also likely constitutes an adaptation. Overarchingly, these data support the premise that
the successful integration of commensal microbial and nutrient derived signals provides
a crucial immunological advantage to the host.
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Models:	
  

Figure 35. Retinoic acid in the induction of Foxp3+ Treg and helper T cell
responses.
(1) In the absence of an inflammatory stimulus, LpDC are poised to induce Foxp3+ Treg.
This process may occur in response to food or environmentally derived antigen (2)
Commensal microbiota potentially alter the ability of LpDC to induce Foxp3+ Treg. For
example, commensal derived DNA provide a potent tonic signal that favors the
development of various TH programs. Other inflammatory stimuli, especially invasive
pathogens, also lead to the induction of TH programs. These studies, in particular, were
focused on the development of adaptive TH-1 and TH-17 responses. (3) Migratory
CD103+ lamina propria DC possess classical DC functions, including the ability to
initiate T cell responses. Their polarizing capacity may be modified in situ via autocrine
or paracrine RA signaling. (4) RA/RARα signaling critically controls early T cell
activation and proliferation. Although LpDC derived RA is likely instrumental for
upregulation of mucosal homing molecules and acquisition of Foxp3, other sources,
including serum and stroma, may regulate T cell signal transduction events.
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Figure 36. Retinoic acid in the regulation of adaptive T cell responses and
composition in intestinal tissue
(1) RA can directly inhibit cytokine production by effector/memory T cells (Hill et al.,
2008). This metabolite was also shown to suppress T cell expression of IL-6R and IL23R, which may also down-modulate their effector capacity (Hill et al., 2008; Xiao et al.,
2008) (2) The ability of RA to promote the activation of TGF-β may also limit the
outgrowth of TH cells and promote Foxp3+ Treg activities and/or expansion. (3) Vitamin A
sustains the presence of certain commensal microbiota, including SFB, and may be an
important factor for establishing and maintaining commensal diversity.
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CHAPTER	
  6:	
  Material	
  and	
  Methods	
  	
  
General	
  methods:	
  
Mouse strains:
C57BL/6 (WT), B6.SJL (CD45.1), OTII transgenic, and OT-II transgenic RAG-1–/– mice
were purchased from Taconic Farms (Rockville, MD). Foxp3eGFP and DEREG mice were
originally obtained from Dr. M. Oukka (Bettelli et al., 2006) and Dr. T. Sparwasser (Lahl

et al., 2007), respectively, and bred in house. B6.129P2-Tlr9tmAki (Tlr9–/–) (Hemmi et al.,
2000) mice were obtained from Dr. S. Akira (Osaka University) via Dr. R. Seder (Vaccine
Research Center, NIH) and backcrossed 11 generations onto the C57BL/6 background
from Taconic Farms. OTII transgenic Foxp3eGFP mice were generated by crossing the F2
progeny of OTII x Foxp3eGFP breeders. Tlr9–/–Foxp3eGFP mice were generated by crossing
the F1 progeny of Tlr9–/– x Foxp3eGFP breeders. Tlr9–/–B6.SJL mice were generated by
crossing the F1 progeny of Tlr9–/– x B6.SJL breeders. Rarα–/– mice were a generous gift
of Dr. P. Chambon (Chapellier et al., 2002) and obtained via Dr. C. Benoist (Harvard
Medical School), then bred in house. Experiments with Rarb–/– and Rarg–/– mice were
performed under the guidance of Dr. N. Ghyselinck (igbmc, France). B6.129S6-Il6tm1Kopf
(Il-6–/–) mice were purchased from the Jackson Laboratory and B6.129P2-Myd88tmAki
(Myd88–/–) mice were kindly provided by Dr A. Sher.

All mice were bred and maintained under pathogen-free conditions at an American
Association for the Accreditation of Laboratory Animal Care accredited animal facility at
the NIAID and housed in accordance with the procedures outlined in the Guide for the
Care and Use of Laboratory Animals under an animal study proposal approved by the
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NIAID Animal Care and Use Committee. For each experiment, mice were gender, aged
and/or littermate matched. All mice were used between 9 and 13 weeks of age.

Vitamin A diet studies:
Vitamin A deficient (TD.09838, yellow) and sufficient (20,000 IU vitamin A/kg, TD.09839,
orange) diets were purchased from Harlan Teklad Diets. At day 14.5 of gestation,
pregnant females were administered either Vitamin A deficient or sufficient diet and
maintained on diet until weaning of litter. Upon weaning, females were returned to
standard Harlan chow, while weanlings were maintained on special diet until use. Diet
was replaced in feed hopper every 3-4 days to prevent degradation and stored at 4-8oC.
Diet stocks were stored in vacuum-sealed packages and discarded 3 weeks after
opening. For breeding, females were rested on a standard Harlan chow diet for at least 2
weeks prior to re-mating. After 3 birth cycles under the vitamin A deficient diet, females
were retired.

Tissue preparations:
Cells from Spleen (Sp) and mesenteric lymph nodes (mln), were prepared by teasing
and gently smashing the tissue through a 70-µm cell strainer with the rubber end of a
plunger from a 3ml syringe (BD).

In order to prepare small intestinal lamina propria (Lp) tissue cell suspensions, adventitial

fat was carefully stripped away from the whole small intestine. Peyer’s patches (Pp)
were then carefully excised, and the remaining tissue was cut longitudinally, extensively
washed in cold HBSS w/o Ca2+ and Mg2+ (cellgro), then cut into ~ 1cm segments.
Segments were treated with RPMI-1640 medium (Hyclone) containing: 3% FCS,
100µg/ml Penn/Strep, 25 mM HEPES (Hyclone), 50 µM β-mercaptoethanol (β-ME)
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(Gibco 1000X), 5mM EDTA, and 145 µg/ml of Dithiothreitol (DTT) for 20 min in an
incubator at 37ºC/5% CO2 with constant magnetic stirring.
IEL fraction: Tissue was then collected into a hand-held, fine mesh, sieve placed atop a
collection beaker on ice. The pieces were then collected and placed into a 50ml conical
containing 10-15ml of serum free media. Tissue was then further digested in serum free
media containing: 25 mM HEPES and 50 µM β-ME with liberase CI (200 µg/ml, Roche)
or liberase Tl (100 µg/ml, Roche) in conjunction with DNase I (500 µg/ml, Sigma-Aldrich)
under continuous magnetic stirring in an incubator at 37ºC/5% CO2 for 26-30 min.
Digested tissue was then immediately diluted in RPMI-1640 medium containing: 3%
FCS, 100µg/ml Penn/Strep, 25 mM HEPES and 50 µM β-mercaptoethanol, and serially
mashed through 70- and 40-µm cell strainers (BD Biosciences). Cell suspensions were
spun down and resuspended in complete RPMI-1640 medium (Complete) containing:
10% FBS, 100µg/ml Penn/Strep, 25mM HEPES, 2mM L-glutamine, 1 mM Na Pyruvate
(cellgro), 1X MEM nonessential amino acids (MEM) (cellgro) and 50 µM of β-ME – prior
to use.

For Pp preparations, lymphoid aggregates were treated with RPMI-1640 medium
containing: 3% FCS, 100µg/ml Penn/Strep, 25 mM HEPES, 50 µM β-ME, 5mM EDTA,
and 145 µg/ml of DTT for 20 min in an incubator at 37ºC/5% CO2. They were then
washed up-and-down several times with a 1ml pipette and strained from media, which
was then discarded. Next, tissue was resuspended with serum free RPMI-1640
containing: 25mM HEPES, 50 mM β-ME, liberase CI (100 µg/ml) or liberase Tl (50
µg/ml) and 150 µg/ml DNase I, minced, and digested for 20 min prior to serially
smashing through 70- and 40-µm cell strainers.
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CD4+ T cell purification for in vitro studies:
Sp and peripheral LNs were harvested, teased apart and gently passed through a 70µm
filter. After washing, cells were RBC lysed in ACK-lysis buffer (Lonza) for 1.5 min on ice,
washed again and then enriched for CD4+ T cells using a negative selection CD4 T cell
isolating kit and an autoMACs™ as outlined above. The enriched fraction was further
labeled with a mAb cocktail containing: α-CD4 (RM4-5), α-CD25 (7D4), α-CD44, (IM7)
and α-CD62L (MEL-14), where indicated. Cells were then sort purified on a
FACSVantage™ or FACSAria™. When eGFP reporter strains were used, eGFP+ cells
were also excluded. All antibodies were purchased from eBioscience.

CFSE labeling of T cells:
Cells were labeled at a final density of 1x107cell/ml in 1µM CFSE (CellTrace™ Kit,
Invitrogen) dissolved in HBSS w/o Ca2+ and Mg2+ for 7 min in an incubator at
37oC/5%CO2. Labeling was quenched by washing cells 2X in complete RPMI
supplemented with 30% FBS. Finally, cells were resuspended in ice-cold PBS for
adoptive transfer via tail vein injection or, alternatively, in complete RPMI as described
above for in vitro assays.

Dendritic Cell (DC) purification:
For LpDC, Lp tissue cell suspensions were obtained as described. Cells were then well
resuspended in a 1.077 g/cm3 iso-osmotic NycoPrep™ medium (Accurate Chemical &
Scientific Corp.) and gently overlaid with serum free media (one intestine: 5ml
NycoPrep™ medium + 2ml serum free media in 15ml conical). The low-density fraction
was collected after centrifugation at 1650 x g for 15 min with the brake off. Note: The
NycoPrep™ gradient excludes debris, red blood cells and decreases lymphocyte
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numbers without significantly altering the composition of the different subsets of LpDC.
Cells were then washed in 4 volumes of RPMI-1640 medium containing: 3% FCS,
100µg/ml Penn/Strep, 25 mM HEPES, 50 µM β-mercaptoethanol and incubated with a
mixture of mAb containing: blocking α-CD16/32 (2.4G2) and Rat IgG (Jackson
Immunoresearch); α-CD11c (HL-3), α-MHC II (I-Ab, AF6-120.1); a non-DC component
including, α-NK1.1 (PK136) and α-B220 (RA3-6B2); and the DNA intercalater 7-Aminoactinomycin D (7-AAD, eBioscience) in order to exclude dead cells. α-CD103 mAb (2E7)
was added in experiments where these cells were desired. All antibodies were
purchased from eBioscience unless noted. LpDC were defined as CD11c+MHCII+ cells
and were sort purified on a FACSVantage™ or FACSAria™. In some experiments
CD103+ and CD103– LpDC were separated. Purity was verified and always exceeded
90% or cells were not used.

For SpDC, Sp were thoroughly perfused with Liberase CI (100 µg/ml) and DNase I (150
µg/ml) in serum free media, prepared as described above using a tuberculin syringe
(BD). Perfused Sp were then cut into fragments and digested for 25 min in an incubator
at 37ºC/5% CO2. During the last 5 min, 5mM EDTA was added. Sp cell suspensions
were then gently smashed through a 70µm filter, washed, and enriched for mononuclear
cells using the NycoPrep™ gradient, as detailed for LpDC. Cells were subsequently
labeled using the CD11c+ magnetic bead positive selection kit (Miltenyi Biotec) per the
manufacturer’s instructions, washed, 40µm filtered, and ran through an autoMACs™
machine using the purification program, Posseld2. Cells were then washed and
incubated with a mixture of mAb containing: blocking α-CD16/32 (2.4G2), α-CD11c (HL3), α-MHC II (AF6-120.1), and 7-AAD. Labeled cells were sorted as described above to
purity resulting in > 98%.
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Flow cytometry:
All antibodies used were obtained from eBioscience unless specified otherwise. All cell
acquisition was performed using an LSRII machine with FACSDiVa software (BD
Biosciences). Data were analyzed using FlowJo software (TreeStar). To calculate
absolute numbers, the fraction of a particular subset to singlet gated, total living cells
was multiplied by the total cellularity of the tissue based on trypan blue exclusion.

Statistics:
Groups were compared with Prism software (GraphPad) using the unpaired or paired
Student’s t test.
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In vivo generation of Foxp3+ Treg (oral feeding protocol):
Cells were extracted from the mesenteric lymph nodes (mln) of OT-II transgenic RAG-1–
/–

mice and then adoptively transferred into B6.SJL (CD45.1) hosts. Alternatively, cells

were extracted from the spleen (Sp) and secondary LNs of OTII transgenic Foxp3eGFP
mice (CD45.2). They were then labeled using a negative selection CD4 T cell isolating
kit (Miltenyi Biotec) per the manufacturer’s instructions, washed, 40µm filtered, and ran
through an autoMACs™ on the sensitive mode to obtain highly enriched CD4 T cells.
These cells were labeled with a non-CD4+ T cell cocktail of mAb, including: blocking α
-CD16/32 (2.4G2), α-CD8α (53-6.7), α-NK1.1 (PK136), and α-B220 (RA3-6B2); and
α-CD25 (7D4). Cells were then sort purified on a FACSAria™ to obtain a pure
CD4+CD25–eGFP– population, subsequently labeled with CFSE, and then adoptively
transferred into 10 wk-old B6.SJL (CD45.1) hosts on diet study. In each case, recipients
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received 1x106 cells and were fed 1.5% OVA (grade V; Sigma-Aldrich) dissolved into
autoclaved drinking water for 5 consecutive days. Solution was replaced every 48 hrs.
Tissues were collected on day 6, and Foxp3 expression was assessed in transferred
cells by intracellular staining as detailed below.

Assessment of DC costimulatory activity:
MHC II+ CD11c+ DC were stained with the following fluorescent dye-conjugated mAb:
α-CD11b (M1/70), α-CD103 (2E7), α-CD40 (3/23, BD Biosciences), α-CD80 (16-10A1,
BD Biosciences) and α-CD86 (GL-1, BD Biosciences)

In vitro Foxp3+ Treg induction assay and analysis:
105 CD4+eGFP– T cells or CD4+CD25–CD62+CD44– naïve T cells from WT, OT-II, Rara–/–
, Rarb–/– or Rarg–/– mice were cultured with 2.5 x 103 – 2 x 104 purified Lp or SpDC in
250µl of complete medium (10% FBS, 25mM HEPES, 2mM L-glutamine, 100µg/ml
Penn/Strep, 1 µM Na Pyruvate, 1X MEM, 50 µM of β-ME) with soluble α-CD3ε mAb (1
µg/ml) (145-2C11, BD Bioscience) and recombinant hTGF-β (0.6 or 3 ng/ml) (Cell
Science or R&D Systems) for 5 days. For each Rar–/– mouse, the appropriate littermate
controls were used. The precise ratio of T cells to DC used is provided in the text. In
some experiments the following were included in the cococulture conditions:
1. All-trans retinoic acid (Sigma) or vehicle control at varying concentrations
2. Retinoic acid receptor inhibitors: LE540 (Wako Chemicals USA) and LE135
(Tocris Bioscience) or vehicle control. Each were added at 1µM
3. α-TGF-β mAb (1D11.16.8) or isotype control mAb MOPC (31C) (both from
ATCC) at 10µg/ml.
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All-trans retinoic acid, LE540 and LE135 were resuspended in Biotechnology
Performance Certified DMSO (Sigma). Human recombinant hIL-2 (5 ng/ml) (Peprotech)
was added to cultures wells every other day beginning on day 2. On day 5, cells were
stained with α-CD4 mAb (RM4-5) and 7-AAD, to discriminate live/dead cells. Foxp3+
cells were then detected either by eGFP expression and/or α−Foxp3 (FJK-16) following
fixation and permeabilization with the kit provided by eBioscience in accordance with the
manufacturerʼs protocol.

For viability assays, cultured cells were additionally stained with annexin V (BD
Biosciences) and 7-AAD (1:50) in annexin-V binding buffer (BD Biosciences) per
manufacturer’s instructions to detect dying/dead cells.

For phenotypic assessment, eGFP+CD4+ cells were further stained for α-CD103 (2E7) or
α-α4β7 (DATK32) mAb, α-CD25 (PC61.5) and 7-AAD. Live cells were analyzed by flow
cytometry.

In vitro suppression Assays:

Treg ability to suppress T cell proliferation was determined as previously reported
(Thornton and Shevach, 1998). Briefly, CD4+GFP+ Treg that were obtained after sorting
cells from SpDC cocultures, LpDC cocultures or ex vivo were cultured in 96-well flatbottom plates (Costar) with 5 x 104 freshly isolated CD4+GFP- T cells used as responder
T cells. For antigen presenting cells, splenocytes were depleted of CD90+ cells using a
positive selecting isolation kit and running through an autoMACs™. They were then
irradiated and cultured at 105 per well. Cells were stimulated with 0.5 µg/ml α-CD3 (145-
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2C11) mAb for 72 hours in an incubator at 37ºC/5% CO2. Cultures were pulsed with
[3H]TdR (MP Biomedicals, Solon, OH) at 1 µCi/well for the last 8 hours of culture.

Retinal dehydrogenase (RALDH) activity in DC:
Single-cell suspensions were incubated in ice-cold HBSS with blocking α-CD16/32
(2.4G2) and 0.2mg/ml Rat IgG, and stained with the following fluorochrome-conjugated
mAb: α-CD11c (N418), MHC II (M5/114.15.2), α-CD11b (M1/70), α-F4/80 (BM8), αCD103 (2E7) and α-TCR-β (H57-597) for 15min on ice. Surface labeled cells were then
washed and resuspended in 100µl of ALDEFLUOR assay buffer containing 1/100
ALDEFLUOR® reagent. Control wells were pre-incubated with (1/25) DEAB solution that
came with the kit. Samples were then stored in an incubator at 37oC/5% CO2 for 30min
away from light. Cells were then washed with 150ml of fresh ALDEFLUOR assay buffer,
centrifuged, and resuspended in 200ml of ALDEFLUOR assay buffer containing
0.3µg/ml DAPI (Sigma Aldrich) to discriminate living/dead cells. All reagents were
prepared according to the manufacturer’s protocol (STEMCELL Technologies).
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T cell phenotype:
Single-cell suspensions were stained with fluorochrome-conjugated to the following
antibodies: α-TCR-β (H57-597), α-CD4 (RM4-5), α-CD8α (53-6.7), α-CD25 (PC61.5) in
the presence of for 15min on ice. For examination of transcription factors and cellular
proliferation, cells were subsequently treated with the Foxp3 staining kit (ebioscience) in
accord with the manufacturer’s instructions and stained for 30-45 min on ice with Ki-67
(B56, BD Pharmingen), Foxp3 (FJK-16s), T-bet (eBio4B10) and/or RORγ(t) (AFKJS-9)
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or isotype controls: mouse IgG1 (BD Pharmingen) rat IgG2a (eBR2a), mouse IgG1
(clone P3) - in 1/100 α-mouse CD16/32 and 0.2mg/ml purified Rat IgG.

In vitro T cell/LpDC coculture assays:
CD4+eGFP– T cells or CD4+CD25–CD62+CD44– naïve T cells from Foxp3eGFP, Tlr9–/–
Foxp3eGFP, WT, Tlr9–/– or Myd88–/– mice were cocultured with purified LpDC at a 1:10 ratio in
complete medium, as described above, in Foxp3+ Treg cell polarizing conditions. These
conditions included soluble α−CD3 (1 µg/ml) (145-2C11) and rhTGF-β (0.6 ng/ml) (R&D

Systems). 5 ng/ml of rhIL-2 was supplemented in cocultures every 2 days. In experiments
detailed in Figure 17 the following were added to co-coculture conditions: a) peptidoglycan
(PGN, from Staphylococcus aureus), ultra-pure lipopolysaccharide (LPS, E. coli K12),
flagellin (Flgn, from S. typhimurium), ODN 1826 (CpG, 5ʼ-tccatgacgttcctgacgtt-3ʼ) at the
indicated concentrations. All were purchased from Invivogen. In experiments detailed in
Figures 20 and 21, various combinations of mAb including: α-IL-6 (MP5-20F3), α-IL-6R
(D7715A7), α-IL12/23p40 (C17.8), α-IL27p28 (R&D) and/or α-IFN-γ (XMG1.2 or 11B11), or
isotype controls α-IgG1κ (R3-34) and/or α-IgG2α (R35-95) were added at the initiation of
cocultures in Foxp3+ Treg cell polarizing conditions containing CpG (10 µg/ml). All antibodies
were purchased from BD Biosciences, excluding α-IL27p28, which was purchased from R&D
Systems. On day 5, cells were surface stained with the following fluorochrome-conjugated

antibodies: α-CD4 (RM4-5), α-α4β7 (DATK32), α-CD25 (PC61.5), and the viability marker 7AAD. Foxp3 cells were detected by eGFP expression and/or α−Foxp3 (FJK-16) following
fixation and permeabilization with the kit provided by eBioscience in accordance with the
manufacturerʼs protocol.
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ELISA:

Upon harvest of coculture supernatants, IL-4, IL-10, IFN-γ and IL-17A were quantitated
with the DuoSet® ELISA system (R&D Systems) per the manufacturer’s instructions.

Gut flora DNA extraction:
Gut contents from the caecum and the colon of naïve C57BL/6 mice were collected and
washed in cold PBS. The pellet was resuspended in lysis buffer (10 mM Tris/HCl, 50 mM
EDTA, pH 8.0) containing lysozyme (0.5 mg/ml; Sigma-Aldrich). After incubation at 37°C for
2 h, 2 mg/ml of proteinase K and 1% SDS were added and the sample incubated at 60°C for
3 h. DNA was then purified by a series of 7 consecutive phenol-chloroform-isoamyl alcohol
affinity extractions.

Intracellular cytokine staining of ex vivo isolated cells from naïve mice:
For assessment of CD4+ T cells from WT Foxp3eGFP and Tlr9–/–Foxp3eGFP mice, cell
suspensions were enriched for T cells by incubating with CD90.2 positive selecting
magnetic beads (Miltenyi Biotec) in accordance with the manufacturer’s protocol. T cells
were obtained by running the labeled suspension through an autoMACs™ on the
program Posseld2. Enriched T cell suspensions were then mitogenically stimulated with
phorbol 12-myristate 13-acetate (PMA, 50ng/ml) + ionomycin (5µg/ml) for 4 hours in UBottom 96-well plates containing complete (200µl/well) media and Brefeldin A (BFA,
GolgiPlug™). Residual DMSO was then washed from wells and cells were incubated
with 1/500 of Molecular Probes LIVE/DEAD® Fixable Blue Dead cell stain kit (Invitrogen)
in HBSS according to the manufacturer’s guidelines to distinguish healthy from dying
cells, and subsequently fixed in 1.6% paraformaldehyde (PFA, Electron Microscopy
Sciences) prior to staining intracellularly for cytokines. For intracellular cytokine staining,
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cells were stained with the following fluorochrome-conjugated antibodies: α-TCR-β, αCD4, α-CD8α, α-IFN-γ (XMG1.2), α-IL-17A (eBio17B7), α-IL-10 (JES5-16E3) or isotype
controls: rat IgG1, rat IgG2a, ratIgG2b, and mouse IgG1 (clone P3) in the presence of αmouse CD16/32 and 0.2mg/ml of Rat IgG for 45 min on ice in FACS buffer containing

0.5% saponin from Quillaja bark (Sigma).

E. cuniculi infection Protocol:
Parasite cultivation: A rabbit isolate of E. cuniculi was obtained from Waterborne Inc.
and used throughout the study. The parasites were maintained by continuous passage
in rabbit kidney (RK13) cells obtained from the American Type Culture Collection (ATCC
#CCL37) and maintained as previously described (Bouladoux et al., 2003).

For infection: Spores were resuspended in sterile PBS, and immediately used for
inoculation of mice or cell cultures. Mice were infected by intragastric gavage with 5×106
fresh spores in a volume of 200 µl. In some experiments, mice were infected i.p. using
the same number of spores of E. cuniculi.

For CD25+ cell depletion: C57BL/6 and Tlr9−/− mice were injected i.p. with 0.5 mg of antiCD25 (clone PC61.5) or the corresponding isotype control (clone GL113) 3 days
preceding and on day 0 and day 7 of infection.

Quantification of E. cuniculi in tissues:
Duodenum (1cm piece starting at 3cm) and liver (weighed out piece from same lobe)
were removed from infected mice and instantly snap frozen in liquid nitrogen. Tissues
were next homogenized and then digested with proteinase K (Invitrogen or Qiagen).
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DNA was subsequently extracted either with phenol-chloroform-isoamyl alcohol followed
by ethanol precipitation or with the DNeasy® Tissue kit from Qiagen. Quantitative
real-time PCR was performed in triplicates with 50 ng of total tissue DNA, the iQ SYBR
Green Supermix (BioRad), and the following primers specific for a 268-bp DNA
sequence of the SSU rRNA gene from E. cuniculi (Weiss and Vossbrinck, 1998): forward
5’-GTGAGACCCTTTGACGGTGT-3’ and reverse 5’-CTCAGACCTTCCGATCTTCG-3’.
Real-time PCR was conducted on a Bio-Rad iCycler under the following conditions:
3 min at 95°C; 40 cycles of: 45 s at 95°C, 60 s at 60°C, and 45 s at 72°C. Genomic DNA
were extracted from known amounts of E. cuniculi with the QIAamp DNA stool mini-kit
(Qiagen) and used as PCR standards. A standard curve was generated by linear
regression on plotted cycle threshold (CT) values of the standards against the logarithms
of parasite numbers using iCycler iQ Optical System software (version 3.1; Bio-Rad).

In vitro recall assay to E. cuniculi

Single-cell suspensions of Sp, mln, IEL, Lp, and Pp of vaccinated or E. cuniculi-infected mice
were prepared as described above. BMDC were generated as previously described (Lutz et
al., 1999). Leukocytes (5×105) were incubated with 1×105 BMDC in 250 µl RPMI, 55 mM
2-β mercaptoethanol, and 10% FBS per well of a 96-well U-bottom plate. BMDC were
previously incubated for 8 hrs with or without recombinant vaccinia virus expressing OVA
protein (10 pfu / BMDC), E. cuniculi spores (parasite:BMDC ratio, 10:1) or OVA peptide (1
µg/ml) in the presence of 20 ng/ml GM-CSF (Peprotech) and washed before culture with
leukocytes. After 3 days at 37°C in 5% CO2, culture supernatants were collected for cytokine
assays. IFN-γ, IL-4, IL-6, IL-10, and IL-17 were quantitated in culture supernatants of
restimulated leukocytes using the DuoSet® ELISA system.
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Antibiotic treatment:

3-wk or 8-wk-old C57BL/6 male mice were provided ampicillin (1 g/l), vancomycin
(500 mg/l), neomycin trisulfate (1 g/l), and metronidazole (1 g/l) in drinking water as
previously described (Rakoff-Nahoum et al., 2004). All antibiotics were purchased from
Sigma-Aldrich. Where indicated, mice also orally received: 100 µg CpG ODN 1826 in
sterile PBS (Coley Pharmaceutical) or 500 µg of extracted gut floral DNA in sterile water
or 25 mg/kg of LPS from Escherichia coli (serotype 026:B6 from Sigma-Aldrich) once
weekly from the start of the antibiotic course.

Chapter	
  4:	
  
T cell phenotype:
Single-cell suspensions were incubated in ice-cold HBSS with 1/100 α-mouse CD16/32,
1/500 LIVE/DEAD® to exclude dead cells, and stained with the following fluorochromeconjugated antibodies: α-TCR-β (H57-597), α-CD4 (RM4-5), α-CD8α (53-6.7), α-CD25
(PC61.5), α-CD44 (IM7), α-CD62L (MEL-14), α-CD103 (2E7), and α-α4β7 (DATK32) for
15min on ice. For examination of transcription factors and cellular proliferation, cells
were subsequently treated with the Foxp3 staining kit (eBioscience) in accord with the
manufacturer’s instructions and stained for 30-45 min on ice with Ki-67 (B56, BD
Pharmingen), Foxp3 (FJK-16s), T-bet (eBio4B10) and/or RORγ(t) (AFKJS-9) or isotype
controls: mouse IgG1 (BD Pharmingen) rat IgG2a (eBR2a), mouse IgG1 (clone P3) - in
1/100 α-mouse CD16/32 and 0.2mg/ml purified Rat IgG.

E. coli LT (R129G)Vaccine Protocol:
For vaccination, mice were orally inoculated with an isotonic bicarbonate buffer (7.5%,
200µl/mouse). 10min later, mice were gavaged with a 200µl mixture of 1mg of OVA and
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20 µg of the mutant form of E. coli LT (R129G) prepared in the same buffer. For
reconstitution experiments with RA, mice were vaccinated again on day 4. Immune
responses were then assessed on day 8. For all other experiments, mice were
vaccinated once per week and immune responses were assessed one week after the
final challenge.

T. gondii Infection Protocol:
The parental ME-49 type II strain (ATCC no. 50840) (American Type Culture Collection,
Manassas, VA, USA) of T. gondii was electroporated with RFP and selected for red
fluorescence. ME-49 clone C1 was established and passed through mice. To obtain
tissue cysts, brains were removed from C57BL/6 mice that were inoculated with three
cysts by gavage 1–2 months prior and homogenized in 1 ml of phosphate buffer saline
(pH 7.2). Cysts were counted on the basis of 2 aliquots of 20 µl. Diet study mice were
infected orally with 10 cysts at 9.5-11.5 wks of age. STAg was prepared as previously
described (Grunvald et al., 1996).

Parasite Burden:
Human fibroblast (Hs27; ATCC no. CRL-1634) cultures were used to quantify parasite
burden as described previously (Pfefferkorn and Pfefferkorn, 1976) and (Roos et al.,
1994). In brief, titrations of single-cell tissue suspensions (1x104 up to 1x106 cells) were
added onto confluent fibroblast monolayers cultured in DMEM (Sigma) supplemented
with 100mg/ml Penn/Strep and 10% FBS (in 24-well plates). Plaques were detected by
fluorescence using an Axiovert 40 inverted microscope (Zeiss) outfitted with an RFP
filter. Titration results are reported in Plaque Forming Units (PFUs).

In vivo RA reconstitution:
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250µg of all-trans-RA (Sigma Aldrich), resuspended in 30µl of Biotechnology
Performance Certified DMSO was administered intraperitoneally to vitamin A insufficient
(VAI) mice every other day. 24hrs after the 3rd injection, mice were infected with T. gondii
or vaccinated. Injection of RA continued until takedown of the mice. Mice not receiving
RA, received DMSO vehicle instead. RA was stored at -80oC in pure DMSO in amber
ependorf tubes. Aliquots were one use only.

Intracellular cytokine staining:
Tissues were harvested from infected or vaccinated mice, pooled by group, and
enriched for T cells by incubating with CD90.2 selecting magnetic beads (Miltenyi) in
accord with the manufacturer’s protocol. T cells were obtained by running the labeled
suspension through an Automacs (Miltenyi) on the program Posseld2. For T. gondii, T
cells (2.5x105) were incubated with irradiated BMDCs (5x104) ± STAg (5mg/ml). For
vaccine, T cells (2.5x105) were incubated with SpDC (5x104) ± OVA (100mg/ml)
(Worthington). Cells were cultured for 14 hrs in an incubator at 37oC/5%CO2 in
250µl/well in 96-well flat bottom plates. BFA was added for the final 7 hrs of culture.
Cells were washed with FACS buffer and stained with 1/500 LIVE/DEAD® fixable Blue
Dead cell stain kit in HBSS on ice for 15min. After washing 1X with FACS buffer, cells
were fixed with 1.6% PFA for 20 min at room temp. For intracellular cytokine staining,
cells were stained with the following fluorochrome-conjugated antibodies: α-TCR-β, αCD4, α-CD8α, α-IFN-γ (XMG1.2), α-IL-17A (eBio17B7), α-Foxp3 (FJK-16), α-T-bet
(eBio4B10), or isotype controls: rat IgG1, rat IgG2a, and mouse IgG1 (clone P3) in the
presence of α-mouse CD16/32 and 0.2mg/ml purified Rat IgG for 45 min on ice in FACS
buffer containing 0.5% saponin. All antibodies were purchased from eBioscience.
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ELISA:
Tissues were harvested from infected or vaccinated mice, pooled by group, and
enriched for T cells as described above. For T. gondii, T cells (2.5x105) were incubated
with irradiated day-6 BMDCs (5x104) ± STAg (5mg/ml) in 250ml/well in 96-well round
bottom plates for 48 hrs at 37oC, 5% CO2. For vaccine, T cells (2.5x105) were incubated
with day-7 BMDCs (5x104) that had been infected or not for 8hrs with recombinant
vaccinia virus expressing OVA (MOI 10:1) for 72hrs at 37oC, 5% CO2. Upon harvest of
supernatants, IFN-γ and IL-17A was quantitated with the DuoSet® system. In initial
vaccine experiments, pooled suspensions were not T cell enriched, but rather cultured at
5x105 cells to 1x105 infected or uninfected BMDCs.

CD4+ T cell activation/ polarization assays:
Cells were extracted from the Sp and secondary LNs of Rarα–/– or littermate WT mice
and enriched for CD4+ CD62Lhi T cells using the CD4+ CD62Lhi T cell isolation kit II
(Miltenyi Biotec) in accordance with the manufacturer’s protocol. For magnetic selection
steps, cells were 40µm filtered and subsequently passed through manual columns. Cells
were then CFSE labeled as described above, plated in complete media at 3.38-3.5x105
cells/well into 96-well flat bottom plates, and stimulated with 1µg/ml of plate-bound αCD3ε (BD Pharmingen, 145-2C11, coated over night in 100ml at 4oC) + soluble α-CD28
(BD Pharmingen, 37.51) + 50U of rhIL-2 (Peprotech). To assess activation, cells were
harvested after 18hrs and stained for CD4, CD25, CD69 (H1.2F3), and CD71 (R17217)
in HBSS containing 1/500 of the LIVE/DEAD® stain kit, 1/100 of blocking α-CD16/32,
and 0.2mg/ml purified Rat IgG for 15 min on ice. Expression of markers was compared
to unstimulated cells. To assess polarization, cells were further cultured in TH-1 or TH-17
(no rhIL-2) biased conditions, which included: purified α-IL-4 (11B11) + 10ng/ml of rmIL-
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12; or purified α-IL-4 + α-IFN-γ (R4-6A2) + 20ng/ml rmIL-6 + 0.7ng/ml rhTGF-b,
respectively. All cytokines, except hIL-2, were purchased from R&D Systems. 48hrs
post-activation, half the supernatant from each well was removed and measured for the
cytokines (IFN-γ and IL-17A) by ELISA. Complete media, including polarizing cytokines
+ blocking antibodies were replenished as cells were removed from αCD3ε and
transferred into 96-well round bottom plates for 24hrs. CFSE proliferation was then
measured.

Real-time quantitative PCR:
Naïve CD4+ T cells were purified from splenic and peripheral LN of 2 mice/assay. RNA
was then extracted with RNAeasy columns (QIAGEN) and analyzed by quantitative RTPCR according to the manufacturer's instructions using primers for murine Rara, Rarb,
and Rarg (QIAGEN).

Immunoblotting and Reagents:
Lysates were immunoblotted with the following antibodies: anti-phosphoSer473Akt and
anti-Akt (Cell Signaling Technology).
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